Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003888	s-timotee	u/ml (u/ml)	4424	4784	0.04%
3003888	s-timotee	— (—)	3698	3847	100.00%	Distribution not available
3003888	timotei	— (—)	523	544	100.00%	Distribution not available
3003888	timotei	u/ml (u/ml)	212	220	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dermatitis and eczema

2345

5923

2.50

320.61

1.1

6.07

5.32

u/ml

1.17

1411

2882

Asthma (only as main-diagnosis)

2454

2524

5.88

307.65

1.1

1.0

5.50

5.16

u/ml

0.32

1573

1030

Asthma, hospital admission 2, infections

1609

4035

4.05

307.65

1.1

5.81

5.99

u/ml

0.14

1081

1931

Asthma

2521

2524

5.45

307.65

1.1

1.0

5.60

5.16

u/ml

0.44

1586

1030

Other diseases of upper respiratory tract

2178

3961

2.92

307.65

1.1

1.0

6.38

5.00

u/ml

2.38

1313

1755

Desensitization to allergens

558

680

10.39

307.65

1.1

10.21

6.52

u/ml

3.19

443

387

Conjunctivitis

2036

6050

2.90

307.65

1.1

6.86

5.33

u/ml

3.38

1394

2952

Asthma, excluding more controls

2492

2489

5.44

307.65

1.1

1.0

5.61

5.22

u/ml

0.38

1575

1016

Chronic rhinitis, nasopharyngitis and pharyngitis

866

1923

4.69

307.65

1.1

1.0

4.38

4.47

u/ml

0.06

506

860

Asthma and allergy

1029

991

11.78

307.65

1.2

1.0

6.83

6.55

u/ml

0.14

814

439

Asthma-related infections

1609

4035

4.05

307.65

1.1

5.81

5.99

u/ml

0.14

1081

1931

Disorders of conjunctiva

2079

6216

2.76

307.65

1.1

6.83

5.26

u/ml

3.58

1415

3017

Atopic dermatitis

1854

5043

3.13

307.65

1.1

7.16

5.73

u/ml

2.50

1201

2500

Vasomotor and allergic rhinitis

2205

2947

8.07

307.65

1.1

1.0

7.61

5.32

u/ml

5.34

1582

1369

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1709

5058

3.42

307.65

1.1

7.13

5.29

u/ml

3.86

1204

2378

Chronic lower respiratory diseases

3370

5095

3.63

307.65

1.1

5.56

5.95

u/ml

0.51

2043

2427

Allergic asthma (mode)

1374

1585

9.31

307.65

1.1

1.0

6.16

6.11

u/ml

0.03

1053

690

Asthma and allergy, excluding more controls

1031

1005

11.64

307.65

1.2

1.0

6.81

6.57

u/ml

0.12

816

454

Asthma/COPD (KELA code 203)

2703

5065

3.78

307.65

1.1

5.11

5.96

u/ml

1.51

1648

2414

Asthma (only as main-diagnosis), excluding more controls

2440

2489

5.86

307.65

1.1

1.0

5.52

5.22

u/ml

0.27

1569

1016

Asthma (mode)

2532

2533

5.58

307.65

1.1

1.0

5.60

5.14

u/ml

0.47

1600

1033

Asthma (diagnoses ohter than nonallergic)

2737

5644

4.18

307.65

1.1

5.45

5.88

u/ml

0.56

1810

2635

1400

3394

4.28

307.65

1.2

1.1

5.82

6.35

u/ml

0.46

946

1674

Chronic sinusitis

980

2509

4.03

307.65

1.1

1.0

3.47

4.17

u/ml

0.96

573

1076

Allergic conjunctivitis

1762

5361

3.33

307.65

1.1

7.09

5.38

u/ml

3.56

1239

2547

Asthma, unspecified (mode), excluding more controls

1118

2186

3.93

307.65

1.1

1.0

5.02

4.87

u/ml

0.09

607

874

Atopic dermatitis, strict definition with reimbursement

1168

3305

3.59

307.65

1.2

1.1

7.79

6.42

u/ml

1.58

845

1697

Asthma, hospital admissions , main diagnosis only

2633

5792

4.18

307.65

1.1

5.55

5.80

u/ml

0.28

1729

2741

Asthma, including avohilmo

3656

4756

4.48

307.65

1.1

5.65

5.91

u/ml

0.30

2183

2253

Pollen allergy

1708

2100

9.56

307.65

1.2

1.1

8.13

5.92

u/ml

3.61

1287

1071

Allergic rhinitis

2126

2943

8.04

307.65

1.2

1.1

7.75

5.52

u/ml

4.80

1548

1386

Allergic asthma (mode), excluding more controls

1374

1582

9.32

307.65

1.1

1.0

6.16

6.10

u/ml

0.04

1053

689

Asthma, unspecified (mode)

1122

2210

3.92

307.65

1.1

1.0

5.02

4.83

u/ml

0.11

608

883

Nasal polyp

483

734

6.89

303.91

1.2

1.0

3.10

4.81

u/ml

1.59

322

312

Suggestive for eosinophilic asthma

328

323

11.00

296.75

1.2

1.0

2.99

5.41

u/ml

1.24

235

143

Obesity related asthma

771

1890

4.22

281.49

1.1

4.31

5.09

u/ml

0.66

436

822

Other pulmonary diagnosis

1460

2561

2.91

247.76

1.1

1.0

6.04

5.25

u/ml

0.75

835

1047

Atopic dermatitis, strict definition

1116

3716

3.09

246.96

1.1

7.92

6.50

u/ml

1.66

815

1986

ILD differential diagnosis

1436

2533

2.89

241.33

1.1

1.0

6.12

5.14

u/ml

1.00

821

1033

COPD differential diagnosis

1435

2534

2.89

240.73

1.1

1.0

6.12

5.14

u/ml

1.00

821

1033

Excluding asthma or asthma-COPD overlap

1437

2561

2.86

237.28

1.1

1.0

6.09

5.25

u/ml

0.81

821

1047

Cough

918

2693

3.32

232.83

1.1

4.60

5.99

u/ml

1.43

516

1344

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

925

2933

3.13

216.08

1.1

1.0

5.35

4.42

u/ml

0.90

509

1251

Childhood asthma (age<16)

580

1062

4.56

212.50

1.1

1.0

8.25

7.21

u/ml

0.50

404

519

Childhood asthma (age<16), excluding more controls

580

1063

4.55

212.09

1.1

1.0

8.25

7.21

u/ml

0.50

404

519

Oral corticosteroids

1989

5507

2.18

197.68

1.1

5.14

5.43

u/ml

0.29

1170

2696

ILD medications: prednisolone, methylprednisolone, prednisone

2092

5621

2.11

190.38

1.1

5.65

5.64

u/ml

0.01

1216

2819

Biological medicines for asthma

166

123

17.15

184.34

1.3

1.1

2.99

7.30

u/ml

1.41

119

Diseases of the respiratory system

1066

1895

2.86

176.96

1.1

1.0

6.16

5.30

u/ml

0.65

590

785

Asthma-related pneumonia

615

1779

3.53

175.75

1.1

5.60

6.07

u/ml

0.25

414

837

Asthma-related pneumonia or sepsis

616

1787

3.52

175.24

1.1

5.59

6.03

u/ml

0.23

415

844

Asthma, hospital admissions 3, pneumonia

616

1787

3.52

175.24

1.1

5.59

6.03

u/ml

0.23

415

844

Undetermined asthma

299

535

5.81

159.47

1.1

1.0

4.09

5.18

u/ml

0.48

174

219

Undetermined asthma, excluding more controls

299

536

5.80

159.16

1.1

1.0

4.09

5.23

u/ml

0.51

174

217

Abnormalities of breathing

1771

5037

2.07

155.18

1.1

5.26

6.25

u/ml

1.52

1009

2593

Childhood allergy (age < 16)

728

2056

3.11

154.06

1.2

1.1

8.59

8.39

u/ml

0.09

543

1178

ILD medications

2095

5929

1.94

150.81

1.1

5.63

5.86

u/ml

0.22

1228

3023

Inflammatory bowel disease treatment related agents

2072

6118

1.92

145.48

1.1

5.47

5.73

u/ml

0.25

1192

3112

Deviated nasal septum

494

1478

3.41

134.19

1.1

1.0

4.15

4.77

u/ml

0.40

272

629

Adverse effects, not elsewhere classified

576

1914

3.14

133.27

1.1

5.03

5.71

u/ml

0.49

413

1031

First line medication for Crohn's disease

2012

5841

1.89

132.96

1.1

5.61

5.88

u/ml

0.25

1172

2985

Chronic diseases of tonsils and adenoids

1305

3846

2.18

132.29

1.1

1.0

6.05

5.07

u/ml

0.97

724

1722

Symptoms and signs involving the circulatory and respiratory systems

1920

5068

1.92

131.89

1.1

5.53

6.27

u/ml

0.98

1085

2609

FESS (DNB20)

339

839

4.24

123.29

1.2

1.1

2.70

5.36

u/ml

3.78

213

424

Ethmoidectomy

342

869

4.12

119.94

1.2

1.1

2.67

5.38

u/ml

3.92

215

438

Dermatitis due to ingested food

269

564

5.30

116.96

1.3

1.1

7.07

7.91

u/ml

0.27

225

343

Urticaria

737

3025

2.51

112.61

1.1

4.80

5.58

u/ml

0.73

475

1620

Urticaria and erythema

802

3542

2.32

103.51

1.1

4.80

5.55

u/ml

0.76

515

1871

Other medical care

662

2389

2.53

102.89

1.1

9.70

4.82

u/ml

7.90

495

1165

Other and unspecified effects of external causes

685

2874

2.45

99.87

1.1

5.03

6.31

u/ml

1.33

468

1560

Non-allergic asthma (mode)

313

837

3.79

99.58

1.1

1.0

2.73

5.24

u/ml

2.07

150

361

Non-allergic asthma (mode), excluding more controls

313

845

3.75

98.22

1.1

1.0

2.73

5.18

u/ml

2.01

150

365

Personal history of allergy to analgesic agent

27.57

97.81

1.5

1.1

1.83

5.94

u/ml

1.17

Diseases of the skin and subcutaneous tissue

1620

4569

1.80

91.01

1.1

6.09

5.59

u/ml

0.48

964

2174

Dyspnoea

1351

5456

1.85

90.94

1.1

5.06

4.95

u/ml

0.10

779

2735

Personal history of allergy to drugs, medicaments and biological substances

13.08

82.60

1.4

1.1

2.31

5.50

u/ml

1.01

Acute upper respiratory infections

1605

5790

1.72

82.40

1.1

5.53

5.60

u/ml

0.04

877

2948

Allergic contact dermatitis

313

1000

3.24

77.45

1.1

5.86

5.03

u/ml

0.33

178

476

Polypectomy (DHB20)

155

299

5.44

76.72

1.2

1.1

2.13

6.47

u/ml

2.84

106

143

Acute sinusitis

946

4703

1.89

70.64

1.1

5.43

5.79

u/ml

0.23

530

2417

Diseases of the eye and adnexa

1544

4625

1.69

70.33

1.1

6.91

5.64

u/ml

1.57

941

2290

Acute upper respiratory infections of multiple and unspecified sites

1262

5469

1.73

67.92

1.1

5.65

5.79

u/ml

0.10

701

2821

Any reimbursement code in KELA

1275

3664

1.77

67.66

1.1

6.26

5.96

u/ml

0.22

761

1827

Insomnia

1441

6366

1.67

67.49

1.1

5.56

5.82

u/ml

0.22

728

3295

Dermatitis

824

4298

1.93

67.13

1.1

4.76

4.89

u/ml

0.09

467

2024

Sleep disorders

1441

6399

1.64

63.95

1.1

5.53

5.80

u/ml

0.23

738

3327

Other and unspecified urticaria

443

1889

2.41

62.57

1.1

4.54

5.85

u/ml

1.10

278

1014

Medical observation and evaluation for suspected diseases and conditions

1064

3032

1.81

62.20

1.1

5.44

5.80

u/ml

0.27

651

1474

Other and unspecified dermatitis

693

3536

1.98

61.07

1.1

4.49

4.91

u/ml

0.30

395

1683

1643

5354

1.60

61.05

1.1

5.12

5.60

u/ml

0.50

890

2676

Sleep apnoea, including avohilmo

1349

5096

1.65

59.74

1.1

4.19

5.13

u/ml

1.44

656

2589

D07AA Corticosteroids, weak (group I)

415

1762

2.43

59.23

1.2

1.1

7.73

6.12

u/ml

1.08

305

1008

Bronchitis

1616

6529

1.57

58.37

1.1

5.99

5.65

u/ml

0.27

894

3336

Sleep disorders (combined)

1680

5713

1.56

55.92

1.1

5.36

6.10

u/ml

0.92

842

3039

Behavioural syndromes associated with physiological disturbances and physical factors

1458

6631

1.57

54.07

1.1

5.47

5.90

u/ml

0.42

764

3494

Asthma mixed form (mode)

102

196

5.38

50.62

1.1

1.0

4.70

5.12

u/ml

0.10

Asthma mixed form (mode), excluding more controls

102

196

5.38

50.61

1.1

1.0

4.70

5.12

u/ml

0.10

Diarrhoea and gastroenteritis of presumed infectious origin

1525

6608

1.53

49.95

1.1

5.50

5.70

u/ml

0.17

838

3437

Pain in joint

935

3507

1.72

48.04

1.1

5.39

6.22

u/ml

0.72

513

1877

Examination and observation for other reasons

901

3021

1.74

47.75

1.1

5.24

5.75

u/ml

0.31

511

1465

Voice disturbances

380

1711

2.26

47.04

1.1

4.09

4.85

u/ml

0.44

203

828

Chronic laryngitis and laryngotracheitis

174

527

3.37

46.89

1.1

1.0

5.56

3.92

u/ml

0.49

211

Early onset COPD, excluding more controls

179

555

3.26

46.21

1.1

1.0

4.91

3.07

u/ml

0.60

100

191

Dentofacial anomalies [including malocclusion]

1207

6245

1.57

45.10

1.1

6.51

5.49

u/ml

1.00

662

3279

Headache

1111

5607

1.60

45.04

1.1

5.58

5.94

u/ml

0.28

585

2925

Idiopathic urticaria

162

5.80

44.39

1.2

1.1

4.22

5.25

u/ml

0.28

Migraine

957

4777

1.64

43.52

1.1

5.22

6.50

u/ml

1.56

524

2531

Other special examinations and investigations of persons without complaint or reported diagnosis

990

3032

1.67

43.52

1.1

6.37

5.80

u/ml

0.38

542

1474

Special screening examination for infectious and parasitic diseases

557

2149

1.94

43.47

1.1

1.0

5.31

6.49

u/ml

0.97

339

1035

Asthma and opportunity respiratory infection

7.11

43.41

1.1

1.0

2.00

6.49

u/ml

1.09

Sleep apnoea

1163

4824

1.57

42.65

1.1

3.90

4.95

u/ml

1.65

566

2424

Migraine, single triptan purchase ok & required. ICD-code if available is included

1293

5836

1.51

40.21

1.1

5.96

6.09

u/ml

0.09

670

3080

Triptan medication for migraine, single purchase ok

1293

5836

1.51

40.21

1.1

5.96

6.09

u/ml

0.09

670

3080

Symptoms and signs involving speech and voice

414

2058

2.04

39.64

1.1

4.04

4.80

u/ml

0.49

219

1011

Other acute lower respiratory infections

763

4376

1.68

38.81

1.2

1.1

6.17

6.05

u/ml

0.07

470

2385

Bronchiectasis

145

5.34

37.95

1.1

1.93

5.89

u/ml

1.62

Recurrent or chronic depression

663

2703

1.74

36.84

1.1

5.33

5.95

u/ml

0.43

353

1421

COPD/asthma/ILD related infections

1477

5099

1.46

36.43

1.1

5.47

5.57

u/ml

0.08

798

2563

COPD/asthma related infections

1477

5099

1.46

36.43

1.1

5.47

5.57

u/ml

0.08

798

2563

Dermatographic urticaria

164

564

3.02

36.20

1.2

1.1

2.92

5.63

u/ml

2.19

294

Depression or dysthymia

904

3120

1.61

35.70

1.1

5.45

5.81

u/ml

0.24

470

1643

Neurotic, stress-related and somatoform disorders

1371

6641

1.46

35.39

1.1

5.62

5.82

u/ml

0.16

777

3416

Anxiety disorders

1373

6647

1.45

34.79

1.1

5.61

5.81

u/ml

0.17

780

3416

Episodal and paroxysmal disorders

1652

5997

1.41

34.02

1.1

5.39

6.15

u/ml

0.98

879

3230

Any death

2257

0.30

33.09

1.0

1.1

2.79

3.80

u/ml

0.32

1098

Intestinal infectious diseases

1589

6492

1.41

32.98

1.1

5.22

5.73

u/ml

0.49

857

3367

Gastro-oesophageal reflux disease

831

4571

1.58

32.94

1.1

4.25

4.85

u/ml

0.56

398

2326

Temporomandibular joint disorders, including avohilmo

793

5020

1.58

31.37

1.1

5.88

6.04

u/ml

0.09

439

2601

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

649

1939

1.69

30.45

1.1

6.02

6.75

u/ml

0.43

343

1036

Pain in throat and chest

1129

4634

1.47

30.36

1.1

4.86

6.05

u/ml

1.55

608

2347

COPD

250

922

2.23

29.59

1.0

4.24

3.64

u/ml

0.19

124

364

Persons encountering health services for examination and investigation

922

3032

1.54

29.16

1.1

6.14

5.80

u/ml

0.21

517

1474

Malignant neoplasm

504

4995

0.59

28.56

1.1

5.05

4.49

u/ml

0.31

225

2534

Irritable bowel syndrome

417

2322

1.82

28.54

1.1

4.56

5.58

u/ml

0.77

215

1194

Covid-19 suspected case

419

2348

1.82

28.23

1.1

5.27

6.22

u/ml

0.46

207

1264

Pain (limb, back, neck, head abdominally)

1068

3656

1.47

27.78

1.1

6.18

6.01

u/ml

0.10

581

1999

Other headache syndromes

595

3672

1.63

27.75

1.1

4.92

5.26

u/ml

0.20

323

1841

Provisional assignment of new diseases of uncertain etiology

729

4722

1.55

27.53

1.1

5.30

5.86

u/ml

0.38

379

2511

Speech therapy

297

1503

2.00

27.26

1.1

2.39

5.06

u/ml

4.44

137

756

Codes for special purposes

729

4733

1.55

27.25

1.1

5.30

5.85

u/ml

0.37

379

2518

Low back pain

1044

5194

1.45

27.11

1.1

4.70

5.74

u/ml

1.18

537

2685

Other chronic obstructive pulmonary disease

232

869

2.21

27.07

1.0

4.32

3.36

u/ml

0.32

118

340

Anxiety disorders, excluding more controls

1209

5592

1.42

26.82

1.1

5.60

5.70

u/ml

0.07

692

2872

Any event in cancer register

633

5833

0.63

26.79

1.1

5.80

4.68

u/ml

0.83

284

3002

Dorsalgia

1420

5538

1.38

26.35

1.1

5.31

6.10

u/ml

0.90

757

2907

All anxiety disorders

1064

5905

1.44

26.22

1.1

6.13

6.18

u/ml

0.03

618

3101

Solid cancers, helper endpoint

492

4785

0.60

26.08

1.1

5.06

4.30

u/ml

0.44

217

2398

Other dorsopathies, not elsewhere classified

1459

5597

1.37

25.86

1.1

5.41

6.18

u/ml

0.89

772

2951

Malignant neoplasm, wide definition for exclusion

568

5294

0.63

25.82

1.1

5.22

4.69

u/ml

0.29

260

2702

Triptan medication for migraine, min. 3 purchases

1001

5321

1.45

25.74

1.1

5.47

5.84

u/ml

0.27

512

2737

Abnormalities of heart beat

409

2285

1.77

25.73

1.1

5.01

5.80

u/ml

0.41

204

1122

Acute bronchitis

499

2959

1.67

25.25

1.1

5.61

5.58

u/ml

0.01

281

1592

Exposure to unspecified factor

1378

7321

1.36

24.74

1.1

5.31

5.76

u/ml

0.43

802

3814

Acetic acid derivatives and related substances

354

978

1.90

24.42

1.1

7.99

7.19

u/ml

0.26

176

549

Anxiety (asthma-related co-morbidities)

1030

5641

1.42

24.24

1.1

6.17

6.26

u/ml

0.06

603

2952

Conjunctivitis (acute, non atopic)

417

2430

1.73

24.16

1.1

6.58

5.19

u/ml

0.89

256

1258

Tonsillectomy and adenotomy

1124

5617

1.41

24.09

1.1

6.71

6.09

u/ml

0.53

642

3093

Myalgia

348

1948

1.81

23.53

1.1

3.33

5.38

u/ml

2.90

198

993

Persons encountering health services for specific procedures and health care

1522

6864

1.34

23.46

1.1

6.55

5.45

u/ml

1.53

957

3502

Atopic conjunctivitis

107

374

2.97

23.14

1.2

1.1

6.72

6.49

u/ml

0.05

208

Other disorders of lacrimal gland

399

2335

1.73

23.03

1.1

4.07

5.15

u/ml

0.78

214

1124

Soft tissue disorders

1527

5910

1.34

22.99

1.1

5.91

6.09

u/ml

0.14

844

3179

Caries of enamel

1272

6804

1.36

22.34

1.1

5.19

5.55

u/ml

0.36

717

3525

Other specific joint derangements/joint disorders

1171

5532

1.38

22.15

1.1

5.47

6.21

u/ml

0.75

628

2964

Mycoses

1132

7208

1.37

22.14

1.1

5.05

5.77

u/ml

0.75

576

3773

Eosinophilic disease (BM)

8.05

21.86

1.3

1.0

1.21

2.49

u/ml

0.33

Disorders of lacrimal system

470

2915

1.62

21.46

1.1

4.31

5.03

u/ml

0.45

243

1408

Depression

1322

6713

1.34

21.42

1.1

5.58

5.93

u/ml

0.33

720

3466

Lower back pain or/and sciatica

1347

6609

1.34

21.29

1.1

4.48

5.65

u/ml

1.84

694

3367

Abnormal findings on diagnostic imaging of lung

348

1919

1.75

21.15

1.1

3.69

3.83

u/ml

0.06

164

907

Dorsopathies

1495

5764

1.32

21.13

1.1

5.91

6.16

u/ml

0.19

795

3081

Diseases of the musculoskeletal system and connective tissue

1002

3583

1.41

21.00

1.1

6.95

6.32

u/ml

0.44

560

2006

Coxibs

349

1025

1.81

20.98

1.1

8.05

7.57

u/ml

0.14

179

584

Functional dyspepsia

320

1817

1.78

20.64

1.1

3.79

5.45

u/ml

1.22

159

902

Other anxiety disorders

813

4959

1.43

20.28

1.1

5.75

6.44

u/ml

0.52

466

2635

Other soft tissue disorders, not elsewhere classified

1304

5754

1.34

20.02

1.1

5.57

5.96

u/ml

0.32

703

3073

Soft tissue disorders related to use, overuse and pressure

280

1546

1.83

19.84

1.1

4.71

4.72

u/ml

0.00

136

718

Parasetamol

1185

4444

1.36

19.83

1.1

6.65

6.55

u/ml

0.06

645

2387

Exposure to other specified factors

1051

7127

1.36

19.67

1.1

6.05

5.77

u/ml

0.21

646

3708

Bronchitis, not specified as acute or chronic

351

2.81

19.50

1.1

4.84

5.66

u/ml

0.21

159

Mood [affective] disorders

1363

6752

1.31

19.14

1.1

5.41

5.93

u/ml

0.54

738

3487

Opioids

1385

5489

1.32

18.94

1.1

5.78

5.94

u/ml

0.12

733

2836

Allergic urticaria

164

769

2.19

18.91

1.1

6.03

6.04

u/ml

0.00

116

424

Lichen simplex chronicus and prurigo

266

3.07

18.81

1.1

5.75

5.11

u/ml

0.09

126

Mood disorders

1361

6754

1.31

18.65

1.1

5.42

5.92

u/ml

0.53

737

3488

Codeine or tramadol medication

1433

6047

1.30

18.29

1.1

4.76

5.50

u/ml

0.99

734

3060

Selective serotonin reuptake inhibitors

1298

5150

1.32

18.29

1.1

5.61

6.14

u/ml

0.44

688

2706

Codeine

1281

5289

1.32

18.23

1.1

4.82

5.54

u/ml

0.90

663

2703

Certain infectious and parasitic diseases

1031

3800

1.37

17.91

1.1

6.19

5.79

u/ml

0.26

553

1960

Gastrointestinal diseases

1052

3897

1.36

17.80

1.1

6.64

6.28

u/ml

0.22

576

2143

Neurological diseases

1342

5173

1.31

17.60

1.1

5.78

6.37

u/ml

0.57

723

2824

Other joint disorders

1394

5681

1.30

17.51

1.1

5.86

6.27

u/ml

0.33

754

3062

Migraine with aura

430

2764

1.57

17.31

1.1

4.94

6.40

u/ml

1.20

246

1443

Other antidepressants

1281

5025

1.31

17.07

1.1

5.59

5.98

u/ml

0.34

667

2610

Chronic conjunctivitis

189

3.41

17.01

1.1

5.08

6.18

u/ml

0.26

Neurological diseases, wide definition

635

2180

1.48

16.88

1.1

6.14

6.90

u/ml

0.46

343

1280

Cystitis

1084

4853

1.33

16.78

1.1

5.19

5.42

u/ml

0.15

544

2502

Renal tubulo-interstitial diseases

565

6089

0.69

16.75

1.1

3.39

5.47

u/ml

3.99

297

3138

Allergic contact dermatitis due to drugs in contact with skin

107

4.29

16.72

1.1

1.0

7.31

3.12

u/ml

0.55

Candidiasis

380

2398

1.60

16.55

1.1

5.20

5.52

u/ml

0.13

194

1260

Propionic acid derivatives

408

1281

1.61

16.28

1.1

7.02

7.73

u/ml

0.27

225

775

Viral infections characterized by skin and mucous membrane lesions

1125

7378

1.31

16.15

1.1

6.06

5.60

u/ml

0.38

590

3908

COPD (mode)

144

533

2.13

15.48

1.0

4.82

2.78

u/ml

0.51

182

Follow-up examination after treatment for conditions other than malignant neoplasms

543

2451

1.48

15.42

1.1

5.63

5.51

u/ml

0.05

273

1148

Haemorrhage from respiratory passages

262

1377

1.73

15.24

1.1

3.89

5.77

u/ml

1.44

142

660

Diseases of oesophagus, stomach and duodenum

1301

6107

1.28

14.85

1.1

4.13

5.39

u/ml

2.34

655

3177

Abdominal and pelvic pain

1327

5236

1.28

14.61

1.1

5.22

5.98

u/ml

0.74

703

2827

Pain and other conditions associated with female genital organs and menstrual cycle

369

2187

1.57

14.60

1.1

5.13

6.40

u/ml

0.76

187

1166

Somatoform disorder

229

1317

1.76

14.39

1.1

4.75

5.32

u/ml

0.25

121

658

Migraine with aura and triptan purchases

298

1841

1.64

14.38

1.1

5.74

5.79

u/ml

0.02

171

994

Early onset COPD

179

954

1.89

14.35

1.1

4.91

4.35

u/ml

0.14

100

445

Migraine without aura

386

2534

1.54

14.29

1.1

5.70

6.39

u/ml

0.32

219

1364

Diabetes, insulin treatment (Kela reimbursement)

702

5778

0.73

14.27

1.1

4.70

4.98

u/ml

0.18

348

2991

Diseases of middle ear and mastoid

902

5593

1.33

14.20

1.1

6.39

6.27

u/ml

0.07

525

3066

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

552

3467

1.43

14.12

1.1

4.06

4.61

u/ml

0.46

274

1712

All kidney diseases

785

7161

0.75

14.09

1.1

3.58

5.57

u/ml

4.32

415

3741

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1438

6245

1.26

13.94

1.1

4.96

5.74

u/ml

1.03

826

3224

Pruritus

132

643

2.08

13.81

1.1

5.26

4.77

u/ml

0.14

305

Depression medications

654

2353

1.41

13.76

1.1

6.84

7.25

u/ml

0.20

354

1347

Mood disorders, excluding more controls

1191

5580

1.28

13.67

1.1

5.29

5.67

u/ml

0.34

644

2847

Anti-inflammatory and antirheumatic products, non-steroids

394

1285

1.55

13.49

1.1

6.46

7.74

u/ml

0.61

218

778

Non-allergic asthma

398

2.37

13.36

1.0

1.06

4.84

u/ml

3.55

167

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

685

5583

0.74

13.32

1.1

4.76

5.01

u/ml

0.15

343

2910

Injuries to the wrist and hand

1306

7226

1.26

13.28

1.1

5.48

5.77

u/ml

0.24

715

3803

General symptoms and signs

1469

5938

1.24

12.93

1.1

5.07

5.87

u/ml

1.04

797

3111

Acute bronchiolitis

195

999

1.81

12.90

1.3

1.1

7.72

7.68

u/ml

0.01

151

675

Symptoms and signs involving the digestive system and abdomen

1311

5237

1.26

12.83

1.1

5.09

5.97

u/ml

0.93

699

2828

Oxicams

211

677

1.78

12.64

1.1

4.80

5.27

u/ml

0.14

107

374

Schizophrenia or delusion

171

3010

0.56

12.61

1.0

1.1

3.21

6.38

u/ml

3.32

1602

Herpesviral [herpes simplex] infections

359

2391

1.52

12.45

1.1

7.29

5.33

u/ml

1.21

197

1252

Fenamates

166

601

1.89

12.44

1.1

3.17

5.40

u/ml

1.83

334

Schizophrenia, schizotypal and delusional disorders

173

3015

0.57

12.31

1.0

1.1

3.21

6.37

u/ml

3.30

1606

Other bacterial diseases

648

5856

0.74

12.28

1.0

1.1

5.16

4.96

u/ml

0.11

359

3046

Eosinophilia

4.46

12.07

1.3

1.1

1.21

6.36

u/ml

1.40

Simple and mucopurulent chronic bronchitis

105

3.67

12.07

1.1

5.37

7.48

u/ml

0.15

Paracetamol or NSAID medication

282

877

1.63

11.98

1.1

8.51

7.01

u/ml

0.55

163

556

Schizophrenia

1437

0.39

11.94

1.0

1.1

3.37

6.53

u/ml

1.88

774

Allergic colitis

458

2.27

11.92

1.2

1.1

8.34

7.06

u/ml

0.19

316

Malignant neoplasm of breast, HER2-negative

196

2160

0.59

11.88

1.1

4.35

3.08

u/ml

0.45

976

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

123

621

2.01

11.77

1.1

3.36

5.49

u/ml

1.26

327

Other nutritional deficiencies

853

6224

1.30

11.71

1.1

4.17

5.54

u/ml

2.40

457

3172

Other diseases of hard tissues of teeth

627

2371

1.37

11.66

1.1

5.39

5.54

u/ml

0.07

331

1181

Symptoms and signs involving the skin and subcutaneous tissue

800

6024

1.31

11.62

1.1

5.81

4.98

u/ml

0.52

431

3065

Arthropathies

1396

5753

1.23

11.52

1.1

6.26

6.22

u/ml

0.02

756

3122

Persons encountering health services in other circumstances, wide

1482

6246

1.23

11.50

1.1

5.27

5.74

u/ml

0.49

837

3224

Malignant neoplasm of breast, including Hilmo

215

2272

0.61

11.47

1.1

3.97

3.26

u/ml

0.25

1035

Malignant neoplasm of breast, HER2-negative, including Hilmo

215

2272

0.61

11.47

1.1

3.97

3.26

u/ml

0.25

1035

Malignant neoplasm of breast

204

2198

0.60

11.45

1.1

4.22

3.16

u/ml

0.37

998

ILD, hospital admissions 1, main diag only

382

2.27

11.39

1.1

3.82

3.79

u/ml

0.01

181

Inflammatory diseases of female pelvic organs

831

4719

1.30

11.35

1.1

5.19

5.08

u/ml

0.07

431

2334

Heartburn

135

713

1.92

11.31

1.1

5.65

4.99

u/ml

0.13

371

Acute pharyngitis

279

1785

1.57

11.30

1.1

7.49

6.83

u/ml

0.24

166

1055

Disorders of eyelid, lacrimal system and orbit

911

5413

1.28

11.25

1.1

4.27

4.98

u/ml

0.72

471

2732

Other diseases of urinary system

1218

5513

1.25

11.22

1.1

5.16

5.56

u/ml

0.33

630

2882

Other menopausal disorders

293

1056

1.58

11.08

1.1

2.57

3.89

u/ml

1.39

136

480

Diabetes medication

864

6545

0.78

11.07

1.1

4.79

5.24

u/ml

0.36

430

3414

Emphysema

3.64

11.06

1.1

1.64

4.94

u/ml

1.23

Kela-code for severe mental illness

209

3376

0.61

11.04

1.1

2.62

6.06

u/ml

7.69

113

1784

Diseases of the ear and mastoid process

1552

6438

1.21

10.96

1.1

6.01

5.47

u/ml

0.55

823

3373

Enthesopathies of lower limb, excluding foot

254

1614

1.59

10.94

1.1

4.73

5.20

u/ml

0.17

134

779

Trochanteric bursitis

131

693

1.91

10.91

1.1

3.91

4.12

u/ml

0.06

318

Mouth breathing

440

3122

1.42

10.90

1.1

4.62

5.12

u/ml

0.30

233

1677

Migraine without aura and triptan purchases

297

1972

1.53

10.60

1.1

6.25

5.73

u/ml

0.18

161

1061

Pain in thoracic spine

187

1111

1.70

10.58

1.1

5.65

5.89

u/ml

0.07

547

Diabetes, varying definitions

875

6497

0.79

10.45

1.1

5.05

5.25

u/ml

0.13

434

3400

Other enthesopathies

310

2080

1.50

10.41

1.2

1.1

5.10

4.49

u/ml

0.26

153

982

Disorders of skin appendages

648

4923

1.32

10.41

1.1

6.04

6.30

u/ml

0.13

353

2625

Sciatica+with lumbago

544

3703

1.36

10.39

1.1

3.44

4.66

u/ml

1.67

287

1844

Diabetes mellitus

884

6532

0.79

10.39

1.1

5.00

5.31

u/ml

0.23

441

3419

Transport accidents

622

4036

1.33

10.37

1.1

7.67

5.75

u/ml

1.25

348

2034

Rotator cuff syndrome

528

2777

1.37

10.30

1.1

4.04

4.01

u/ml

0.02

249

1275

Benign neoplasm: Colon, unspecified

148

828

1.80

10.30

1.1

2.90

3.42

u/ml

0.26

374

Other and unspecified vaccines and biological substances

4.97

10.23

1.2

1.1

2.38

5.45

u/ml

0.52

Pain in limb

1015

5436

1.25

10.23

1.1

5.89

5.81

u/ml

0.05

532

2874

ILD, hospital admissions

440

2.11

10.18

1.1

3.74

3.48

u/ml

0.06

211

Prurigo nodularis

3.96

10.18

1.1

1.0

1.48

4.19

u/ml

1.14

Oedema, not elsewhere classified

288

1886

1.51

10.16

1.1

3.42

4.75

u/ml

1.00

161

938

Other and unspecified tonsillitis

587

3705

1.34

10.15

1.1

7.44

6.57

u/ml

0.51

323

2076

Unspecified threat to breathing

4.05

10.15

1.2

1.1

2.94

6.65

u/ml

0.87

Vocal cord dysfunction

184

984

1.69

10.14

1.2

1.1

5.43

5.29

u/ml

0.03

507

Other interstitial pulmonary diseases

441

2.10

10.12

1.1

3.74

3.48

u/ml

0.07

212

Accidents

1103

4447

1.25

10.08

1.1

6.10

5.41

u/ml

0.60

622

2238

Interstitial lung disease endpoints

442

2.10

10.07

1.1

3.74

3.48

u/ml

0.07

212

Interstitial lung disease

442

2.10

10.07

1.1

3.74

3.48

u/ml

0.07

212

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

270

1777

1.54

10.06

1.1

6.20

5.54

u/ml

0.25

141

928

Dysphagia

198

1209

1.65

10.06

1.1

4.57

5.01

u/ml

0.14

110

595

Nummular dermatitis

327

2.29

10.01

1.1

1.0

2.94

4.82

u/ml

0.66

152

Intestinal infectious diseases

1184

7347

1.23

9.98

1.1

5.33

5.80

u/ml

0.39

676

3849

Other and unspecified nonorganic psychotic disorders

121

2183

0.55

9.93

1.0

1.1

2.79

7.24

u/ml

7.06

1201

Other noninfective gastroenteritis and colitis

308

2086

1.49

9.90

1.2

1.1

6.34

6.25

u/ml

0.02

187

1166

Suppurative and unspecified otitis media

639

4329

1.32

9.83

1.1

6.70

6.66

u/ml

0.02

379

2454

Other bacterial diseases

824

6609

0.79

9.82

1.1

5.40

5.26

u/ml

0.09

458

3446

Unspecified privation

132

727

1.84

9.79

1.1

5.64

5.73

u/ml

0.02

374

Other chronic obstructive pulmonary disease, including avohilmo

317

1778

1.48

9.76

1.0

1.1

3.58

3.69

u/ml

0.04

159

820

Other respiratory diseases principally affecting the interstitium

106

543

1.96

9.73

1.1

3.41

3.64

u/ml

0.06

266

Injuries to the ankle and foot

1001

7194

1.24

9.65

1.1

6.46

5.81

u/ml

0.50

583

3817

Other viral diseases

614

4655

1.32

9.63

1.1

6.87

6.42

u/ml

0.20

340

2610

Cervicobrachial syndrome

239

1546

1.56

9.59

1.1

3.63

4.74

u/ml

0.72

120

724

Benign neoplasm: Colon

329

2165

1.46

9.57

1.1

2.89

3.60

u/ml

0.63

157

992

Lichen simplex chronicus

144

2.98

9.56

1.0

1.1

7.24

5.02

u/ml

0.18

Dental pulpitis, including avohilmo

1254

6716

1.22

9.50

1.1

5.20

5.87

u/ml

0.72

657

3476

Disturbances of skin sensation

359

2528

1.43

9.46

1.1

4.97

5.25

u/ml

0.12

200

1290

Schizophrenia or delusion, excluding more controls

171

2757

0.61

9.45

1.0

1.1

3.21

5.90

u/ml

2.55

1448

Other inflammation of eyelid

150

867

1.75

9.44

1.1

4.82

5.44

u/ml

0.19

456

Other external causes of accidental injury

1095

4447

1.24

9.41

1.1

6.09

5.41

u/ml

0.58

621

2238

Dermatophytosis

675

5238

1.29

9.29

1.1

4.90

5.54

u/ml

0.48

347

2716

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

330

2.06

9.25

1.1

3.73

4.27

u/ml

0.13

167

Cervicocranial syndrome

118

639

1.87

9.24

1.1

7.59

5.09

u/ml

0.54

313

Mental and behavioural disorders due to alcohol, excluding acute intoxication

216

3307

0.65

9.24

1.1

4.20

5.62

u/ml

0.67

116

1710

General examination and investigation of persons without complaint and reported diagnosis

747

3032

1.29

9.21

1.1

5.01

5.80

u/ml

0.65

397

1474

Disease of hard tissues of teeth, NOS

581

2284

1.34

9.21

1.1

4.57

5.78

u/ml

1.09

299

1113

Other diseases of lip and oral mucosa

412

2991

1.39

9.08

1.1

4.62

5.21

u/ml

0.33

221

1504

Obesity

786

6032

1.26

8.91

1.1

3.77

5.44

u/ml

3.48

424

3057

Obesity and other hyperalimentation

788

6042

1.26

8.89

1.1

3.75

5.44

u/ml

3.55

426

3061

Hyperkinetic disorders, excluding more controls

292

1921

1.48

8.88

1.1

6.52

8.26

u/ml

0.89

184

1176

Shoulder lesions

736

3493

1.28

8.82

1.1

3.81

4.51

u/ml

0.57

344

1689

Dermatitis due to substances taken internally

333

2.20

8.82

1.1

1.0

12.04

5.22

u/ml

1.51

170

Alcohol use disorder, Swedish definition

298

3914

0.69

8.80

1.1

4.46

5.39

u/ml

0.45

154

2014

Dislocation, sprain and strain of joints and ligaments of knee

791

5810

1.26

8.77

1.1

5.57

5.70

u/ml

0.08

425

2970

Injury, poisoning and certain other consequences of external causes

785

3101

1.27

8.70

1.1

6.59

5.23

u/ml

1.16

433

1585

Other intervertebral disc disorders

892

4319

1.25

8.57

1.1

3.57

4.86

u/ml

2.39

434

2175

COPD, hospital admissions

231

1278

1.53

8.57

1.0

1.1

4.32

3.75

u/ml

0.17

118

575

External causes of morbidity and mortality

932

3764

1.25

8.52

1.1

6.03

5.40

u/ml

0.47

520

1918

Chronic gastritis

163

990

1.65

8.52

1.1

1.98

3.83

u/ml

1.81

456

Alcohol dependence

1678

0.53

8.50

1.1

2.54

5.28

u/ml

1.70

853

375

4525

0.73

8.47

1.1

4.31

5.71

u/ml

0.96

194

2346

Alcohol use disorder, ICD-based

201

3072

0.65

8.39

1.1

3.91

5.64

u/ml

0.83

106

1592

COPD, early/later onset

232

1287

1.52

8.39

1.0

1.1

4.32

3.72

u/ml

0.18

118

580

Other and unspecified drugs and medicaments

102

546

1.89

8.36

1.1

3.53

5.81

u/ml

1.07

287

Female infertility

448

2009

1.36

8.31

1.1

5.33

5.72

u/ml

0.18

210

1041

Lumbar disc prolapse

661

3973

1.28

8.25

1.1

3.60

4.76

u/ml

1.60

324

1990

Other and unspecified rosacea

101

542

1.89

8.22

1.1

3.82

4.79

u/ml

0.31

255

Postviral fatigue syndrome

3.48

8.15

1.1

2.69

8.16

u/ml

1.38

Restless leg syndrome

134

786

1.72

8.08

1.1

6.62

5.28

u/ml

0.30

395

Oter anti-inflammatory and antirheumatic agents, non-steroids

144

460

1.74

8.07

1.1

2.69

4.22

u/ml

0.77

230

Female infertility, cervical, vaginal, other or unspecified origin

406

1935

1.37

8.03

1.1

5.29

5.52

u/ml

0.09

192

992

Disorders of the thyroid gland

1093

5897

1.21

8.02

1.1

4.54

5.47

u/ml

1.22

542

3030

Occupational exposure to risk-factors

154

2.72

7.95

1.1

8.74

6.31

u/ml

0.32

Peritonsillar abscess

221

1469

1.51

7.92

1.1

1.0

4.76

5.12

u/ml

0.18

119

683

Later onset COPD, excluding more controls

165

2.44

7.87

1.0

1.05

1.27

u/ml

0.10

350

4325

0.73

7.86

1.1

4.53

5.57

u/ml

0.59

184

2251

Factors influencing health status and contact with health services

358

1282

1.41

7.85

1.1

6.85

6.26

u/ml

0.21

201

591

Mental and behavioural disorders due to psychoactive substance use

396

4923

0.74

7.85

1.1

4.89

5.83

u/ml

0.51

212

2555

Disorders of synovium and tendon

589

4022

1.29

7.85

1.1

4.20

5.03

u/ml

0.73

295

2010

Injuries to the knee and lower leg

1481

6995

1.18

7.84

1.1

5.61

5.77

u/ml

0.12

800

3655

Other disorders of patella

223

1492

1.51

7.78

1.1

3.73

5.31

u/ml

1.20

118

737

All chronic kidney diseases

268

3130

0.70

7.78

1.0

1.1

5.46

5.32

u/ml

0.04

130

1673

Generalized anxiety disorder

281

1969

1.44

7.77

1.1

6.37

6.95

u/ml

0.23

168

1065

Other general symptoms and signs

107

592

1.83

7.75

1.1

2.05

6.62

u/ml

6.04

379

Any gastric operation

1238

5204

1.20

7.72

1.1

6.36

6.16

u/ml

0.12

678

2804

GASTRO-related operations

1238

5204

1.20

7.72

1.1

6.36

6.16

u/ml

0.12

678

2804

Excessive, frequent and irregular menstruation

561

2367

1.31

7.69

1.1

5.74

6.17

u/ml

0.23

289

1261

ILD, hospital admission 2, with pulmonary infections

247

2.28

7.68

1.1

1.0

4.91

4.20

u/ml

0.12

110

Substance abuse

378

4779

0.74

7.66

1.1

4.94

5.82

u/ml

0.45

205

2485

Unspecified mental disorder

279

3933

0.71

7.66

1.1

2.96

5.92

u/ml

4.98

150

2083

Olecranon bursitis

230

2.33

7.58

1.0

1.1

5.71

5.45

u/ml

0.03

106

Psychiatric diseases

1200

5032

1.20

7.55

1.1

6.23

5.61

u/ml

0.53

627

2652

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

481

3277

1.32

7.54

1.1

6.29

7.84

u/ml

1.14

289

1979

Other (not insulin) diabetes medications

707

5226

0.80

7.49

1.1

3.78

4.53

u/ml

0.74

332

2619

Fibromyalgia

122

714

1.73

7.48

1.1

4.37

5.56

u/ml

0.44

344

Acute suppurative otitis media

509

3669

1.31

7.47

1.1

7.58

7.01

u/ml

0.29

313

2126

Benign neoplasm of other and ill-defined parts of digestive system

133

797

1.68

7.42

1.1

2.85

4.32

u/ml

0.81

384

Internal derangement of knee

403

3001

1.34

7.40

1.1

5.61

5.31

u/ml

0.08

201

1499

Other viral diseases, not elsewhere classified

420

3149

1.34

7.40

1.1

6.60

6.23

u/ml

0.12

225

1794

Disturbance of activity and attention

293

2050

1.42

7.38

1.1

6.07

7.69

u/ml

0.91

186

1278

Type 2 diabetes

776

5584

0.81

7.37

1.1

4.59

4.73

u/ml

0.09

370

2817

Insulin medication

359

4074

0.74

7.37

1.0

1.1

6.24

5.37

u/ml

0.37

182

2215

Diaphragmatic hernia

242

1665

1.46

7.31

1.1

2.84

4.28

u/ml

1.25

126

751

Organic, including symptomatic, mental disorders

1220

0.56

7.29

1.0

1.1

4.83

3.46

u/ml

0.31

576

Other/unspecified dorsalgia

382

2818

1.35

7.29

1.1

4.92

5.21

u/ml

0.13

221

1449

Hypertrophy of breast in women and men

237

1629

1.47

7.26

1.1

4.62

4.97

u/ml

0.11

114

788

Seborrhoeic dermatitis

478

1.88

7.26

1.1

4.68

4.59

u/ml

0.02

233

Acute laryngitis and tracheitis

234

1587

1.47

7.11

1.2

1.1

5.74

7.56

u/ml

0.96

142

966

Biguanides

667

5064

0.80

7.10

1.1

3.73

4.56

u/ml

0.80

313

2523

Mental and behavioural disorders due to alcohol

306

4026

0.73

7.01

1.1

4.02

5.62

u/ml

1.08

162

2094

Diseases of external ear

347

2566

1.36

6.95

1.1

6.31

5.81

u/ml

0.19

202

1376

Malignant neoplasm of breast, HER-positive

135

1684

0.62

6.95

1.1

2.67

2.55

u/ml

0.05

731

Liquid cancers, helper endpoint

129

1817

0.62

6.95

1.1

4.94

4.52

u/ml

0.09

904

COPD, hospital admissions 1, only main diagnosis

160

869

1.58

6.93

1.0

1.1

3.40

3.82

u/ml

0.11

403

Other diseases of oesophagus

352

2.00

6.92

1.1

5.93

5.48

u/ml

0.06

178

Obesity, other/unspecified

430

3284

1.32

6.92

1.1

3.40

5.33

u/ml

3.18

243

1681

Malignant neoplasm of breast, ER-positive, including Hilmo

141

1720

0.63

6.90

1.1

2.59

2.53

u/ml

0.02

749

Otalgia

117

694

1.71

6.90

1.1

4.32

5.78

u/ml

0.54

408

Other contact dermatitis

494

1.84

6.89

1.1

6.00

4.49

u/ml

0.31

233

Disorders of thyroid, IBD co-morbidities

243

1180

1.46

6.88

1.0

1.1

3.83

5.71

u/ml

1.58

129

629

Cervicalgia

192

1280

1.51

6.85

1.1

5.12

4.99

u/ml

0.04

623

Hyperkinetic disorders

307

2193

1.39

6.83

1.1

6.53

7.64

u/ml

0.51

198

1363

Cerebrovascular diseases

300

2894

0.73

6.82

1.1

3.98

4.05

u/ml

0.03

135

1376

Malignant neoplasm of digestive organs

1208

0.56

6.73

1.0

1.1

6.84

3.40

u/ml

0.66

556

Hypothyreosis and Thyroxine purchase for inclusion criteria

1052

5800

1.19

6.72

1.1

4.55

5.40

u/ml

1.01

519

2974

Hypothyroidism, other/unspecified

1018

5613

1.20

6.69

1.1

4.67

5.45

u/ml

0.87

503

2878

Congenital malformations, deformations and chromosomal abnormalities

902

6923

1.20

6.68

1.1

5.77

6.01

u/ml

0.16

487

3736

Exfoliative dermatitis

6.07

6.68

1.1

7.78

6.19

u/ml

0.14

Noninflammatory disorders of female genital tract

622

2479

1.27

6.65

1.1

6.62

6.46

u/ml

0.07

319

1338

Rosacea

129

792

1.65

6.64

1.1

4.45

5.54

u/ml

0.33

383

Dislocation, sprain and strain of joints and ligaments at neck level

229

1595

1.45

6.62

1.1

6.79

6.46

u/ml

0.10

131

864

Diarrhoea and gastroenteritis of presumed infectious origin

883

6615

1.21

6.62

1.1

4.76

5.89

u/ml

1.58

515

3525

Continuous positive airway pressure

197

1117

1.49

6.57

1.1

3.29

4.04

u/ml

0.42

635

Hypertrophy of breast

216

1492

1.46

6.51

1.1

4.42

4.59

u/ml

0.05

101

710

Irregular menses

707

4549

1.23

6.48

1.1

5.04

5.33

u/ml

0.21

372

2278

Cervical disc disorders

284

2058

1.39

6.48

1.1

1.86

4.30

u/ml

6.50

131

939

Oesophagitis

221

2.24

6.47

1.2

1.1

4.65

5.26

u/ml

0.12

111

Disorders of breast

570

4127

1.26

6.44

1.1

4.42

4.41

u/ml

0.00

293

2004

Other disorders of urethra and urinary system

744

4395

1.23

6.40

1.1

4.96

5.32

u/ml

0.23

369

2205

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

908

0.45

6.37

1.0

0.40

3.10

u/ml

8.50

406

Diseases of oral cavity, salivary glands and jaws

582

2372

1.27

6.34

1.1

4.73

5.53

u/ml

0.51

312

1182

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

378

2875

1.32

6.33

1.1

5.46

6.30

u/ml

0.43

219

1544

Infections with a predominantly sexual mode of transmission

646

4887

1.24

6.27

1.1

5.94

6.72

u/ml

0.56

340

2632

Type 2 diabetes, definitions combined, including avohilmo

727

5156

0.82

6.26

1.1

4.18

4.53

u/ml

0.27

342

2587

Renal failure

127

1774

0.63

6.26

1.0

1.1

5.41

4.60

u/ml

0.18

896

Excessive attrition of teeth

704

5772

1.22

6.26

1.1

5.46

5.62

u/ml

0.10

383

2981

Striking against or struck by other objects

441

3431

1.29

6.19

1.1

6.06

6.78

u/ml

0.39

255

1966

Infective dermatitis

571

1.73

6.16

1.1

5.22

4.31

u/ml

0.20

257

4.16

6.10

1.0

1.1

0.49

8.36

u/ml

—

Hypothyroidism, strict autoimmune

870

4777

1.20

6.06

1.1

4.76

5.27

u/ml

0.43

422

2448

Substance abuse, excluding more controls

378

4186

0.77

6.02

1.1

4.94

5.75

u/ml

0.41

205

2143

Benign neoplasm: Liver/bile ducts

159

2.44

6.02

1.0

1.1

1.51

5.03

u/ml

1.56

997

5099

1.19

5.99

1.1

5.84

5.57

u/ml

0.19

588

2563

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

997

5099

1.19

5.99

1.1

5.84

5.57

u/ml

0.19

588

2563

Subjective visual disturbances

256

1854

1.39

5.93

1.1

4.02

5.69

u/ml

1.51

146

964

Benign neoplasm: Liver

142

2.52

5.92

1.0

1.1

1.67

5.21

u/ml

1.35

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

211

2.23

5.91

1.0

1.1

5.16

4.85

u/ml

0.05

110

Ganglion

243

1747

1.40

5.89

1.1

4.19

5.44

u/ml

0.68

130

863

Type 2 diabetes, strict (exclude DM1)

716

5091

0.82

5.86

1.1

4.07

4.53

u/ml

0.38

337

2548

Inflammatory diseases of prostate (prostatitis)

490

1.77

5.85

1.1

4.65

6.08

u/ml

0.52

246

Acute and transient psychotic disorders

980

0.50

5.84

1.0

1.1

7.28

5.95

u/ml

0.17

502

Other diseases of intestines

1392

6881

1.15

5.78

1.1

5.34

5.82

u/ml

0.42

695

3730

Vasomotor rhinitis (mode)

384

1.87

5.77

1.1

2.86

4.87

u/ml

0.72

198

Other disorders of eyelid

257

1778

1.38

5.76

1.1

4.76

3.84

u/ml

0.36

116

798

Type 2 diabetes, definitions combined

716

5081

0.82

5.76

1.1

4.07

4.51

u/ml

0.36

337

2545

Other specified disorders of external ear

120

2.62

5.74

1.0

1.1

4.39

7.33

u/ml

0.44

COPD related to multimorbidity

168

952

1.49

5.72

1.0

3.36

3.80

u/ml

0.15

410

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

701

4583

1.22

5.67

1.0

1.1

4.60

4.87

u/ml

0.19

320

2266

Visual disturbances

481

3832

1.26

5.63

1.1

3.78

5.69

u/ml

3.11

269

2011

Stroke, including SAH

214

2172

0.71

5.59

1.1

3.25

3.57

u/ml

0.14

1049

Hypothyroidism, levothyroxine purchases

482

2154

1.27

5.59

1.1

6.23

6.41

u/ml

0.07

259

1227

Hypothyroidism and >3 levothyroxin purchases

482

2154

1.27

5.59

1.1

6.23

6.41

u/ml

0.07

259

1227

Septicaemia

174

2350

0.69

5.58

1.1

7.69

5.26

u/ml

0.78

102

1242

Panic disorder

241

1751

1.39

5.56

1.1

5.88

6.67

u/ml

0.35

143

926

Other systemic involvement of connective tissue

227

1632

1.40

5.52

1.1

5.58

4.87

u/ml

0.23

117

809

Heart failure, not strict

363

3188

0.77

5.51

1.0

1.1

4.84

4.11

u/ml

0.29

164

1563

Other enthesopathy of foot (+metatarsalgia)

108

668

1.63

5.48

1.1

3.12

5.60

u/ml

1.23

325

Immunodeficiencies

363

1.88

5.47

1.1

6.13

6.47

u/ml

0.06

209

Otitis externa

255

1873

1.37

5.47

1.1

6.96

6.06

u/ml

0.31

149

1013

Ovarian cyst

462

2103

1.27

5.44

1.1

4.97

5.62

u/ml

0.41

232

1091

Other diseases of the respiratory system

115

724

1.60

5.39

1.1

6.18

4.41

u/ml

0.35

380

Other respiratory disorders and diseases

115

724

1.60

5.39

1.1

6.18

4.41

u/ml

0.35

380

Other extrapyramidal and movement disorders in other diseases

186

1297

1.44

5.39

1.1

6.09

5.20

u/ml

0.24

650

Disorders of other endocrine glands

505

4001

1.25

5.38

1.1

3.87

5.83

u/ml

2.68

259

2231

Epiphora

2.97

5.34

1.0

6.21

4.33

u/ml

0.15

Other reaction to severe stress, and adjustment disorders

516

4173

1.24

5.33

1.1

5.53

5.90

u/ml

0.21

294

2155

Postmenopausal atrophic vaginitis

190

722

1.46

5.33

1.1

1.65

3.13

u/ml

1.68

301

Other systemic involvement of connective tissue (FG)

224

1596

1.39

5.32

1.1

5.51

4.75

u/ml

0.24

114

771

Other and unspecified nerve root and plexus disorders, also in other diseases

196

1384

1.43

5.32

1.1

3.71

5.09

u/ml

0.69

690

Genitourinary diseases

827

3478

1.20

5.31

1.1

5.91

6.60

u/ml

0.50

456

2008

Other disorders of breast

147

985

1.51

5.27

1.1

4.70

4.81

u/ml

0.03

492

Care involving use of rehabilitation procedures

655

4992

1.21

5.23

1.1

3.20

4.71

u/ml

2.76

369

2512

Acute tubulo-interstitial nephritis

414

4501

0.79

5.22

1.1

3.27

5.43

u/ml

3.74

225

2315

Hypermobility syndrome

594

1.66

5.21

1.1

6.49

5.62

u/ml

0.14

318

Other septicaemia

146

2062

0.68

5.18

1.1

8.18

5.22

u/ml

0.85

1097

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

802

0.48

5.14

1.1

6.20

7.37

u/ml

0.16

437

Polyarthropathies

525

4216

0.81

5.14

1.1

4.43

5.40

u/ml

0.78

267

2171

Metatarsalgia

610

1.64

5.13

1.1

2.99

5.48

u/ml

1.11

297

Hypothyroidism (congenital or acquired)

483

2183

1.26

5.09

1.1

6.26

6.40

u/ml

0.05

261

1249

Viral and other specified intestinal infections

470

3649

1.25

5.09

1.1

6.50

7.52

u/ml

0.45

289

2128

Stroke, excluding SAH

189

1936

0.71

5.08

1.1

3.21

3.46

u/ml

0.09

925

Noninfective enteritis and colitis

529

4307

1.23

5.07

1.1

6.29

5.81

u/ml

0.21

282

2357

Disorders of tooth development and eruption

238

1413

1.37

5.05

1.1

6.10

6.56

u/ml

0.14

138

785

Herpesviral [herpes simplex] infections

132

873

1.53

5.05

1.1

8.07

5.11

u/ml

0.97

454

Other diseases of intestine

574

1.65

5.03

1.1

4.41

3.70

u/ml

0.19

282

Viral pneumonia

130

860

1.52

4.97

1.1

6.24

5.90

u/ml

0.08

456

All influenza

260

1947

1.34

4.94

1.1

6.28

5.94

u/ml

0.08

150

1071

Insulin, combination of fast acting with intermediate-acting or long-acting

359

4170

0.78

4.93

1.0

1.1

6.24

5.23

u/ml

0.45

182

2245

Infections of the skin and subcutaneous tissue

688

5714

1.20

4.92

1.1

5.66

5.76

u/ml

0.06

389

3098

Other and unspecified polyneuropathies, also in other diseases

108

687

1.58

4.90

1.1

5.43

4.58

u/ml

0.22

323

Mental retardation, wide definition

616

0.43

4.88

1.1

1.2

0.67

5.64

u/ml

11.76

428

Uterine polyps

518

1.67

4.88

1.0

1.1

2.76

4.06

u/ml

0.64

236

Dementia, including avohilmo

747

0.56

4.88

1.0

2.13

2.72

u/ml

0.15

337

Flat foot [pes planus] (acquired)

565

1.64

4.85

1.1

3.17

4.48

u/ml

0.62

273

Erysipelas

426

4052

0.80

4.84

1.1

5.37

4.71

u/ml

0.34

223

1995

Unspecified acute lower respiratory infection

160

1111

1.45

4.81

1.1

4.81

6.44

u/ml

0.77

101

594

Malaise and fatigue

478

3112

1.24

4.81

1.1

3.95

5.48

u/ml

2.29

264

1627

Immunodeficiency with predominantly antibody defects

203

2.12

4.81

1.1

6.88

6.81

u/ml

0.01

121

Injury of muscle and tendon at shoulder and upper arm level

235

1742

1.35

4.78

1.1

2.37

4.21

u/ml

3.18

108

835

STROKE

317

2778

0.77

4.77

1.1

3.24

4.24

u/ml

0.77

146

1341

Chondrocostal junction syndrome [Tietze]

204

2.09

4.72

1.2

1.1

2.43

5.76

u/ml

1.11

Other disorders of eye and adnexa

170

1199

1.43

4.72

1.1

3.47

6.04

u/ml

2.28

645

Fissure and fistula of anal and rectal regions

226

1670

1.36

4.72

1.1

5.05

5.27

u/ml

0.06

101

869

Other degenerative diseases of the nervous system

1054

0.62

4.71

1.0

1.1

3.57

5.08

u/ml

0.48

512

Visual disturbances and blindness

499

4076

1.23

4.71

1.1

3.79

5.67

u/ml

3.20

283

2146

Pain, not elsewhere classified

307

2372

1.30

4.70

1.1

5.06

5.65

u/ml

0.24

166

1252

Ocular pain

107

689

1.57

4.67

1.0

1.1

3.30

5.73

u/ml

1.50

369

Nonalcoholic fatty liver disease

103

657

1.58

4.67

1.1

4.65

4.50

u/ml

0.04

317

Schizoaffective disorder

694

0.47

4.66

1.0

1.1

1.15

6.39

u/ml

8.61

366

COPD, hospital admission 2, with asthma infections

141

820

1.48

4.65

1.1

4.05

4.30

u/ml

0.06

375

Other gastritis (incl. Duodenitis)

148

1019

1.46

4.65

1.2

1.1

3.06

4.70

u/ml

1.02

490

Condition for Implicit Sepsis (Organ dysfunction codes)

640

5386

0.84

4.64

1.1

4.85

5.12

u/ml

0.17

345

2782

Tinnitus

194

1403

1.39

4.64

1.1

6.10

4.80

u/ml

0.37

678

Radiculopathy

111

721

1.55

4.62

1.1

3.43

4.49

u/ml

0.32

322

Mental retardation

601

0.44

4.62

1.1

1.2

0.67

5.72

u/ml

11.83

421

Viral warts

289

2225

1.31

4.58

1.1

7.27

6.52

u/ml

0.26

139

1242

Inflammatory disease of uterus

196

1426

1.39

4.57

1.1

3.95

5.28

u/ml

0.93

110

725

Unspecified chronic bronchitis

2.99

4.56

1.1

1.0

8.30

5.56

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

907

6840

0.86

4.56

1.1

5.06

5.40

u/ml

0.26

469

3599

Sequelae of other external causes

312

1.85

4.55

1.1

4.99

5.10

u/ml

0.01

161

Subacute thyroiditis

214

2.04

4.55

1.0

1.1

3.85

4.51

u/ml

0.15

108

Any operation in hilmo

212

1.78

4.52

1.1

11.05

10.01

u/ml

0.12

117

Tramadol

818

4289

1.17

4.50

1.1

3.92

4.84

u/ml

1.14

424

2165

ILD-related respiratory insufficiency

2.95

4.45

1.1

1.53

5.76

u/ml

—

Anomalies of dental arch relationship, including avohilmo

329

2330

1.28

4.44

1.1

7.01

6.70

u/ml

0.11

191

1358

Fall on same level involving ice and snow

557

4631

1.21

4.44

1.1

5.41

5.52

u/ml

0.05

302

2374

Mental and behavioural disorders due to opioids

408

0.34

4.37

1.1

4.20

7.70

u/ml

—

226

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

318

1.82

4.33

1.1

5.93

6.28

u/ml

0.04

185

Congenital malformations, deformations and chromosomal abnormalities

816

6687

1.17

4.32

1.1

5.88

6.11

u/ml

0.15

440

3634

Type 2 diabetes, wide definition

455

3563

0.82

4.32

1.0

1.1

4.62

4.15

u/ml

0.24

210

1710

Spondylolisthesis/Spondylolysis

147

1027

1.44

4.31

1.1

5.83

4.77

u/ml

0.27

483

Benign neoplasm: Choroid

225

1.97

4.31

1.1

1.0

5.60

4.21

u/ml

0.20

105

Bruxism

152

2.23

4.30

1.1

3.91

3.55

u/ml

0.06

Extrapyramidal and movement disorders

251

1912

1.32

4.29

1.1

5.07

4.78

u/ml

0.10

114

941

Other complications of surgical and medical care, not elsewhere classified

102

664

1.55

4.27

1.1

2.64

5.36

u/ml

2.21

337

Myotonic disorders

3.38

4.24

1.3

1.0

9.01

5.84

u/ml

—

Spondylosis

388

2539

1.25

4.24

1.1

3.09

3.88

u/ml

0.57

180

1170

Explicit Sepsis

219

2711

0.75

4.24

1.1

7.00

5.34

u/ml

0.58

125

1426

Other symptoms and signs involving the circulatory and respiratory systems

334

1.78

4.23

1.1

1.0

7.05

6.28

u/ml

0.09

176

Transplanted organ and tissue status

735

0.51

4.22

1.1

4.71

5.75

u/ml

0.16

421

Embedded and impacted teeth

518

3547

1.21

4.20

1.1

7.85

7.61

u/ml

0.08

299

2045

Nontoxic goitre/thyroid nodule

205

1524

1.35

4.16

1.1

3.82

3.92

u/ml

0.03

103

711

Benign neoplasm of colon, rectum, anus and anal canal

378

2636

1.25

4.16

1.1

3.30

3.70

u/ml

0.25

178

1192

Disorders of sclera, cornea, iris and ciliary body

553

4631

1.20

4.12

1.1

6.53

5.25

u/ml

0.88

306

2395

Unspecific neurodegenerative disorder

548

0.54

4.10

1.0

0.93

1.99

u/ml

0.83

246

Chronic periodontitis, including avohilmo

715

5599

0.85

4.09

1.1

4.04

4.97

u/ml

0.97

372

2779

Certain disorders involving the immune mechanism

183

1342

1.37

4.09

1.1

5.16

5.31

u/ml

0.05

106

696

Disorders of ocular muscles, binocular movement, accommodation and refraction

603

5049

1.19

4.08

1.1

4.06

6.34

u/ml

4.05

331

2751

Adenomyosis (Endometriosis of uterus)

118

800

1.48

4.08

1.1

2.01

4.91

u/ml

3.20

384

Selective deficiency of immunoglobulin G [IgG] subclasses

4.05

4.06

1.1

12.87

3.79

u/ml

—

COPD-related respiratory insufficiency

258

1.87

4.06

1.0

0.80

4.52

u/ml

3.45

111

Peripheral artery disease

1072

0.64

4.05

1.0

4.28

3.36

u/ml

0.16

489

Other immunodeficiencies

2.61

4.03

1.1

4.24

5.05

u/ml

0.10

Erysipelas

268

3039

0.78

4.02

1.0

1.1

5.17

4.62

u/ml

0.22

139

1491

Superficial injury of wrist and hand

278

2171

1.29

4.02

1.1

4.89

6.80

u/ml

1.31

157

1211

Other disorders of white blood cells

267

1.85

4.01

1.2

1.1

1.55

5.96

u/ml

2.89

140

Nonsuppurative otitis media

399

2807

1.24

4.01

1.1

7.93

7.75

u/ml

0.06

251

1644

Degenerative diseases of the nervous system

506

0.51

4.00

1.1

1.0

0.95

2.79

u/ml

1.36

224

Dysplasia of cervi uteri

318

1819

1.27

3.99

1.1

5.80

5.23

u/ml

0.24

152

924

Atypical facial pain

304

1.80

3.99

1.1

4.75

4.73

u/ml

0.00

149

Endocrine, nutritional and metabolic diseases

1210

5419

1.13

3.99

1.1

5.79

6.27

u/ml

0.42

641

2967

Other deformities of toe(s)

137

2.22

3.97

1.0

1.1

0.36

5.64

u/ml

2.17

Obsessive-compulsive disorder

130

906

1.45

3.97

1.1

5.17

6.98

u/ml

0.74

520

Mycoses

244

1875

1.31

3.97

1.1

4.34

5.74

u/ml

0.79

132

984

Other/unspecified enthesopathies of lower limb, excluding foot

494

1.61

3.96

1.1

4.08

5.41

u/ml

0.48

242

Dialysis, with operation codes

707

0.52

3.96

1.1

5.26

5.07

u/ml

0.03

388

Mental retardation, excluding more controls

553

0.47

3.96

1.1

1.2

0.67

6.34

u/ml

12.85

380

Nonorganic sleeping disorders, excluding more controls

256

1982

1.30

3.96

1.1

6.02

6.11

u/ml

0.03

151

1046

Thyroiditis

518

1.60

3.95

1.0

1.1

3.33

4.87

u/ml

0.69

273

Periodontitis

720

5605

0.86

3.95

1.1

4.03

4.96

u/ml

0.99

373

2784

Pulmonary eosinophilia, not elsewhere classified

3.87

3.93

1.2

1.0

0.56

3.14

u/ml

—

Menorrhagia

375

1672

1.25

3.90

1.1

3.78

5.01

u/ml

0.87

179

851

Any dementia

556

0.55

3.89

1.0

2.64

2.82

u/ml

0.03

246

Blepharochalasis

149

1065

1.40

3.88

1.1

4.81

2.74

u/ml

0.66

457

Impingement syndrome of shoulder

168

1226

1.38

3.87

1.0

1.1

1.72

3.84

u/ml

2.21

554

Disorders of choroid and retina

444

3819

0.82

3.87

1.1

5.29

4.63

u/ml

0.23

224

1854

Abnormal findings in secretions and smears from cervix uteri vagina vulva

655

4220

1.18

3.86

1.1

4.58

4.89

u/ml

0.22

308

2082

Gluteal tendinitis

193

1.99

3.84

1.0

1.1

2.76

4.21

u/ml

0.35

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

612

3293

1.19

3.84

1.1

5.44

5.78

u/ml

0.21

337

1720

Disorders of muscles

657

1.52

3.83

1.1

3.29

6.19

u/ml

1.96

317

Keratitis

359

2906

1.24

3.81

1.1

7.01

5.60

u/ml

0.72

202

1510

Pleural plaque

120

2.26

3.80

1.0

1.06

2.63

u/ml

—

Ischaemic Stroke, excluding all haemorrhages

172

1730

0.74

3.78

1.0

1.1

2.78

3.41

u/ml

0.28

819

Infections with a predominantly sexual mode of transmission

448

3713

1.21

3.75

1.1

5.09

6.00

u/ml

0.64

235

1966

Other and unspecified acute skin changes due to ultraviolet radiation

2.94

3.75

1.0

4.67

4.06

u/ml

—

Vulvovaginal ulceration/inflammation in other diseases

638

1.52

3.74

1.1

7.27

6.04

u/ml

0.25

344

Implicit viral Sepsis

237

1831

1.30

3.72

1.1

4.44

5.33

u/ml

0.45

134

966

Any dementia, excluding more controls

534

0.55

3.71

1.0

2.82

3.96

u/ml

0.23

235

Dyshidrosis [pompholyx]

103

2.38

3.71

1.1

6.52

6.90

u/ml

0.05

Polyneuropathies and other disorders of the peripheral nervous system

130

916

1.42

3.70

1.1

5.00

4.19

u/ml

0.25

452

Impacted teeth

397

2901

1.23

3.68

1.1

8.01

8.00

u/ml

0.00

228

1700

Benign neoplasm: Small intestine

116

2.26

3.65

1.2

1.0

0.89

4.10

u/ml

1.75

Candidiasis

136

970

1.41

3.64

1.1

3.80

5.84

u/ml

0.87

511

Certain infectious and parasitic diseases

1263

5642

1.12

3.64

1.1

5.71

5.85

u/ml

0.11

682

2945

Complications predominantly related to the puerperium

342

2773

1.24

3.63

1.1

4.68

5.01

u/ml

0.17

169

1395

Benign neoplasm: Sigmoid colon

649

1.50

3.61

1.0

2.54

3.44

u/ml

0.41

296

Dental operations

566

2451

1.19

3.60

1.1

4.60

4.77

u/ml

0.08

290

1219

Sexual dysfunction

2.49

3.58

1.0

1.1

2.19

4.22

u/ml

—

Open wound of wrist and hand

504

4148

1.19

3.58

1.0

1.1

5.58

6.12

u/ml

0.30

266

2229

Benign neoplasm: Transverse colon

329

1.71

3.58

1.1

1.0

2.46

3.66

u/ml

0.47

150

Acute appendicitis, no complications

657

5629

1.17

3.58

1.1

4.70

5.39

u/ml

0.57

334

2893

Ehlers-Danlos syndrome

2.41

3.58

1.1

1.0

10.14

6.25

u/ml

0.33

Polyuria

144

1040

1.39

3.57

1.1

4.56

4.60

u/ml

0.01

521

malignant neoplasm of male genital organs

652

0.62

3.57

1.0

1.1

6.24

3.95

u/ml

0.27

305

Endometriosis

404

1942

1.22

3.57

1.1

3.95

5.27

u/ml

1.18

197

991

Injuries to the neck

274

2171

1.27

3.56

1.1

6.52

6.32

u/ml

0.07

152

1174

Other arthrosis

427

2443

1.21

3.56

1.1

2.40

4.17

u/ml

2.67

212

1127

All influenza (not pneumonia)

170

1263

1.35

3.56

1.1

7.19

6.31

u/ml

0.14

707

Other otitis externa (chronic)

438

1.61

3.55

1.0

1.1

6.94

5.89

u/ml

0.17

244

Dementia

665

0.61

3.54

1.0

2.15

2.78

u/ml

0.16

303

Other infestations

2.75

3.51

1.0

1.1

6.54

4.75

u/ml

—

Other diseases of stomach and duodenum

228

1.86

3.51

1.1

4.43

5.30

u/ml

0.15

112

Appendicitis, broad definition

822

6509

1.14

3.49

1.1

4.53

5.34

u/ml

0.84

413

3312

ILD, hospital admissions 3, with pneumonia sepsis

214

1.88

3.49

1.1

5.82

3.83

u/ml

0.30

Other acquired deformities of musculoskeletal system and connective tissue

251

1.81

3.47

1.1

3.74

5.43

u/ml

0.35

133

Systemic connective tissue disorders

275

2187

1.26

3.46

1.1

5.49

4.63

u/ml

0.34

141

1079

Other predominantly sexually transmitted diseases, not elsewhere classified

333

2710

1.24

3.45

1.1

5.92

6.67

u/ml

0.35

176

1482

Contracture of joint

3.04

3.43

1.0

1.1

14.40

9.71

u/ml

—

Implicit Sepsis

490

4376

0.84

3.43

1.1

4.85

5.04

u/ml

0.10

266

2241

Other obstetric conditions, not elsewhere classified

615

3351

1.17

3.43

1.1

5.35

5.80

u/ml

0.30

339

1741

Postpartum care and examination

180

1505

0.75

3.43

1.1

5.14

5.82

u/ml

0.28

804

Insulin, intermediate and long-acting

317

3790

0.81

3.42

1.0

1.1

6.66

5.36

u/ml

0.56

165

2038

Superficial injury of lower leg

279

2227

1.26

3.42

1.1

6.32

6.73

u/ml

0.13

149

1197

Substance use, excluding alcohol

143

1943

0.73

3.41

1.1

6.40

6.71

u/ml

0.06

1046

Diseases of appendix

825

6524

1.14

3.41

1.1

4.53

5.33

u/ml

0.84

414

3320

Bacterial Sepsis

190

2124

0.76

3.41

1.0

1.1

4.74

4.83

u/ml

0.03

1072

Crossbite

163

1123

1.36

3.40

1.1

7.28

7.01

u/ml

0.07

116

737

Sub-endpoint used in defining T1D endpoints

211

2671

0.77

3.39

1.0

1.1

6.65

6.37

u/ml

0.08

125

1522

Meniscus derangement

487

2757

1.19

3.39

1.1

3.25

4.64

u/ml

2.15

240

1306

Hypothyroidism, strict autoimmune, 3 medication purchases required

908

5403

1.14

3.38

1.1

4.61

5.21

u/ml

0.56

431

2734

Recurrent aphthous stomatitis , including avohilmo

153

1129

1.36

3.37

1.1

5.34

5.82

u/ml

0.14

629

Deep bite that required surgery

2.42

3.36

1.0

1.1

7.92

5.34

u/ml

—

Urticaria due to cold and heat

2.70

3.36

1.1

11.51

6.00

u/ml

—

Other/unspecified enthesopathies, not elsewhere classified

398

1.62

3.33

1.3

1.1

6.21

5.16

u/ml

0.16

175

Unspecified event, undetermined intent

183

1.95

3.32

1.3

1.1

5.47

6.87

u/ml

0.28

107

Autoimmune diseases excluding thyroid diseases

1058

6477

0.89

3.32

1.1

6.64

5.76

u/ml

0.66

556

3484

Benign neoplasm: Duodenum

2.57

3.31

1.3

1.0

0.90

4.55

u/ml

—

Concussion

632

4449

1.16

3.30

1.1

5.52

6.47

u/ml

0.56

362

2428

Obesity due to excess calories

536

4575

1.18

3.30

1.1

4.09

5.28

u/ml

1.31

279

2351

Alzheimer disease, including avohilmo

436

0.53

3.30

1.1

1.0

1.01

1.74

u/ml

0.40

181

Haemorrhoids and perianal venous thrombosis

216

1674

1.29

3.30

1.1

5.06

4.85

u/ml

0.06

838

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

543

4619

1.17

3.30

1.1

6.12

6.53

u/ml

0.22

312

2514

Short Achilles tendon (acquired)

135

2.10

3.30

1.1

1.0

3.38

6.47

u/ml

0.56

Primary hyperparathyroidism

407

1.61

3.29

1.0

0.85

3.24

u/ml

3.13

194

Drug-induced adrenocortical insufficiency

109

2.25

3.29

1.1

0.27

7.21

u/ml

2.81

Other viral hepatitis

610

0.54

3.27

1.2

1.1

3.73

7.10

u/ml

0.99

319

Single spontaneous delivery

334

2166

0.81

3.27

1.1

5.35

6.17

u/ml

0.42

185

1151

Autoimmune diseases excluding thyroid diseases, strict definition

1036

6364

0.89

3.25

1.1

6.76

5.77

u/ml

0.75

539

3424

Hard cardiovascular diseases

588

4080

0.86

3.25

1.1

3.67

4.43

u/ml

0.74

270

2093

Sicca syndrome [Sjögren]

456

1.57

3.25

1.1

4.54

4.05

u/ml

0.11

213

Thyroiditis, ILD-related definition

139

1018

1.38

3.24

1.1

2.61

5.66

u/ml

2.89

532

Fibroblastic disorders

138

1008

1.37

3.23

1.1

2.21

4.35

u/ml

2.45

456

Other/unspecified soft tissue disorders related to use, overuse and pressure

164

1.98

3.21

1.1

1.0

6.50

6.66

u/ml

0.02

Urethritis and urethral syndrome

110

2.21

3.21

1.1

3.75

9.74

u/ml

1.33

Other bursopathies

626

1.48

3.21

1.0

1.1

3.61

4.91

u/ml

0.56

286

Diseases of arteries, arterioles and capillaries

274

2516

0.80

3.20

1.1

4.18

4.23

u/ml

0.02

123

1229

Other infective otitis externa

364

1.64

3.20

1.0

1.1

4.33

4.56

u/ml

0.03

195

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

454

3790

1.19

3.20

1.1

4.10

6.15

u/ml

3.09

275

2121

Other and unspecified disorders of vitreous body

234

1819

1.27

3.19

1.0

1.1

1.99

3.30

u/ml

1.65

108

786

Metabolic disorders

772

5367

0.88

3.18

1.1

4.44

4.93

u/ml

0.37

395

2770

Benign neoplasm of eye and adnexa

466

1.55

3.18

1.1

4.03

4.40

u/ml

0.07

229

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

684

0.57

3.18

1.0

6.68

3.21

u/ml

—

304

Acute appendicitis

778

6392

1.14

3.17

1.1

4.51

5.32

u/ml

0.82

391

3254

Otitis media, unspecified

214

1540

1.29

3.17

1.2

1.1

6.34

7.34

u/ml

0.38

137

950

Deep bite

207

1412

1.30

3.16

1.1

6.98

7.23

u/ml

0.07

128

895

Acute otitis externa, noninfective

2.51

3.15

1.1

1.0

2.83

4.49

u/ml

—

L04AD Calcineurin inhibitors

952

0.64

3.14

1.1

6.27

5.79

u/ml

0.09

557

Toxic effect of contact with venomous animals

305

1.69

3.14

1.1

4.95

7.14

u/ml

0.40

168

Appendectomy

750

6298

1.14

3.11

1.1

4.63

5.42

u/ml

0.77

394

3206

Galactorrhea

2.45

3.11

1.1

6.37

6.13

u/ml

0.02

Other specified/unspecified soft tissue disorders

187

1.89

3.11

1.1

1.0

6.53

6.15

u/ml

0.04

Injury of muscle and tendon at lower leg level

129

940

1.38

3.10

1.1

2.69

5.85

u/ml

3.50

483

Rheumatism, unspecified

103

722

1.43

3.09

1.1

2.13

4.05

u/ml

1.74

329

Coronary artery bypass grafting

460

0.55

3.09

1.0

4.54

3.92

u/ml

0.08

197

Other sleep disorders

104

731

1.43

3.09

1.1

4.34

5.91

u/ml

0.48

384

Endometriosis of pelvic peritoneum

196

1448

1.30

3.08

1.1

4.53

5.14

u/ml

0.25

736

Polyarthrosis

111

731

1.41

3.08

1.1

1.0

1.02

3.77

u/ml

3.74

295

Deforming dorsopathies

270

2176

1.25

3.08

1.1

7.50

5.67

u/ml

0.65

138

1138

Hypersensitivity pneumonitis due to organic dust

2.72

3.08

1.1

1.0

0.42

8.28

u/ml

—

Viral hepatitis

662

0.57

3.08

1.2

1.1

3.57

6.81

u/ml

1.00

347

Other and unspecified mental retardation

336

0.40

3.07

1.1

1.2

1.12

5.38

u/ml

—

264

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

651

0.57

3.07

1.1

3.77

3.85

u/ml

0.02

316

Nephropathy related operations

701

0.58

3.07

1.1

5.19

4.91

u/ml

0.04

384

Complications of medical and surgical care

677

5433

1.15

3.06

1.1

4.47

4.71

u/ml

0.14

351

2707

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

854

6642

0.88

3.06

1.1

5.56

5.08

u/ml

0.28

476

3442

Palmar fascial fibromatosis [Dupuytren]

399

1.58

3.06

1.0

1.89

3.71

u/ml

1.54

173

Diseases of male genital organs

499

2134

1.18

3.05

1.1

6.07

6.82

u/ml

0.40

289

1253

Presence of other functional implants

223

1957

0.79

3.05

1.1

4.35

3.62

u/ml

0.29

916

Other specified/unspecified bacterial intestinal infections

330

1.65

3.05

1.1

2.77

6.19

u/ml

1.62

175

Other diseases of anus and rectum

215

1685

1.28

3.05

1.1

6.17

5.08

u/ml

0.38

101

877

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

270

1.73

3.04

1.0

1.1

2.40

6.79

u/ml

2.61

162

Suppurative otitis media, unspecified

218

1.82

3.04

1.0

1.1

5.27

8.00

u/ml

0.41

135

Cholecystectomy

591

4407

1.16

3.04

1.1

3.77

4.12

u/ml

0.21

272

2113

Erosion of teeth , including avohilmo

325

2677

1.22

3.03

1.1

5.61

6.37

u/ml

0.35

193

1440

Androgenic alopecia

2.82

3.02

1.1

1.0

1.48

2.12

u/ml

—

Polyp of the female genital tract

289

1340

1.24

3.01

1.1

3.30

4.82

u/ml

1.07

135

646

Peroneal tendinitis

2.28

2.99

1.0

1.1

1.01

6.29

u/ml

1.66

Lateral epicondylitis

120

870

1.39

2.99

1.2

1.1

5.02

4.98

u/ml

0.01

397

Idiopathic pulmonary fibrosis

154

1.96

2.99

1.0

4.76

3.54

u/ml

0.11

Benign neoplasm: Stomach

347

1.62

2.99

1.1

4.18

3.24

u/ml

0.20

159

Oligomenorrhoea

333

1.64

2.98

1.0

1.1

3.78

6.44

u/ml

1.29

180

Other shoulder lesions

662

1.44

2.97

1.1

3.65

6.00

u/ml

1.19

322

Use of anticholinesterases

450

0.54

2.97

1.1

1.0

1.40

1.92

u/ml

—

184

N06DA Anticholinesterases

450

0.54

2.97

1.1

1.0

1.40

1.92

u/ml

—

184

Dislocation, sprain and strain of joint and ligaments of hip

134

2.03

2.97

1.1

10.96

7.89

u/ml

0.30

Type 1 diabetes, wide definition

189

2414

0.78

2.96

1.1

7.55

6.45

u/ml

0.35

117

1394

Fracture at wrist and hand level

375

3133

1.20

2.94

1.1

6.34

6.39

u/ml

0.02

209

1720

Other and unspecified follicular disorders

265

1.72

2.94

1.1

2.73

5.91

u/ml

1.14

140

Special screening examination for neoplasms

198

1.83

2.94

1.1

1.0

4.76

4.64

u/ml

0.01

Other disorders of bone

217

1717

1.27

2.93

1.1

5.74

6.18

u/ml

0.14

117

909

Cerebrovascular diseases (FINNGEN)

210

1881

0.79

2.93

1.1

3.62

4.36

u/ml

0.31

913

Separation of retinal layers (serosa)

206

1.81

2.92

1.1

4.61

5.87

u/ml

0.20

103

Benign neoplasm: Ascending colon

428

1.55

2.92

1.1

3.31

3.88

u/ml

0.14

198

Disorders of parathyroid gland

112

796

1.39

2.91

1.1

2.05

3.86

u/ml

1.17

382

Synovial cyst of popliteal space [Baker]

281

1.68

2.89

1.1

1.0

1.70

5.00

u/ml

2.27

133

Other disorders of adrenal gland

360

1.60

2.86

1.1

4.02

6.07

u/ml

0.61

214

Persons encountering health services in other circumstances

450

3820

1.18

2.84

1.1

5.76

6.56

u/ml

0.44

227

2020

Excessive earwax

430

3565

1.18

2.84

1.1

5.60

5.29

u/ml

0.13

227

1866

Patellar tendinitis

130

2.04

2.84

1.1

7.51

7.81

u/ml

0.02

Abrasion of teeth

306

2524

1.22

2.83

1.1

3.44

4.88

u/ml

1.53

169

1221

Disorders of refraction and accommodation

363

3033

1.20

2.82

1.1

3.40

6.31

u/ml

4.86

200

1717

Impetigo

547

1.48

2.82

1.2

1.1

5.71

5.82

u/ml

0.02

341

Pre-eclampsia or poor fetal growth

303

3646

0.82

2.82

1.1

3.62

5.14

u/ml

1.10

148

1829

Atherosclerosis, excluding cerebral and coronary sclerosis

872

0.68

2.82

1.1

1.0

4.75

2.80

u/ml

0.36

383

Other and unspecified local infections of skin and subcutaneous tissue

662

1.43

2.80

1.1

6.16

5.10

u/ml

0.22

360

Colonic or urogenital fistula

229

1834

1.25

2.80

1.1

4.97

5.33

u/ml

0.11

104

943

Other diseases of peritoneum

209

1.79

2.80

1.0

1.1

4.20

4.50

u/ml

0.04

Premenstrual syndrome

104

2.17

2.79

1.0

1.1

1.83

4.60

u/ml

—

Haemangioma, any site

572

1.46

2.78

1.1

3.57

5.08

u/ml

0.55

307

Noninfectious colitis NAS

142

1071

1.33

2.78

1.1

4.81

6.25

u/ml

0.49

585

Other disorders of penis

663

1.43

2.78

1.1

3.68

7.47

u/ml

1.59

401

Carpal tunnel syndrome

527

4015

1.16

2.77

1.1

4.05

4.16

u/ml

0.06

251

1930

Condition for Implicit Sepsis (Organ dysfunction codes)

778

6039

0.89

2.76

1.1

5.36

5.30

u/ml

0.04

417

3149

Other disorders of the musculoskeletal system and connective tissue

103

739

1.40

2.76

1.1

3.16

4.81

u/ml

0.67

351

Ehlers-Danlos syndrome

132

2.03

2.76

1.1

1.0

10.14

5.88

u/ml

0.39

Exclusions for E4_PCOS_CONSORTIUM

774

5462

0.89

2.76

1.1

4.05

5.63

u/ml

2.35

367

2883

Acute alcohol intoxication

143

1877

0.76

2.76

1.1

3.76

5.78

u/ml

0.89

979

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

340

1.60

2.75

1.1

3.33

6.67

u/ml

0.93

171

Alzheimer disease

360

0.53

2.74

1.0

1.28

1.96

u/ml

—

151

Other predominantly sexually transmitted diseases, not elsewhere classified

252

2048

1.24

2.74

1.1

5.31

6.14

u/ml

0.37

135

1114

Other and/or unspecified nontoxic goitre

388

1.56

2.72

1.0

1.1

2.21

3.80

u/ml

0.92

178

Implicit bacterial Sepsis

147

1703

0.76

2.72

1.0

1.1

3.98

4.35

u/ml

0.11

829

Alcohol withdrawal state with delirium

297

0.40

2.71

1.0

1.1

1.76

5.67

u/ml

—

140

Covid-19 confirmed case

304

2517

1.21

2.71

1.1

5.26

5.66

u/ml

0.17

170

1344

Use of disulfiram, acamprosate or naltrexone

638

0.59

2.71

1.1

0.93

5.32

u/ml

6.73

321

Kidney transplant status

392

0.48

2.70

1.2

1.1

4.44

6.58

u/ml

—

236

Other abnormal products of conception

522

2986

1.16

2.70

1.1

5.37

5.51

u/ml

0.07

253

1517

Other and unspecified trigeminal disorders

2.32

2.70

1.0

1.75

5.63

u/ml

—

Defects in the complement system

2.48

2.69

1.2

1.1

5.77

5.91

u/ml

—

Insulin, fast-acting (human)

101

1388

0.72

2.69

1.0

1.1

6.21

6.87

u/ml

0.17

770

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

151

1140

1.32

2.68

1.2

1.1

6.09

6.12

u/ml

0.01

730

Other noninflammatory disorders of vulva and perineum

710

1.40

2.68

1.0

1.1

5.73

5.57

u/ml

0.04

368

Autonomic disorders

119

2.05

2.68

1.0

1.1

4.40

8.29

u/ml

0.80

Sulfonylureas

676

0.65

2.67

1.0

1.1

1.08

3.04

u/ml

2.11

310

Implicit Sepsis

611

5090

0.88

2.67

1.1

4.70

5.15

u/ml

0.32

331

2621

Type 1 diabetes

213

2645

0.80

2.66

1.0

1.1

6.55

6.31

u/ml

0.07

127

1531

Other acute skin changes due to ultraviolet radiation

133

1.97

2.66

1.1

1.0

2.63

3.65

u/ml

0.17

Acute renal failure

784

0.64

2.66

1.0

1.1

5.74

4.60

u/ml

0.16

388

Biomechanical lesions, not elsewhere classified

220

1.74

2.66

1.2

1.1

1.99

5.08

u/ml

1.42

103

Other puerperal infections

137

1038

1.33

2.65

1.1

5.56

5.85

u/ml

0.10

566

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.43

2.65

1.1

1.0

4.43

5.17

u/ml

—

Type 1 diabetes, wide definition, subgroup 1

185

2333

0.79

2.65

1.0

1.1

7.23

6.42

u/ml

0.25

114

1348

Testicular hypofunction

191

1.80

2.64

1.1

2.89

7.56

u/ml

1.65

Budesonide

137

1037

1.33

2.64

1.1

6.90

6.28

u/ml

0.13

529

Nausea and vomiting

261

2092

1.23

2.64

1.1

5.09

5.98

u/ml

0.48

149

1189

Other local infections of skin and subcutaneous tissue

696

1.40

2.63

1.1

5.93

5.00

u/ml

0.20

375

Disorders of eyelid in diseases classified elsewhere

177

1.83

2.61

1.1

10.22

4.73

u/ml

0.74

Contraceptive management

535

3258

1.15

2.61

1.1

5.56

5.40

u/ml

0.07

268

1673

Diseases of tongue

282

1.64

2.61

1.1

1.0

5.68

5.31

u/ml

0.05

128

Other inflammation of vagina/vulva

370

1.56

2.59

1.1

4.84

5.29

u/ml

0.07

194

Acute alcohol intoxication, ICD10

126

1664

0.75

2.57

1.1

3.92

6.17

u/ml

0.92

888

Pulmonary embolism

161

1249

1.29

2.57

1.0

1.1

4.63

4.22

u/ml

0.11

592

Complications associated with artificial fertilization

186

1.81

2.57

1.0

1.1

1.64

7.70

u/ml

3.42

102

Poor fetal growth

131

1717

0.76

2.56

1.1

5.58

5.52

u/ml

0.01

917

Other mycoses, not elsewhere classified/unspecified

2.26

2.56

1.1

1.0

13.40

9.08

u/ml

0.21

Pulmonary heart disease

161

1251

1.29

2.55

1.0

1.1

4.63

4.20

u/ml

0.11

594

Major anomalies of jaw size

224

1.72

2.53

1.0

1.1

8.65

8.01

u/ml

0.05

128

Other bursitis of knee

2.31

2.53

1.0

1.01

10.59

u/ml

—

Reimbursement for rheumatic diseases

400

4649

0.85

2.53

1.1

4.61

5.05

u/ml

0.20

191

2379

Lichen ruber planus, wide definition including periferal and oral lichen planus

150

1157

1.30

2.53

1.0

1.1

4.71

3.97

u/ml

0.20

540

Persistent mood disorders

184

1457

1.27

2.53

1.1

4.81

5.91

u/ml

0.50

100

743

Primary_lymphoid and hematopoietic malignant neoplasms

1072

0.70

2.53

1.1

7.82

4.64

u/ml

0.52

560

Sacrococcygeal disorders, not elsewhere classified

194

1.77

2.52

1.1

1.59

5.21

u/ml

1.94

Nonorganic sleeping disorders

256

2104

1.22

2.52

1.1

6.02

6.06

u/ml

0.01

151

1134

Persons encountering health services in circumstances related to reproduction

771

4629

1.12

2.51

1.1

5.19

6.03

u/ml

0.78

419

2541

Ulcer of vagina/vulva

202

1.76

2.51

1.1

11.60

3.84

u/ml

0.80

103

Alcoholic liver disease

382

0.50

2.51

1.1

1.18

4.48

u/ml

—

176

Falls/tendency to fall

1396

6407

1.09

2.51

1.1

5.74

u/ml

0.00

753

3362

Haemangioma and lymphangioma, any site

652

1.41

2.51

1.1

3.63

5.65

u/ml

0.87

352

Viral infections characterized by skin and mucous membrane lesions

431

3705

1.17

2.51

1.1

6.41

5.35

u/ml

0.59

240

2021

Other maternal disorders predominantly related to pregnancy

736

4101

1.13

2.50

1.1

4.44

5.31

u/ml

0.86

335

2067

Secondary uncertain malignant neoplasm

486

0.55

2.50

1.1

4.80

4.22

u/ml

0.08

241

Arthropod-borne viral fevers and viral haemorrhagic fevers

165

1291

1.28

2.49

1.1

5.90

5.89

u/ml

0.00

101

700

Stomatitis and related lesions

213

1719

1.24

2.49

1.1

7.20

5.98

u/ml

0.38

110

933

Bicipital tendinitis

202

1.75

2.49

1.1

1.0

7.40

5.19

u/ml

0.25

Benign neoplasm of middle ear and respiratory system

325

1.58

2.49

1.1

4.09

4.22

u/ml

0.03

167

Acne

197

1577

1.26

2.48

1.1

7.30

8.10

u/ml

0.23

113

928

Thyroiditis, unspecified

2.17

2.47

1.0

1.1

5.02

4.75

u/ml

—

Other neurological diseases

404

3701

0.86

2.47

1.1

3.60

4.69

u/ml

0.96

207

1836

Antihypertensive medication - note that there are other indications

1060

5093

1.11

2.46

1.1

5.71

6.80

u/ml

1.24

566

2856

Use of pramipexole

132

1005

1.32

2.45

1.1

5.03

3.73

u/ml

0.38

474

Medicines for HER+ breast cancer

175

2087

0.79

2.45

1.1

3.59

3.60

u/ml

0.00

914

Malignant neoplasm of skin

198

1690

0.80

2.44

1.1

3.68

3.09

u/ml

0.24

770

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

271

2247

1.21

2.44

1.1

4.24

6.34

u/ml

1.90

134

1194

Other prurigo

2.94

2.43

1.1

11.24

8.08

u/ml

—

Hyperparathyroidism

639

1.40

2.43

1.1

1.0

2.41

3.56

u/ml

0.52

297

Inflammation of lacrimal passages (acute and unspecified)

2.20

2.43

1.2

1.1

0.53

3.09

u/ml

—

Drug-induced cataract

117

1.99

2.42

1.2

1.1

2.28

7.52

u/ml

1.73

Lichen planus, including avohilmo

125

947

1.32

2.41

1.0

1.1

5.39

4.29

u/ml

0.26

442

Otitis externa, unspecified

126

957

1.32

2.41

1.1

5.89

6.10

u/ml

0.05

526

Impacted maxillary canine

147

1.91

2.41

1.0

1.1

4.04

8.70

u/ml

1.57

103

Anosmia

107

2.02

2.40

1.1

0.97

2.85

u/ml

—

Panniculitis affecting regions of neck and back

197

1.74

2.40

1.1

2.23

5.32

u/ml

1.41

Mental and behavioural disorders due to cannabinoids

386

0.51

2.39

1.1

1.38

7.73

u/ml

6.56

229

Persistent delusional disorders

414

0.53

2.39

1.0

1.1

1.60

5.03

u/ml

1.74

204

Spinal osteochondrosis

2.46

2.39

1.1

6.39

11.02

u/ml

—

Retained placenta and membranes, without haemorrhage

127

967

1.32

2.39

1.1

3.12

4.41

u/ml

0.70

465

Malignant neoplasm of respiratory system and intrathoracic organs

463

0.59

2.38

1.0

1.1

10.24

2.81

u/ml

0.55

210

LeFortI or BSSO operation

394

1.52

2.38

1.1

3.95

5.80

u/ml

0.47

202

Procedures for purposes other than remedying health state

132

1.92

2.37

1.1

5.40

3.79

u/ml

0.15

Adhesive capsulitis of shoulder

108

803

1.35

2.37

1.1

4.36

4.33

u/ml

0.00

359

L04AA Selective immunosuppressants

148

1890

0.78

2.37

1.0

1.1

4.76

5.90

u/ml

0.50

999

L02BG Aromatase inhibitors

115

1516

0.76

2.37

1.1

2.77

3.46

u/ml

0.30

675

Other bacterial intestinal infections

182

1452

1.26

2.37

1.1

3.19

5.67

u/ml

2.27

744

Coeliac disease

134

1030

1.31

2.36

1.1

5.65

6.08

u/ml

0.09

573

Suicide or other Intentional self-harm

200

2466

0.81

2.36

1.1

4.18

6.12

u/ml

1.16

1302

Viral pneumonia (unknown virus, not influenza)

460

1.47

2.35

1.1

8.11

6.18

u/ml

0.31

250

Chondropathies

167

1322

1.27

2.34

1.1

5.84

6.74

u/ml

0.29

690

Speech and linguistic disorders, excluding more controls

162

1203

1.28

2.33

1.1

6.55

8.41

u/ml

0.58

102

791

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

169

1.79

2.33

1.1

4.62

4.80

u/ml

0.02

Any mental disorder

1258

5768

1.09

2.33

1.1

6.07

5.56

u/ml

0.44

682

3003

Redundant prepuce, phimosis and paraphimosis

195

1556

1.25

2.32

1.1

7.40

7.58

u/ml

0.04

123

908

Diseases of salivary glands

295

2478

1.19

2.32

1.1

3.71

5.33

u/ml

1.39

151

1267

Nontoxic single thyroid nodule

404

1.50

2.31

1.1

5.96

4.64

u/ml

0.17

197

Sequelae of external causes of morbidity and mortality

187

1501

1.25

2.31

1.1

4.28

5.36

u/ml

0.49

117

771

Viral haemorrhagic fevers, not elsewhere classified/unspecified

149

1164

1.29

2.31

1.1

6.31

5.59

u/ml

0.12

625

Other diseases of liver

152

1191

1.28

2.31

1.1

4.42

4.67

u/ml

0.09

593

Atrial septal defect, secundum type

417

0.54

2.30

1.0

1.2

2.73

5.09

u/ml

0.54

301

Pericarditis

148

1.84

2.29

1.2

1.1

4.82

6.75

u/ml

0.32

Malignant neoplasm of breast, ER-negative, including Hilmo

1122

0.73

2.28

1.1

5.62

2.76

u/ml

0.49

507

Iron deficiency

310

1.57

2.28

1.1

3.48

6.36

u/ml

1.10

179

Presence of cardiac and vascular implants and grafts

128

1234

0.77

2.27

1.0

1.1

5.95

3.43

u/ml

0.59

596

Other and unspecified visual disturbances

614

1.39

2.26

1.1

3.25

5.71

u/ml

1.82

319

Disorders of orbit

263

1.61

2.24

1.0

1.1

1.61

5.39

u/ml

3.51

138

Other specified disorders of muscle

142

1.85

2.24

1.0

1.1

2.19

5.76

u/ml

1.59

Other spirochaetal diseases

245

2031

1.21

2.24

1.1

4.40

5.18

u/ml

0.44

126

1017

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

391

1.49

2.23

1.1

1.12

4.51

u/ml

3.67

190

Other superficial mycoses

134

1040

1.30

2.22

1.1

4.82

6.74

u/ml

0.71

574

Gingivitis and periodontal diseases

1129

5324

1.10

2.22

1.1

5.83

5.34

u/ml

0.39

599

2748

Other noninflammatory disorders of vagina

524

1.42

2.22

1.0

1.1

6.50

5.38

u/ml

0.22

258

Other specified and unspecified disorders of eye and adnexa

187

1.73

2.22

1.1

0.43

7.62

u/ml

5.23

Benign neoplasm: Skin of ear and external auricular canal

121

1.91

2.21

1.0

1.40

4.98

u/ml

—

Atrial septal defect

523

0.60

2.21

1.0

1.2

2.91

5.67

u/ml

0.79

370

Dementia in Alzheimer disease

179

0.42

2.21

1.0

—

1.18

—

Other spirochaetal diseases

250

2080

1.21

2.21

1.1

4.48

5.11

u/ml

0.34

129

1043

Delivery

354

2184

0.85

2.20

1.1

4.78

6.19

u/ml

0.96

192

1162

Pain associated with micturition

101

754

1.35

2.20

1.0

1.1

7.43

5.93

u/ml

0.20

409

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

165

1.77

2.20

1.0

4.48

4.71

u/ml

0.03

Type 1 diabetes, strict (exclude DM2)

114

1481

0.76

2.19

1.1

6.48

7.33

u/ml

0.21

916

Tic disorders

212

1.70

2.19

1.1

1.2

4.09

6.99

u/ml

0.94

155

Generalized epilepsy, strict definition

250

1.63

2.19

1.1

1.2

4.81

7.16

u/ml

0.39

157

Tic and related disorders

220

1.68

2.18

1.1

1.2

3.96

7.17

u/ml

1.17

162

Emotional disorders starting during childhood or adolecense, excluding more controls

114

849

1.33

2.17

1.1

6.54

8.81

u/ml

0.74

565

Anogenital herpesviral [herpes simplex] infection

163

1301

1.26

2.17

1.1

5.80

6.36

u/ml

0.17

727

Chronic kidney disease

1122

0.73

2.16

1.0

1.1

6.36

4.68

u/ml

0.23

584

Non-selective monoamine reuptake inhibitors

260

2095

1.20

2.16

1.1

2.91

3.84

u/ml

0.65

147

943

Nerve, nerve root and plexus disorders

1059

5926

1.10

2.16

1.1

4.53

4.95

u/ml

0.38

505

3000

Residual foreign body in soft tissue

362

1.50

2.16

1.1

5.97

7.18

u/ml

0.21

193

Benign paroxysmal vertigo

190

1542

1.24

2.15

1.1

4.19

4.69

u/ml

0.23

733

Unspecified/other endometriosis

131

1019

1.29

2.15

1.1

5.43

5.73

u/ml

0.08

540

Severe mental retardation

0.00

2.15

0.0

1.2

—

7.12

—

Convergence insufficiency and excess

123

1.91

2.15

1.2

1.1

3.58

6.90

u/ml

0.49

Adrenocortical insufficiency

243

1.62

2.15

1.1

1.95

6.98

u/ml

1.69

142

Diabetic nephropathy, excluding more controls

534

0.64

2.14

1.0

1.1

7.50

4.30

u/ml

0.60

258

Other skin changes

125

966

1.30

2.14

1.1

5.50

4.76

u/ml

0.20

491

Spinal instabilities

152

1.80

2.13

1.0

1.01

5.60

u/ml

2.35

Polyarteritis nodosa and related conditions

2.24

2.13

1.3

1.1

8.52

3.95

u/ml

—

Lichen planus

545

1.40

2.12

1.0

1.1

7.41

3.89

u/ml

0.69

252

Other and specified injuries of hip and thigh

2.07

2.12

1.1

1.0

0.97

9.08

u/ml

—

Pedestrian injured in other and unspecified transport accidents

2.49

2.12

1.2

1.1

1.00

6.59

u/ml

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

207

2015

0.82

2.11

1.0

1.1

3.18

3.52

u/ml

0.13

939

Contact with machinery

563

1.39

2.11

1.1

3.61

5.86

u/ml

0.67

283

Disturbances of smell and taste

190

1.70

2.11

1.1

1.0

0.94

4.29

u/ml

3.07

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

468

4105

1.14

2.10

1.1

4.34

4.71

u/ml

0.20

245

2011

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

244

1.61

2.10

1.0

4.91

4.29

u/ml

0.07

105

Chronic viral hepatitis

520

0.61

2.09

1.2

1.1

3.73

7.02

u/ml

0.94

268

Other erythematous conditions

168

1.74

2.08

1.1

1.54

6.43

u/ml

2.43

Examination and encounter for administrative purposes

168

1.74

2.08

1.0

1.1

4.34

7.24

u/ml

0.53

Hallux rigidus

539

1.40

2.07

1.1

2.48

2.94

u/ml

0.14

230

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

743

5273

0.90

2.07

1.1

4.73

4.50

u/ml

0.14

361

2586

Benign neoplasm: Scapula and long bones of upper limb

2.37

2.07

1.1

8.24

7.58

u/ml

—

Acute generalized exanthematous pustulosis

293

1.55

2.07

1.1

5.65

6.69

u/ml

0.13

168

Benign mammary dysplasia

736

1.34

2.07

1.1

4.96

3.70

u/ml

0.29

348

Other protozoal intestinal diseases

169

1.74

2.06

1.1

2.97

7.12

u/ml

1.24

Type1 diabetes, definitions combined, early onset

1181

0.74

2.06

1.1

7.20

7.48

u/ml

0.05

747

Hypertensive diseases

730

4572

0.90

2.05

1.1

4.90

4.82

u/ml

0.05

356

2349

Nontoxic multinodular goitre

117

902

1.30

2.05

1.1

3.34

3.90

u/ml

0.16

411

Generalized skin eruption due to drugs and medicaments

262

1.58

2.05

1.1

6.06

7.13

u/ml

0.13

151

Sequelae of cerebrovascular disease

1067

0.75

2.04

1.1

4.26

3.19

u/ml

0.28

487

Use of biperiden

274

0.47

2.03

1.0

1.1

1.98

6.16

u/ml

—

136

Mild mental retardation

286

0.48

2.03

1.1

1.2

0.11

7.73

u/ml

—

185

Xerosis cutis

2.53

2.02

1.0

14.28

7.97

u/ml

—

Type 1 diabetes, strict definition

104

1349

0.76

2.02

1.1

7.62

7.57

u/ml

0.01

847

Other retinal artery occlusion

2.52

2.01

1.0

0.29

4.84

u/ml

—

Struck by thrown, projected or falling objec

401

1.46

2.01

1.1

4.53

7.01

u/ml

0.66

228

Certain conditions originating in the perinatal period

201

1470

1.22

2.01

1.2

1.1

6.78

7.82

u/ml

0.36

128

954

Type 1 diabetes, definitions combined

116

1483

0.77

2.01

1.1

7.12

7.34

u/ml

0.04

916

Maternal care for other known or suspected fetal problems

335

2461

0.86

1.99

1.1

4.50

5.57

u/ml

0.61

164

1312

Osteopathies and chondropathies

464

3807

1.14

1.99

1.1

5.80

5.31

u/ml

0.23

246

1938

Other viral diseases

406

3539

1.15

1.99

1.1

7.20

6.42

u/ml

0.26

219

2023

Insulin, fast-acting or short human

253

2991

0.84

1.98

1.1

7.09

5.93

u/ml

0.42

136

1672

Abnormal involuntary movements

112

864

1.30

1.97

1.1

4.44

5.28

u/ml

0.30

451

Hypertension

730

4560

0.90

1.97

1.1

4.90

4.83

u/ml

0.04

356

2342

Coronary atherosclerosis

277

2065

0.85

1.97

1.0

1.1

2.81

3.43

u/ml

0.45

124

967

Helminthiases

1.97

1.1

1.06

5.26

u/ml

—

Viral pneumonia (known virus, not influenza)

134

1.81

1.96

1.2

1.1

2.76

7.96

u/ml

1.27

Burn and corrosion confined to eye and adnexa

164

1.73

1.96

1.1

12.87

7.27

u/ml

0.33

Glucosamine medication

188

1226

1.23

1.96

1.1

1.0

2.92

2.29

u/ml

0.23

519

Other factor of the environment

2.22

1.96

1.0

1.48

9.81

u/ml

—

Melanocytic naevi

297

2540

1.17

1.96

1.1

6.31

5.52

u/ml

0.33

161

1328

Benign neoplasm of mouth and pharynx

554

1.38

1.96

1.0

1.1

6.44

4.47

u/ml

0.47

276

Oxycodone

149

1677

0.80

1.95

1.0

1.1

3.45

4.04

u/ml

0.28

787

Diagnoses used for exclusion with ILD

157

1264

1.25

1.95

1.1

3.49

5.22

u/ml

0.76

633

Female genital prolapse

231

1085

1.21

1.95

1.1

3.57

4.52

u/ml

0.49

104

507

Colorectal adenocarcinoma

559

0.64

1.95

1.0

1.55

3.10

u/ml

1.13

251

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

146

1816

0.80

1.94

1.1

4.71

6.44

u/ml

0.65

989

Intracranial injury

585

4953

1.12

1.94

1.1

5.59

5.90

u/ml

0.13

337

2655

Pulmonary heart disease, diseases of pulmonary circulation

171

1390

1.23

1.94

1.0

1.1

4.40

4.29

u/ml

0.03

674

Zoster [herpes zoster]

345

2939

1.16

1.93

1.0

1.1

5.31

4.82

u/ml

0.21

181

1439

Insulin, fast-acting

253

2983

0.85

1.93

1.1

7.09

5.92

u/ml

0.43

136

1673

Testicular dysfunction

219

1.61

1.92

1.1

2.89

7.08

u/ml

1.58

115

Major coronary heart disease event excluding revascularizations

228

1814

0.84

1.92

1.1

1.0

2.36

3.42

u/ml

0.91

856

Hyperlipidaemia, other/unspecified

188

1421

1.22

1.92

1.1

2.46

3.53

u/ml

0.64

671

Abnormal findings on diagnostic imaging of central nervous system

323

1.50

1.92

1.1

5.18

4.54

u/ml

0.13

173

Respiratory insufficiency

127

1.81

1.92

1.0

1.15

3.51

u/ml

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

166

1.72

1.91

1.1

9.50

5.55

u/ml

0.44

102

Mixed conductive and sensorineural hearing loss

472

1.40

1.91

1.0

1.13

4.21

u/ml

4.10

239

Localized swelling, mass and lump of skin and subcutaneous tissue

270

2297

1.18

1.91

1.1

6.63

5.35

u/ml

0.30

139

1190

Lyme disease

237

1994

1.19

1.90

1.1

4.05

5.03

u/ml

0.65

123

989

139

1013

1.26

1.90

1.0

2.43

2.79

u/ml

0.14

446

Type 1 diabetes, strict definition, subgroup 1

1281

0.76

1.90

1.1

7.09

7.69

u/ml

0.12

801

Right bundle-branch block

1.97

1.90

1.1

3.31

7.33

u/ml

—

Campylobacter enteritis

143

1.77

1.90

1.2

1.1

0.31

7.56

u/ml

4.04

Tongue abnormality

267

1.55

1.90

1.1

2.50

3.85

u/ml

0.61

129

Cholecystitis

523

1.38

1.90

1.1

6.06

4.18

u/ml

0.27

245

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

280

0.50

1.89

1.0

2.64

4.03

u/ml

—

127

Abnormal findings on diagnostic imaging of other body structures

695

1.33

1.89

1.1

3.78

4.27

u/ml

0.17

339

Malignant neoplasm of breast, HER-negative

961

0.73

1.89

1.1

6.66

2.34

u/ml

0.68

435

Spirochaetal infections, other/unspecified

239

2014

1.19

1.89

1.1

4.05

5.08

u/ml

0.70

123

1002

Chronic apical periodontitis

1097

6769

0.92

1.88

1.1

4.52

5.77

u/ml

1.75

580

3463

Haemorrhage in early pregnancy

342

2889

1.16

1.88

1.1

3.85

5.02

u/ml

0.96

151

1478

Ulcerative colitis (strict definition, all Crohn cases excluded)

104

1339

0.77

1.87

1.1

7.00

u/ml

0.00

730

Benign intracranial hypertension

115

1.87

1.86

1.1

2.59

5.50

u/ml

—

Fracture of femur

803

0.72

1.86

1.0

1.1

2.31

4.71

u/ml

2.03

417

Rash and other nonspecific skin eruption

637

1.34

1.86

1.1

6.76

4.86

u/ml

0.41

347

Seborrhoeic keratosis

110

854

1.29

1.86

1.1

2.63

3.79

u/ml

0.56

377

Disorder of lipoprotein metabolism, unspecified

399

1.43

1.86

1.0

1.1

1.69

3.97

u/ml

1.56

196

Other specified/unspecified hearing loss

325

1.48

1.86

1.1

3.26

5.45

u/ml

0.80

170

Ischemic heart diseases

563

3777

0.89

1.85

1.1

3.65

4.22

u/ml

0.51

258

1905

Other disorders starting during childhood or adolecense, excluding more controls

121

914

1.28

1.85

1.1

6.23

7.69

u/ml

0.42

616

Valvular heart disease excluding rheumatic fever

230

1971

0.84

1.84

1.1

5.91

4.31

u/ml

0.63

100

1028

Family history of malignant neoplasm

996

0.74

1.84

1.1

1.81

5.70

u/ml

4.45

499

Mental and behavioural disorders due to sedatives or hypnotics

587

0.66

1.84

1.0

1.1

6.40

6.13

u/ml

0.03

314

Heart failure, strict

178

1525

0.82

1.83

1.0

1.1

5.91

2.93

u/ml

0.87

738

Vascular disorders of the intestines

137

1.76

1.83

1.0

3.70

5.44

u/ml

—

Burns and corrosions confined to eye and internal organs

191

1.64

1.82

1.1

11.44

6.91

u/ml

0.30

Atrial fibrillation and flutter

198

1544

0.83

1.82

1.0

1.1

3.45

4.61

u/ml

0.84

741

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.95

1.82

1.0

1.1

2.44

7.50

u/ml

1.42

Injury of muscle and tendon at ankle and foot level

168

1.69

1.82

1.0

1.1

3.43

6.96

u/ml

0.95

Tic and related disorders

232

1.59

1.81

1.1

1.2

3.96

6.58

u/ml

0.87

171

Perforation of tympanic membrane

701

1.32

1.81

1.1

4.27

6.00

u/ml

0.62

381

Infective bursitis

123

1.80

1.81

1.0

1.1

6.61

7.30

u/ml

—

Congenital absence, atresia and stenosis of large intestine

0.00

1.80

0.0

1.2

—

11.53

—

Bilateral sagittal split ramus osteotomy operation

320

1.49

1.80

1.0

1.1

3.86

6.25

u/ml

0.48

165

Exposure to other and unspecified inanimate mechanical forces

641

1.34

1.80

1.1

4.46

6.15

u/ml

0.64

353

Calculus of kidney and ureter

194

1612

1.21

1.80

1.1

4.76

5.16

u/ml

0.12

107

807

Other disorders of cornea

512

1.37

1.79

1.1

8.44

4.93

u/ml

0.63

253

All-cause Heart Failure

174

1492

0.82

1.79

1.0

1.1

5.82

2.95

u/ml

0.82

718

Gastric ulcer

520

1.37

1.79

1.1

1.86

4.00

u/ml

1.50

245

Malignant neoplasm of prostate, including Hilmo

567

0.73

1.79

1.0

5.44

3.17

u/ml

0.28

252

Polyarthritis, unspecified

184

1.64

1.79

1.1

6.63

4.75

u/ml

0.30

Malignant neoplasm of prostate

529

0.72

1.79

1.0

1.1

6.09

3.27

u/ml

0.32

231

Early lumbar disc prolapse, operated

135

1083

1.25

1.78

1.1

4.31

6.18

u/ml

0.94

557

Oral lichen planus, including avohilmo , including avohilmo

304

1.49

1.78

1.0

1.1

3.47

3.73

u/ml

0.05

145

Scleritis and episcleritis

429

1.41

1.77

1.1

4.19

4.84

u/ml

0.12

220

Contusion of toe(s) with damage to nail

2.01

1.77

1.1

1.0

14.41

7.21

u/ml

—

Post-traumatic stress disorder

135

1085

1.25

1.76

1.1

4.61

6.33

u/ml

0.58

610

Other retinal disorders

314

2820

0.87

1.76

1.0

1.1

4.65

5.00

u/ml

0.15

164

1410

Dizziness and giddiness

665

4774

1.11

1.76

1.1

4.81

4.74

u/ml

0.04

334

2392

Oral lichen planus

1.91

1.76

1.0

7.22

2.45

u/ml

—

Leiomyoma of uterus

492

3128

0.89

1.75

1.1

2.64

3.73

u/ml

1.45

202

1469

Bleeding

555

4391

0.90

1.75

1.1

5.42

4.99

u/ml

0.17

288

2237

Inflammatory disorders of breast

645

1.33

1.74

1.1

5.43

5.81

u/ml

0.10

337

Benign neoplasms

1214

6214

1.08

1.73

1.1

5.36

6.16

u/ml

0.90

626

3305

Other follicular disorders

628

1.33

1.73

1.1

6.00

6.01

u/ml

0.00

329

Non-seminoma of testis, including Hilmo

0.00

1.73

0.0

1.1

—

8.33

—

Heart failure,strict

174

1484

0.83

1.72

1.0

1.1

6.04

2.88

u/ml

0.92

718

Malignant neoplasm of bronchus and lung, including Hilmo

476

0.67

1.72

1.0

1.1

4.64

2.49

u/ml

0.31

215

Ptosis of eyelid

389

1.42

1.72

1.1

3.45

3.71

u/ml

0.04

183

Fasciculation

2.09

1.72

1.0

2.97

6.55

u/ml

—

Dialysis

256

0.50

1.72

1.3

1.1

0.60

6.77

u/ml

—

157

Myocarditis

323

1.46

1.72

1.1

7.98

5.46

u/ml

0.53

164

Other demyelinating diseases of the central nervous system

357

0.58

1.70

1.0

1.1

0.85

6.53

u/ml

—

189

Implicit bacterial Sepsis

182

1885

0.83

1.70

1.0

1.1

3.72

4.32

u/ml

0.23

930

Fever of other and unknown origin

560

4490

1.11

1.69

1.1

4.68

5.98

u/ml

1.30

310

2369

Varicose veins

317

2748

0.87

1.69

1.1

3.26

3.38

u/ml

0.04

117

1224

Inflammatory disease of cervix uteri

316

1.46

1.69

1.1

2.23

2.55

u/ml

0.15

143

Spirochaetal infections, other/unspecified

450

1.38

1.69

1.1

3.70

4.23

u/ml

0.14

235

Hordeolum and other deep inflammation of eyelid

476

1.38

1.69

1.1

1.36

5.86

u/ml

5.36

271

Benign neoplasm of other and unspecified female genital organs

219

1.56

1.68

1.1

8.32

2.63

u/ml

1.09

107

Demyelinating diseases of the central nervous system

820

0.73

1.68

1.0

1.1

4.59

5.69

u/ml

0.22

437

Single delivery by caesarean section

251

1683

0.85

1.68

1.1

5.90

5.76

u/ml

0.04

122

920

Congenital malformations of the musculoskeletal system, not elsewhere classified

204

1.60

1.68

1.1

9.50

5.85

u/ml

0.40

119

Puerperal sepsis

108

851

1.27

1.67

1.1

2.55

4.62

u/ml

2.41

399

Adenocarcinoma and papilloma adenocarcinoma of rectum

267

0.52

1.67

1.0

2.64

4.14

u/ml

—

120

Cerebral cysts

477

1.37

1.67

1.1

2.54

6.04

u/ml

2.78

266

Neuralgia and neuritis, unspecified

276

1.49

1.67

1.1

3.00

7.14

u/ml

1.34

132

Other/unspecified synovitis and tenosynovitis

728

1.30

1.66

1.0

1.1

4.48

5.79

u/ml

0.41

349

MS-disease / Multiple Sclerosis

702

0.71

1.66

1.0

1.1

5.32

5.42

u/ml

0.01

381

Mucosal proctocolitis

1170

0.77

1.66

1.1

6.25

6.81

u/ml

0.11

626

Other functional intestinal disorders

401

3294

1.13

1.66

1.1

4.92

5.42

u/ml

0.16

207

1790

Pure hypercholesterolaemia

418

3074

0.89

1.65

1.1

4.75

4.14

u/ml

0.29

215

1466

Monoamine oxidase A inhibitors

624

1.32

1.65

1.0

1.1

5.85

4.68

u/ml

0.20

299

Superficial injury of shoulder and upper arm

107

844

1.27

1.65

1.1

2.58

6.31

u/ml

2.89

446

Chronic periodontitis, complicated

287

3275

0.87

1.65

1.1

4.02

4.29

u/ml

0.10

143

1531

Female infertility, tubal origin

402

1.40

1.64

1.1

4.77

5.33

u/ml

0.11

191

Ulcerative colitis (strict definition, require KELA)

128

1579

0.81

1.63

1.1

7.13

6.54

u/ml

0.13

853

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

138

1689

0.81

1.63

1.1

7.47

6.53

u/ml

0.22

921

Extracorporeal dialysis

290

0.55

1.63

1.2

1.1

5.29

6.47

u/ml

—

155

Dental caries

225

1841

1.18

1.62

1.1

5.81

5.92

u/ml

0.03

141

958

Retinal breaks without detachment

704

1.30

1.62

1.1

3.88

4.48

u/ml

0.15

323

Enlarged lymph nodes

145

1186

1.23

1.62

1.1

6.75

6.30

u/ml

0.10

642

Tobacco use

361

1.42

1.62

1.0

1.1

9.30

6.67

u/ml

0.36

178

Cardiovascular diseases

1077

5370

1.08

1.62

1.1

6.48

6.33

u/ml

0.10

585

3017

Lesion of ulnar nerve

109

864

1.27

1.61

1.1

2.27

5.15

u/ml

2.36

420

Acute lymphadenitis

575

1.33

1.61

1.1

4.79

6.34

u/ml

0.45

317

Lifestyle-related condition

2.10

1.61

1.0

1.48

8.18

u/ml

—

Single ventricle heart

0.00

1.61

0.0

1.3

—

6.16

—

Other diseases of pleura

222

1654

1.18

1.60

1.0

1.1

4.63

3.93

u/ml

0.18

819

Bacterial infection, other or unspecified

284

2835

0.87

1.60

1.0

1.1

4.71

4.90

u/ml

0.08

158

1460

Spinal stenosis

251

1634

1.17

1.60

1.1

1.99

3.23

u/ml

1.42

117

698

Other/unspecified rheumatoid arthritis

486

0.66

1.60

1.1

1.23

3.69

u/ml

2.84

229

Endometriosis of ovary

164

1327

1.21

1.60

1.0

1.1

4.28

5.04

u/ml

0.28

654

Major coronary heart disease event

539

3607

0.90

1.60

1.1

3.52

4.16

u/ml

0.57

240

1818

Poisoning by drugs, medicaments and biological substances

221

2586

0.85

1.59

1.1

4.96

6.42

u/ml

0.78

116

1405

Malignant neoplasm of bronchus and lung

364

0.64

1.59

1.0

4.71

2.35

u/ml

0.24

162

Melanocytic naevi of other and unspecified parts of face

413

1.39

1.59

1.2

1.1

6.64

5.25

u/ml

0.26

216

Postdysenteric arthropathy

2.24

1.58

1.1

1.0

2.79

8.14

u/ml

—

Familial hypercholesterolemia

447

1.37

1.57

1.0

1.1

3.92

4.52

u/ml

0.14

229

Care involving dialysis

399

0.62

1.57

1.2

1.1

3.63

4.59

u/ml

0.15

213

Faecal incontinence

346

1.42

1.57

1.1

1.0

1.80

3.42

u/ml

0.85

164

Endometriosis of rectovaginal septum and vagina

482

1.36

1.57

1.1

2.63

5.13

u/ml

1.45

241

Drug-induced neutropenia

324

0.58

1.56

1.1

5.02

4.00

u/ml

—

157

Spondylopathies

646

3510

1.10

1.56

1.1

3.76

4.81

u/ml

0.93

302

1723

Colorectal neuroendocrine tumor and carcinoma

2.13

1.56

1.0

23.21

6.72

u/ml

—

Heterophoria

104

825

1.27

1.55

1.1

6.36

6.69

u/ml

0.07

484

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

125

1536

0.81

1.55

1.1

7.21

6.61

u/ml

0.13

835

Hypersomnia

1.95

1.55

1.2

1.1

4.37

5.30

u/ml

—

Muscle strain

216

1.54

1.55

1.1

4.41

7.58

u/ml

0.63

114

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

316

2773

1.14

1.54

1.1

3.97

5.36

u/ml

1.07

176

1458

Bulimia nervosa (incl. atypical)

459

1.37

1.54

1.1

3.04

7.61

u/ml

3.19

254

Other congenital malformations of tongue, mouth and pharynx

373

1.42

1.54

1.2

3.89

7.16

u/ml

1.76

278

Female infertility, associated with anovulation

128

1042

1.24

1.53

1.0

1.1

6.07

5.47

u/ml

0.18

560

Leiomyosarcoma

3.38

1.53

1.0

—

2.72

—

Disorders of vitreous body

277

2327

1.15

1.52

1.0

1.1

4.56

3.62

u/ml

0.22

131

1044

Unknown and unspecified causes of morbidity

442

1.36

1.52

1.2

1.1

5.93

6.53

u/ml

0.10

231

Misadventures to patients during surgical and medical care

105

836

1.26

1.52

1.1

4.79

5.03

u/ml

0.05

418

Superficial injury of hip and thigh

100

791

1.27

1.52

1.2

1.1

8.49

5.38

u/ml

0.61

412

malignant neoplasm of female genital organs

652

0.71

1.52

1.0

1.1

4.79

2.19

u/ml

0.58

297

Complications of procedures, not elsewhere classified

777

5919

1.09

1.51

1.1

4.83

4.86

u/ml

0.02

401

2957

Benign neoplasm: Skin of eyelid, including canthus

695

1.28

1.50

1.0

1.1

4.60

4.61

u/ml

0.00

326

Barrett oesophagus

154

1.63

1.50

1.1

1.0

0.37

5.14

u/ml

—

Other specified/unspecified dorsopathies

170

1.60

1.49

1.2

1.1

4.77

4.15

u/ml

0.07

Background retinopathy and retinal vascular changes

1.96

1.49

1.0

1.1

7.82

6.31

u/ml

—

Other and unspecified mononeuropathies, also in other diseases

116

1.74

1.49

1.1

1.0

3.85

4.45

u/ml

—

Malignant neoplasm of corpus uteri, including Hilmo

307

0.58

1.49

1.1

1.0

1.47

1.63

u/ml

—

141

Other hammer toe(s) (acquired)

552

1.31

1.49

1.1

3.33

3.36

u/ml

0.00

227

Other orthopaedic follow-up care

292

1.45

1.48

1.1

4.22

3.97

u/ml

0.03

140

Congenital ichthyosis

2.60

1.48

1.1

1.0

3.59

11.37

u/ml

—

False labour

496

2789

1.11

1.47

1.1

5.49

5.38

u/ml

0.06

266

1440

Non-rheumatic valve diseases

227

1903

0.86

1.47

1.1

5.97

4.26

u/ml

0.68

982

Symptoms and signs concerning food and fluid intake

741

1.27

1.47

1.1

2.57

5.86

u/ml

3.11

450

Syncope and collapse

348

2638

1.13

1.46

1.1

4.79

5.73

u/ml

0.57

186

1368

Other disorders of conjunctiva

549

1.32

1.46

1.1

5.48

3.32

u/ml

0.54

243

Other and unspecified injuries of neck

2.15

1.46

1.1

5.37

6.70

u/ml

—

Congenital malformations of trachea and bronchus

1.96

1.46

1.2

4.96

6.65

u/ml

—

Autoimmune thyroiditis

148

1.64

1.46

1.0

1.1

2.09

5.81

u/ml

1.27

Disorders of vitreous body and globe

285

2395

1.14

1.45

1.0

1.1

4.74

3.71

u/ml

0.26

135

1082

Umbilical hernia

209

1789

1.17

1.45

1.1

6.29

5.07

u/ml

0.39

116

913

Unspecified fall

461

4095

1.11

1.44

1.1

5.50

6.11

u/ml

0.36

272

2249

Dermatitis herpetiformis

1.94

1.44

1.0

8.56

6.09

u/ml

—

Pacemaker

864

0.76

1.44

1.0

1.1

1.83

4.04

u/ml

2.13

433

Amblyopia ex anopsia

456

1.35

1.44

1.1

4.24

6.91

u/ml

1.06

292

Maternal care for other conditions predominantly related to pregnancy

312

2699

1.14

1.44

1.1

3.28

5.72

u/ml

3.80

155

1402

Osteoporosis

113

853

1.24

1.43

1.1

5.02

4.08

u/ml

0.18

411

Other congenital malformations of the digestive system

679

1.28

1.43

1.1

1.2

3.45

6.15

u/ml

1.98

459

Ingrowing nail

413

1.37

1.43

1.1

6.31

6.33

u/ml

0.00

228

Bacterial infection, other or unspecified

337

3212

0.89

1.43

1.1

5.31

4.90

u/ml

0.21

188

1651

Disorders of lipoprotein metabolism and other lipidaemias

534

3642

0.91

1.43

1.1

4.22

4.36

u/ml

0.07

261

1774

Laparoscopic right hemicolectomy

133

1.66

1.42

1.0

3.43

4.65

u/ml

—

Poisoning by medicine

201

2343

0.86

1.42

1.1

5.19

6.15

u/ml

0.39

106

1274

Invasive ventilation

436

0.66

1.42

1.1

1.03

5.07

u/ml

4.56

261

ILD medications: immunosuppressive drugs

597

5067

1.10

1.42

1.1

5.54

5.52

u/ml

0.01

312

2561

Cysts of oral region, not elsewhere classified

354

1.39

1.42

1.0

1.1

3.27

6.67

u/ml

1.82

195

Congenital malformations of great arteries

447

0.67

1.41

1.0

1.2

4.41

5.83

u/ml

0.42

339

Alcohol abuse, main dg

105

1298

0.81

1.41

1.1

4.08

6.51

u/ml

0.88

695

Dislocation, sprain and strain of joints and ligaments of thorax

205

1.52

1.41

1.0

1.1

8.58

6.58

u/ml

0.17

106

Alzheimer disease, excluding more controls

217

0.61

1.41

1.1

1.0

1.59

1.31

u/ml

—

DVT of lower extremities and pulmonary embolism

227

1952

1.16

1.41

1.0

1.1

4.00

4.41

u/ml

0.16

120

931

Polycystic ovarian syndrome, consortium definition

867

4759

1.08

1.41

1.1

4.51

5.28

u/ml

0.87

438

2383

Other articular cartilage disorders

1.87

1.40

1.1

1.0

1.71

8.22

u/ml

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

492

4401

1.10

1.40

1.1

4.47

4.74

u/ml

0.14

259

2175

Congenital malformations and deformations of the musculoskeletal system

156

1303

1.20

1.39

1.1

7.25

6.15

u/ml

0.32

100

819

Alopecia areata

214

1.51

1.39

1.0

1.1

12.30

5.41

u/ml

0.76

125

Fall on and from ladder

313

1.41

1.39

1.1

5.87

6.28

u/ml

0.05

160

Diseases of arteries, arterioles and capillaries (FINNGEN)

129

1082

0.82

1.38

1.1

5.28

3.83

u/ml

0.40

525

Urolithiasis

199

1705

1.17

1.38

1.1

4.72

5.09

u/ml

0.12

108

850

Other and unspecified erythematous conditions

158

1.59

1.38

1.1

1.73

6.61

u/ml

2.27

Achilles tendinitis

572

1.30

1.38

1.1

5.52

4.54

u/ml

0.18

262

Disorders of vestibular function (Vertigo)

303

2631

1.13

1.37

1.1

4.42

4.37

u/ml

0.02

145

1242

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

231

1.49

1.37

1.1

9.03

6.76

u/ml

0.22

117

Benign neoplasm: Larynx

104

1.74

1.37

1.2

1.1

3.63

5.67

u/ml

—

Other and unspecified injuries of ankle and foot

435

1.34

1.35

1.1

4.95

5.85

u/ml

0.14

245

Secondary and unspecified malignant neoplasm of lymph nodes

359

0.64

1.35

1.1

4.80

5.02

u/ml

0.03

183

Hernia of abdominal wall

330

2934

1.13

1.35

1.1

5.61

4.70

u/ml

0.39

170

1451

Other specified/unspecified systemic involvement of connective tissue

349

1.38

1.35

1.1

5.60

4.25

u/ml

0.22

167

Macular pucker

357

1.38

1.35

1.0

1.1

1.41

2.41

u/ml

0.72

157

Focal epilepsy

143

1705

0.84

1.35

1.1

4.46

6.23

u/ml

0.95

958

Anogenital herpesviral [herpes simplex] infection

690

1.27

1.35

1.1

3.33

6.45

u/ml

3.01

381

Erythema intertrigo

1.88

1.35

1.0

7.47

5.82

u/ml

—

Overexertion and strenuous or repetitive movements

761

1.25

1.34

1.1

4.57

5.67

u/ml

0.37

398

Emotional disorders and disorders of social functioning with onset specific to childhood

126

1025

1.22

1.34

1.1

6.05

7.65

u/ml

0.51

668

Postmenopausal bleeding

142

627

1.21

1.34

1.1

1.80

3.11

u/ml

0.90

261

Isolated growth hormone deficiency

217

0.53

1.34

1.1

1.3

7.08

7.02

u/ml

—

172

Congenital malformations and deformations of the musculoskeletal system

183

1556

1.18

1.33

1.1

6.87

6.76

u/ml

0.03

112

963

L04AC Interleukin inhibitors

511

0.70

1.33

1.1

3.38

5.87

u/ml

1.08

280

Secondary malignant neoplasm of other and unspecified sites

0.00

1.33

0.0

1.0

—

1.90

—

Chalazion

101

816

1.24

1.33

1.1

4.42

5.69

u/ml

0.52

418

Dental caries, including avohilmo

731

3448

1.09

1.32

1.1

5.12

5.48

u/ml

0.22

381

1757

Personality disorders, excluding more controls

318

2826

1.13

1.32

1.1

4.98

6.06

u/ml

0.64

181

1477

Single delivery by forceps and vacuum extractor

219

1522

0.86

1.32

1.1

4.45

5.96

u/ml

0.95

105

850

Otorrhagia

0.00

1.32

0.0

1.1

—

7.99

—

Congenital malformations of the respiratory system

201

1.51

1.31

1.1

1.2

3.82

6.76

u/ml

0.68

139

Acute nasopharyngitis (common cold)

113

919

1.23

1.31

1.1

6.39

5.69

u/ml

0.16

508

Collagenous colitis

533

1.30

1.31

1.1

6.12

5.10

u/ml

0.19

284

Juvenile osteochondrosis

352

1.38

1.30

1.0

1.1

9.91

7.09

u/ml

0.33

205

Contact with and exposure to communicable diseases

418

4599

0.90

1.30

1.1

6.59

6.47

u/ml

0.05

230

2582

Symptoms and signs involving the nervous and musculoskeletal systems

516

4707

1.10

1.30

1.1

4.44

5.15

u/ml

0.59

271

2469

Other superficial mycoses

153

1.59

1.30

1.1

1.91

6.77

u/ml

1.82

Other congenital malformations of circulatory system

145

1.60

1.30

1.1

1.0

9.25

5.84

u/ml

0.38

Benign neoplasm: Vulva

1.77

1.29

1.1

10.78

1.80

u/ml

—

Symptoms and signs involving emotional state

268

1.43

1.29

1.2

1.1

11.13

5.76

u/ml

0.72

158

Cellulitis

202

1746

1.16

1.28

1.1

4.80

6.05

u/ml

0.63

107

951

Biological medication for rheuma

152

1793

0.84

1.28

1.1

2.98

6.34

u/ml

3.31

967

Episcleritis

370

1.36

1.28

1.1

3.61

4.92

u/ml

0.28

186

Benign neoplasm of major salivary glands

404

1.34

1.28

1.1

1.93

4.29

u/ml

1.63

200

Oral leukoplakia, including avohilmo

1.73

1.27

1.1

0.24

6.95

u/ml

—

Pilonidal cyst

948

0.79

1.27

1.1

6.40

6.68

u/ml

0.04

505

Agranulocytosis

656

0.74

1.27

1.2

1.1

3.54

4.74

u/ml

0.36

344

Rheumatoid arthritis

171

1792

0.85

1.26

1.1

2.71

4.62

u/ml

1.62

810

Viral infections of central nervous system, not elsewhere classified/unspecified

1.84

1.26

1.0

1.1

7.60

6.75

u/ml

—

Bicornuate uterus

1.90

1.26

1.1

4.43

2.36

u/ml

—

Other bursitis of hip

1.83

1.26

1.1

1.0

0.99

7.53

u/ml

—

Pregnancy, childbirth and the puerperium

277

1639

0.88

1.25

1.1

4.72

7.00

u/ml

1.64

144

894

Finngen Rheumatological endpoints

1034

6269

0.94

1.25

1.1

5.14

5.56

u/ml

0.32

535

3258

Intermittent heterotropia

810

0.77

1.25

1.0

1.1

3.49

6.47

u/ml

1.26

521

Conotruncal defects

276

0.60

1.25

1.1

1.2

7.28

6.84

u/ml

0.05

206

Aplastic and other anaemias

187

2020

0.86

1.25

1.1

4.71

4.79

u/ml

0.02

1017

Pneumonia due to Streptococcus pneumoniae

203

1.49

1.25

1.0

1.1

14.84

6.68

u/ml

0.62

Impacted cerumen

502

1.30

1.24

1.1

3.75

5.66

u/ml

0.54

283

Emergency coronary revascularization (for ACS)

531

3528

0.91

1.24

1.1

3.41

4.15

u/ml

0.69

227

1783

Myopia

169

1446

1.17

1.24

1.1

3.99

6.30

u/ml

1.30

794

Benign neoplasm: Parotid gland

329

1.37

1.24

1.1

2.19

4.75

u/ml

1.42

160

Other and unspecified myopathies

339

0.65

1.24

1.0

1.1

2.33

5.55

u/ml

1.71

170

Diffuse brain injury

228

0.57

1.24

1.0

1.1

2.68

5.69

u/ml

—

128

Seropositive rheumatoid arthritis, strict definition

823

0.78

1.24

1.0

1.1

3.74

4.56

u/ml

0.19

393

Other disorders of Eustachian tube

171

1.53

1.24

1.1

10.29

6.76

u/ml

0.27

Disorders of lacrimal system and orbit in diseases classified elsewhere

139

1.60

1.24

1.0

1.1

2.08

3.01

u/ml

0.41

Malignant neoplasm of rectum

278

0.61

1.24

1.1

6.87

3.99

u/ml

—

125

Disorders of gallbladder, biliary tract and pancreas

794

5379

0.93

1.23

1.1

3.65

4.64

u/ml

1.22

376

2681

Colorectal cancer

728

0.76

1.23

1.0

6.60

3.13

u/ml

0.52

323

Calcific aortic valvular stenosis, diagnosis (helper)

624

1.26

1.23

1.0

1.1

2.65

3.81

u/ml

0.34

297

Operations 2 for CAVS

624

1.26

1.23

1.0

1.1

2.65

3.81

u/ml

0.34

297

Benign neoplasm: Bones of skull and face

2.07

1.23

1.0

18.63

9.62

u/ml

—

Lymphoid leukaemia

240

0.58

1.23

1.2

4.47

7.41

u/ml

—

154

Postpartum hemorraghe, parous women as controls

352

2692

1.12

1.22

1.1

5.60

5.02

u/ml

0.29

160

1337

Injury of muscle and tendon at hip and thigh level

628

1.26

1.22

1.2

1.1

6.21

5.00

u/ml

0.34

311

Exposure to other and unspecified animate mechanical forces

314

1.38

1.22

1.1

5.05

6.25

u/ml

0.27

185

Artrosis, including avohilmo

815

4150

1.08

1.21

1.1

5.18

4.79

u/ml

0.21

393

2074

Pre-eclampsia

176

2041

0.86

1.21

1.1

2.66

4.82

u/ml

2.65

1034

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

417

1.32

1.21

1.1

7.03

4.55

u/ml

0.36

214

Vascular diseases of the intestine

1.80

1.21

1.1

1.0

6.16

5.75

u/ml

—

Cardiac murmurs and other cardiac sounds

109

889

1.22

1.20

1.1

10.89

7.19

u/ml

0.92

511

Amputation

263

0.61

1.19

1.0

1.1

13.41

4.89

u/ml

—

122

Other arrhythmias

616

4288

1.08

1.19

1.1

5.07

4.64

u/ml

0.27

293

2168

Event of undetermined intent

568

1.27

1.19

1.2

1.1

4.22

6.29

u/ml

0.91

312

Viral meningitis

315

1.38

1.19

1.0

1.1

7.66

5.91

u/ml

0.27

167

Exclusions for E4_PCOS_BROAD

196

1701

1.16

1.19

1.1

4.10

6.16

u/ml

1.28

987

Benign neoplasm: salivary glands, exclude unknown (D119)

366

1.34

1.19

1.1

2.09

4.37

u/ml

1.34

182

Sequelae of injuries of lower limb

657

1.25

1.19

1.1

3.80

5.02

u/ml

0.47

326

Meralgia paraesthetica

181

1.50

1.19

1.1

1.0

1.02

5.14

u/ml

2.68

Juvenile arthritis (FINNGEN)

658

0.75

1.18

1.1

5.04

7.28

u/ml

0.39

393

Achalasia of cardia

1.89

1.18

1.0

2.37

6.51

u/ml

—

Calcific aortic valvular stenosis, including rheumatic fever

627

1.25

1.18

1.0

1.1

2.65

3.78

u/ml

0.33

299

Actinic keratosis

105

799

1.22

1.18

1.0

3.11

2.25

u/ml

0.27

351

Other and unspecified injuries of lower leg

667

1.25

1.18

1.0

1.1

7.19

6.64

u/ml

0.08

370

Vitiligo

1.80

1.18

1.0

1.1

2.39

3.76

u/ml

—

Delayed milestone in childhood

526

0.73

1.18

1.2

5.12

6.34

u/ml

0.23

411

KRA_PSY_EATING, excluding more controls

145

1226

1.18

1.1

5.74

7.30

u/ml

0.47

711

Other neurotic disorders

206

1.46

1.17

1.3

1.1

1.81

6.15

u/ml

2.55

100

Lichen sclerosus et atrophicus

516

1.28

1.17

1.1

3.89

4.96

u/ml

0.40

245

Generalized epilepsy, mode (most common among epilepsy diagnosis)

334

1.36

1.16

1.1

7.18

6.79

u/ml

0.05

209

Hydronephrosis

578

0.74

1.16

1.0

1.1

2.32

5.10

u/ml

2.38

293

Viral infections of the central nervous system

597

1.26

1.16

1.1

9.61

5.55

u/ml

0.91

321

Congenital malformations of breast

216

1.45

1.15

1.1

2.25

5.85

u/ml

1.52

114

Basal cell carcinoma, including avohilmo

171

1367

0.86

1.15

1.1

2.50

2.74

u/ml

0.12

608

Crushed, pushed or stepped on by crowd or human stampede

107

887

1.21

1.15

1.1

9.25

7.27

u/ml

0.46

512

Focal epilepsy, mode (most common among epilepsy diagnosis)

121

1438

0.84

1.14

1.1

3.80

6.20

u/ml

1.58

805

Prepatellar bursitis

224

1.44

1.14

1.0

1.1

7.98

7.05

u/ml

—

103

Other congenital malformations of ear

192

1.48

1.14

1.1

2.53

6.03

u/ml

1.60

129

Benign lipomatous neoplasm

197

1718

1.15

1.14

1.0

1.1

3.08

4.97

u/ml

2.38

842

Ulcer of oesophagus

191

1.47

1.13

1.2

1.1

3.12

5.90

u/ml

0.68

Use of donepezil

260

0.63

1.13

1.0

2.08

1.68

u/ml

—

102

Crohn disease (strict definition, all UC cases excluded)

475

1.29

1.13

1.1

8.67

6.31

u/ml

0.33

258

Abnormal findings on examination of blood, without diagnosis

299

2457

1.12

1.13

1.1

4.37

5.18

u/ml

0.40

143

1281

Astigmatism

689

1.24

1.12

1.1

4.00

6.53

u/ml

1.28

439

Tooth agenesis EXCLUDE clefts and syndromes

646

1.25

1.12

1.1

10.18

8.22

u/ml

0.31

408

Need for other prophylactic measures

423

1.31

1.12

1.1

5.12

6.01

u/ml

0.20

252

Trigger finger

100

825

1.22

1.12

1.0

1.1

4.12

5.51

u/ml

0.37

377

Viral Sepsis

143

1219

1.18

1.12

1.1

4.98

5.13

u/ml

0.04

661

Unspecified kidney failure

270

0.63

1.11

1.1

1.0

9.15

6.73

u/ml

0.22

131

Myocardial infarction

173

1406

0.86

1.11

1.1

1.0

2.77

3.00

u/ml

0.11

651

Calcific aortic valvular stenosis, operated

633

1.24

1.11

1.0

1.1

2.65

3.78

u/ml

0.33

303

Calcific aortic valvular stenosis

633

1.24

1.11

1.0

1.1

2.65

3.78

u/ml

0.33

303

Skin changes due to chronic exposure to nonionizing radiation

113

869

1.20

1.11

1.0

2.99

2.15

u/ml

0.30

386

Stenosis and insufficiency of lacrimal passages

476

1.29

1.11

1.1

5.52

5.49

u/ml

0.00

250

Alzheimer’s disease, strict definition

282

0.67

1.10

1.0

1.27

1.71

u/ml

—

107

Mandibular retrognathia AND surgery (BSSO)

235

1.42

1.10

1.1

4.39

6.07

u/ml

0.23

120

Hypogonadotropic hypogonadism

193

1.46

1.10

1.1

4.43

7.76

u/ml

0.79

104

Benign neoplasm: Tongue

104

1.65

1.09

1.0

10.63

6.12

u/ml

—

Other disorders of veins

302

2697

1.11

1.09

1.1

4.19

3.79

u/ml

0.17

158

1247

Speech and linguistic disorders

175

1459

1.16

1.09

1.1

6.19

7.73

u/ml

0.51

111

959

Abnormal results of function studies

593

1.25

1.09

1.0

1.1

5.64

5.46

u/ml

0.04

322

Coronary revascularization (ANGIO or CABG)

519

3450

0.92

1.09

1.1

3.45

4.17

u/ml

0.65

224

1742

Bullous disorders

218

1.43

1.09

1.0

1.1

6.89

5.24

u/ml

0.17

102

Tumor necrosis factor alpha inhibitors

140

1635

0.85

1.09

1.1

2.59

6.21

u/ml

3.48

880

Carcinoma in situ of other and unspecified digestive organs

1.74

1.09

1.1

1.0

0.91

4.45

u/ml

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

594

0.76

1.09

1.0

1.1

3.65

4.25

u/ml

0.12

290

Open wound of lower leg

131

1112

1.18

1.09

1.1

6.89

6.92

u/ml

0.00

615

Supplementary factors related to causes of morbidity and mortality classified elsewhere

302

2715

1.11

1.09

1.1

6.76

6.09

u/ml

0.19

165

1481

Caries of dentine

191

1624

1.15

1.08

1.1

6.27

6.04

u/ml

0.06

124

854

Diabetic nephropathy

563

0.75

1.08

1.0

1.1

7.50

4.76

u/ml

0.49

263

Other abnormal immunological findings in serum

161

1.51

1.08

1.1

1.24

5.56

u/ml

2.37

Non-Hodgkin lymphoma, all, including Hilmo

467

0.73

1.07

1.0

1.1

6.94

4.58

u/ml

0.25

237

Other benign neoplasms of skin

245

2178

1.13

1.07

1.1

4.33

5.14

u/ml

0.33

120

1066

Glomerular diseases

1135

0.83

1.07

1.1

5.64

5.74

u/ml

0.02

610

Chronic iridocyclitis

326

0.67

1.07

1.0

1.1

3.65

6.84

u/ml

—

184

Myocardial infarction, unclassifiable

386

0.72

1.06

1.0

1.1

4.07

4.35

u/ml

0.05

168

Congenital malformations of cardiac septa

937

0.81

1.06

1.0

1.2

6.60

6.07

u/ml

0.10

628

Peripheral arterial reconstruction

338

0.68

1.06

1.1

1.0

1.90

3.94

u/ml

—

141

Combinations of oral blood glucose lowering drugs

103

1232

0.83

1.06

1.0

1.1

4.45

3.70

u/ml

0.16

587

Other, unspecified and serous retinal detachments

113

1.60

1.06

1.1

1.0

35.23

5.98

u/ml

—

Fracture of neck

217

0.60

1.06

1.2

1.1

0.60

6.06

u/ml

—

108

Implicit viral Sepsis

142

1217

1.17

1.05

1.1

4.39

5.09

u/ml

0.27

660

Bitten or struck by other mammals

133

1135

1.18

1.05

1.1

5.06

5.91

u/ml

0.29

606

Chronic mastoiditis

1.72

1.05

1.0

1.1

1.92

7.37

u/ml

—

Other peripheral vertigo

392

1.31

1.05

1.1

4.01

4.47

u/ml

0.08

195

Diabetic maculopathy, excluding more controls

691

0.78

1.05

1.0

1.1

7.37

6.39

u/ml

0.12

365

Injuries to unspecified part of trunk, limb or body region

723

1.22

1.05

1.0

1.1

5.82

5.85

u/ml

0.01

388

Diabetic retinopathy, excluding more controls

114

760

0.84

1.05

1.0

1.1

6.65

3.86

u/ml

0.78

351

Alcohol abuse, main dg, excluding more controls

105

1251

0.84

1.04

1.1

4.08

5.97

u/ml

0.63

661

Other congenital malformations

176

1535

1.15

1.04

1.1

5.04

6.23

u/ml

0.46

113

898

Percutaneous Coronary Intervention

519

3446

0.92

1.04

1.1

3.45

4.17

u/ml

0.65

224

1741

Mixed specific developmental disorders

541

0.76

1.04

1.1

1.2

4.49

6.97

u/ml

0.50

407

Lactose intolerance

246

1.39

1.04

1.1

5.88

6.32

u/ml

0.04

145

Fall on and from stairs and steps

208

1835

1.14

1.04

1.1

4.87

5.84

u/ml

0.38

116

950

Phobic anxiety disorders

197

1731

1.14

1.04

1.1

6.22

7.41

u/ml

0.45

115

956

Scleritis

1.75

1.03

1.1

5.61

6.85

u/ml

—

Other and unspecified iridocyclitis

289

1.36

1.03

1.1

10.57

7.20

u/ml

0.36

156

Graves ophthalmopathy

138

1.53

1.03

1.0

1.1

2.08

2.83

u/ml

0.31

Other (seronegative) rheumatoid arthritis, wide

966

0.82

1.03

1.1

2.31

4.51

u/ml

1.75

472

COPD, hospital admissions 3, with asthma pneumonia sepsis

579

1.23

1.02

1.0

1.1

3.64

4.65

u/ml

0.22

269

Acute gastritis

298

1.35

1.02

1.1

1.43

4.84

u/ml

1.91

142

Cystic kidney disease

214

0.60

1.02

1.0

1.1

4.30

7.09

u/ml

—

128

Overjet

491

1.27

1.01

1.2

1.1

8.23

7.51

u/ml

0.13

338

Diseases of the digestive system

326

2941

1.10

1.01

1.1

5.08

5.39

u/ml

0.11

168

1556

Foreign body in alimentary tract

351

1.32

1.01

1.1

6.86

6.47

u/ml

0.06

210

Crohn's disease of large intestine

457

1.28

1.01

1.1

6.91

6.42

u/ml

0.07

251

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

309

3411

0.90

1.01

1.1

6.05

5.93

u/ml

0.04

152

1812

Delayed puberty

148

1.52

1.01

1.0

1.1

9.06

10.67

u/ml

0.15

111

Other congenital malformations of tongue, mouth and pharynx

308

1.35

1.00

1.2

4.34

7.11

u/ml

1.19

234

Contact with other hot fluids

291

1.35

1.00

1.1

5.88

7.25

u/ml

0.20

175

Retinal detachments and breaks

174

1521

1.15

1.00

1.1

7.94

3.69

u/ml

0.81

699

Crohn's disease of small intestine

646

1.23

1.00

1.1

6.99

6.47

u/ml

0.08

351

Ovarian hyperstimulation (induction)

223

1.41

1.00

1.0

1.1

1.72

5.13

u/ml

2.37

117

Sarcoidosis

773

1.21

1.00

1.1

3.94

4.16

u/ml

0.05

362

Other female pelvic inflammatory diseases

133

1141

1.17

0.99

1.1

3.12

4.71

u/ml

1.13

543

Chondromalacia

164

1.47

0.99

1.1

1.0

4.07

5.58

u/ml

0.20

Hyperhidrosis

257

1.37

0.99

1.1

2.97

6.13

u/ml

1.17

139

Other noninflammatory disorders of uterus, except cervix

120

685

1.18

0.99

1.1

1.0

1.50

4.21

u/ml

3.51

302

Habitual aborter

232

1.39

0.98

1.1

6.75

6.16

u/ml

0.05

116

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

684

1.22

0.98

1.1

6.29

6.46

u/ml

0.03

380

Atrophic disorders of skin

114

967

1.18

0.98

1.1

5.72

4.67

u/ml

0.28

485

Other malignant neoplasms of skin (=non-melanoma skin cancer)

172

1348

0.87

0.98

1.1

3.57

2.77

u/ml

0.31

601

Other disorders of electrolyte and fluid balance, not elsewhere classified

0.00

0.98

0.0

1.1

—

4.83

—

Focal epilepsy, strict definition

128

1489

0.86

0.98

1.1

3.98

6.46

u/ml

1.60

838

Streptococcal septicaemia

458

0.74

0.97

1.0

1.1

4.48

5.99

u/ml

0.29

262

Dystonia

336

1.32

0.97

1.1

3.70

4.81

u/ml

0.31

173

Delivery, wide proxy

318

1863

0.90

0.97

1.1

5.49

6.59

u/ml

0.55

168

1003

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

467

3194

0.92

0.97

1.1

4.43

4.77

u/ml

0.18

222

1592

Enterocolitis due to Clostridium difficile

412

0.73

0.97

1.1

6.53

4.68

u/ml

0.34

205

Other disorders of breast and lactation associated with childbirth

216

1.41

0.97

1.0

1.1

7.79

6.09

u/ml

0.16

115

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.97

0.0

1.0

—

4.88

—

Pre-eclampsia or eclampsia

189

2138

0.88

0.97

1.1

2.40

4.75

u/ml

3.49

1076

Other diseases of gallbladder

165

1.46

0.97

1.3

1.0

3.82

5.17

u/ml

0.23

Carcinoma in situ of breast, intraductal

377

0.71

0.97

1.0

1.1

11.79

2.01

u/ml

0.76

160

Chronic myeloproliferative disease

0.00

0.96

0.0

1.1

—

4.56

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

133

1.53

0.96

1.1

1.2

13.92

8.73

u/ml

0.44

Varicella [chickenpox]

434

1.28

0.96

1.1

4.49

6.88

u/ml

0.64

256

Other congenital malformations of skin

390

1.29

0.96

1.1

4.02

5.61

u/ml

0.34

239

Keratoconus

174

1.45

0.96

1.1

13.10

7.17

u/ml

0.53

Caught, crushed, jammed or pinched in or between objects

452

1.27

0.96

1.1

7.91

6.39

u/ml

0.22

250

Open wound of abdomen, lower back and pelvis

242

1.37

0.95

1.2

1.1

5.20

6.99

u/ml

0.27

141

Viral conjunctivitis

166

1.46

0.95

1.0

1.1

5.88

6.27

u/ml

0.04

Malignant melanoma, including Hilmo

692

0.79

0.95

1.1

4.26

3.71

u/ml

0.10

319

Influenza and pneumonia

1213

7340

1.05

0.94

1.1

5.97

5.60

u/ml

0.28

714

3827

Superficial injury of ankle and foot

161

1409

1.15

0.94

1.1

10.61

6.53

u/ml

1.11

104

799

Thyrotoxicosis

202

1793

1.13

0.94

1.0

1.1

3.51

4.81

u/ml

0.91

109

892

Status post-ami

520

0.79

0.94

1.0

1.85

3.33

u/ml

0.82

224

Persons encountering health services for specific procedures, not carried out

669

1.22

0.94

1.1

5.04

5.16

u/ml

0.02

329

Emotional disorders starting during childhood or adolescence

115

974

1.18

0.94

1.1

6.54

7.66

u/ml

0.30

634

Prominent ears

142

1.51

0.94

1.0

1.1

3.68

6.43

u/ml

0.72

Other or ill-defined heart diseases

294

1.33

0.94

1.2

1.1

9.45

6.72

u/ml

0.45

159

Viral conjunctivitis

347

1.31

0.94

1.1

6.34

5.22

u/ml

0.16

195

611

0.78

0.94

1.1

1.2

5.52

6.01

u/ml

0.10

445

Loose body in joint

109

1.57

0.94

1.2

1.1

8.75

9.22

u/ml

—

Hypoplasia of dental enamel, prenatal , including avohilmo

155

0.56

0.94

1.1

1.3

2.30

5.73

u/ml

—

123

Hypertensive diseases (excluding secondary)

600

3735

0.93

1.1

5.14

5.05

u/ml

0.05

304

1945

Cystic kidney disease

233

0.64

0.93

1.0

1.1

3.80

7.56

u/ml

—

138

Congenital malformations of the urinary system

589

0.78

0.93

1.0

1.1

5.55

6.43

u/ml

0.14

371

Familial hypercholesterolemia, with ischemic heart disease

183

1.42

0.93

1.0

3.32

4.14

u/ml

—

Cerebral palsy

220

0.63

0.93

1.1

1.2

11.32

6.05

u/ml

—

147

Basal cell carcinoma

158

1251

0.87

0.93

1.1

2.61

2.52

u/ml

0.04

551

Hypoparathyroidism

150

1.47

0.93

1.1

0.20

5.47

u/ml

—

Wide developmental disorders

685

0.79

0.92

1.1

1.2

3.40

7.12

u/ml

1.29

464

Other congenital malformations

129

1113

1.16

0.92

1.1

4.23

6.21

u/ml

0.92

678

Sacroiliitis, not elsewhere classified

464

1.26

0.91

1.0

1.1

8.66

6.08

u/ml

0.27

245

Other specified and unspecified strabismus

1.62

0.91

1.1

4.31

8.23

u/ml

—

Viral hepatitis, IBD co-morbidity

475

0.75

0.91

1.2

1.1

3.57

7.68

u/ml

1.33

262

Other symptoms and signs involving the nervous and musculoskeletal systems

379

3483

1.09

0.91

1.1

4.05

5.28

u/ml

1.30

197

1835

Crohn disease (strict definition, require KELA)

645

1.22

0.91

1.1

6.81

6.53

u/ml

0.04

357

Injury of unspecified body region

518

1.24

0.91

1.0

1.1

5.70

5.75

u/ml

0.01

286

Monoplegia

1.76

0.90

1.2

1.0

1.04

4.13

u/ml

—

Other juvenile arthritis

563

0.78

0.90

1.1

5.03

7.38

u/ml

0.36

346

Heart failure and coronary heart disease

115

951

0.86

0.90

1.0

3.57

3.27

u/ml

0.06

458

Unspecified misadventure during surgical and medical care

253

1.35

0.90

1.1

1.09

4.76

u/ml

3.00

132

Superficial injury of thorax

114

976

1.17

0.90

1.1

5.31

6.10

u/ml

0.23

510

Congenital malformations of the nervous system

312

0.70

0.89

1.1

6.81

5.96

u/ml

0.09

211

Congenital malformations of breast

194

1.41

0.89

1.1

2.42

5.72

u/ml

1.03

104

Contusion of other and unspecified parts of foot

565

1.23

0.89

1.1

12.99

6.80

u/ml

0.85

323

Ménière disease

376

1.28

0.89

1.0

1.1

5.39

3.52

u/ml

0.41

178

Myocardial infarction, strict

160

1297

0.88

0.89

1.1

1.0

2.93

2.90

u/ml

0.01

596

Fitting and adjustment of other devices

163

1293

1.14

0.89

1.1

1.82

3.86

u/ml

3.19

592

Crohn disease (strict definition, require KELA, min 2 HDR)

638

1.21

0.89

1.1

6.54

6.56

u/ml

0.00

354

Failed attempted abortion

144

1.48

0.89

1.1

1.36

5.19

u/ml

—

Heart failure and antihypertensive medication

118

898

0.86

0.88

1.0

1.1

7.83

4.30

u/ml

0.71

458

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

492

0.76

0.88

1.1

1.2

3.44

6.47

u/ml

0.87

330

Presbyopia

386

1.27

0.88

1.1

3.44

4.26

u/ml

0.22

171

152

1334

1.14

0.88

1.1

3.23

5.52

u/ml

2.17

111

700

Lung cancer and mesothelioma

254

1.32

0.88

1.0

4.37

2.65

u/ml

0.25

Other congenital malformations of skin

767

1.19

0.88

1.1

5.63

5.52

u/ml

0.02

429

Injuries to the thorax

318

2905

1.10

0.87

1.1

6.22

5.48

u/ml

0.30

162

1505

Congenital malformations of the urinary system

616

0.79

0.87

1.0

1.1

5.40

6.38

u/ml

0.16

383

Spermatocele

220

1.37

0.87

1.1

6.62

6.97

u/ml

0.04

103

Septal defects

892

0.83

0.87

1.0

1.2

7.02

5.78

u/ml

0.26

607

Abnormal serum enzyme levels

144

1226

1.15

0.87

1.1

3.35

4.42

u/ml

0.50

620

5-aminosalicylic acid

201

1796

1.12

0.86

1.1

7.62

6.39

u/ml

0.40

926

Left bundle-branch block

229

1.36

0.86

1.1

1.0

2.44

3.73

u/ml

0.48

106

Other congenital malformations of the digestive system

591

1.22

0.86

1.2

3.84

6.48

u/ml

1.60

400

Other abnormal uterine and vaginal bleeding

174

1101

1.13

0.86

1.1

3.65

4.97

u/ml

0.69

552

Other bullous disorders

128

1.49

0.86

1.0

7.59

5.12

u/ml

—

Convergent concomitant strabismus

648

0.80

0.86

1.0

1.1

5.88

6.49

u/ml

0.12

376

severe traumatic brain injury, does not include concussion

912

0.83

0.86

1.1

4.05

4.90

u/ml

0.31

464

Sulfasalazine

220

1977

1.11

0.86

1.0

1.1

5.48

5.32

u/ml

0.04

957

Benign neoplasm of other and unspecified sites

145

1.46

0.85

1.1

1.0

4.46

6.63

u/ml

—

Acne vulgaris

144

1263

1.15

0.85

1.1

8.08

8.00

u/ml

0.02

740

Ankyloglossia

389

1.28

0.85

1.2

3.70

7.24

u/ml

1.95

287

Carcinoma in situ of skin of other and unspecified parts of face

112

1.52

0.84

1.1

1.0

4.70

1.92

u/ml

—

Retention of urine

119

1128

0.86

0.84

1.1

4.07

4.15

u/ml

0.02

553

Degenerative macular diseases

300

1.30

0.84

1.0

1.1

2.31

3.55

u/ml

0.36

139

Sequelae of injuries, of poisoning and of other consequences of external causes

202

1810

1.12

0.84

1.1

2.82

5.61

u/ml

3.63

109

933

Papulosquamous disorders

295

2696

1.10

0.83

1.1

4.10

5.08

u/ml

0.53

148

1346

Graves ophthalmopathy, strict

121

1.50

0.83

1.0

2.03

3.17

u/ml

0.45

Premature rupture of membranes

291

2279

0.91

0.83

1.0

1.1

5.34

5.42

u/ml

0.04

135

1209

Rheumatoid arthritis, including avohilmo

207

2303

0.90

0.83

1.1

3.20

4.59

u/ml

0.98

111

1096

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

292

1.31

0.83

1.1

2.26

4.97

u/ml

1.18

138

Retinal detachment with retinal break

470

1.24

0.83

1.1

15.56

3.79

u/ml

0.77

217

Impotence

178

0.62

0.83

1.1

7.71

7.61

u/ml

—

Malignant melanoma of skin, including Hilmo

568

0.79

0.83

1.1

4.84

3.28

u/ml

0.29

262

Mumps

146

1.45

0.83

1.1

1.0

0.82

6.67

u/ml

—

Non-follicular lymphoma

308

0.71

0.83

1.0

1.1

10.82

4.87

u/ml

—

156

Anomalies of pupillary function

163

1.42

0.82

1.1

7.60

8.03

u/ml

0.05

Congenital deformities of hip

293

1.31

0.82

1.2

1.80

7.34

u/ml

3.19

188

Caries of dentine, including avohilmo

812

3923

1.06

0.82

1.1

5.17

5.59

u/ml

0.27

442

2031

Trigeminal neuralgia

319

1.29

0.82

1.0

1.1

2.33

3.84

u/ml

0.45

148

Malignant melanoma

556

0.79

0.82

1.1

2.80

3.34

u/ml

0.18

252

Use of hypnotics and sedatives

982

5922

0.95

0.82

1.1

4.42

4.98

u/ml

0.50

478

3022

Small fibre neuropathy

105

1.53

0.82

1.2

1.0

1.56

5.04

u/ml

—

188

1.38

0.81

1.0

4.75

7.34

u/ml

0.63

Helminthiases

409

1.26

0.81

1.1

6.05

5.85

u/ml

0.03

233

Other conjunctival vascular disorders and cysts

1.61

0.81

1.2

1.1

3.33

1.33

u/ml

—

6-mercaptopurine

352

0.73

0.81

1.0

1.1

8.14

5.85

u/ml

—

206

Varicose veins of other sites

373

1.26

0.81

1.1

3.43

6.51

u/ml

1.15

187

Injuries to the abdomen, lower back, lumbar spine and pelvis

316

2870

1.09

0.81

1.1

7.13

5.85

u/ml

0.56

190

1511

Viral agents as the cause of diseases classified to other chapters

198

1.37

0.81

1.1

3.42

5.21

u/ml

0.30

111

Secondary hypertension

547

0.79

0.80

1.0

1.1

4.45

5.75

u/ml

0.22

309

Diseases of inner ear

354

3159

1.08

0.80

1.1

4.78

4.39

u/ml

0.18

173

1502

Algoneurodystrophy

259

1.32

0.80

1.1

5.62

5.31

u/ml

0.03

137

Other diseases caused by chlamydiae

139

1.45

0.80

1.2

1.0

11.03

6.00

u/ml

0.35

Other and unspecified mood [affective] disorders

840

1.17

0.80

1.0

1.1

4.77

7.14

u/ml

0.80

456

Marasmic kwashiorkor

0.00

0.80

0.0

1.1

—

4.59

—

Unstable angina pectoris

910

0.86

0.80

1.1

1.0

2.03

2.87

u/ml

0.37

402

Mixed connective tissue disease

392

1.25

0.80

1.1

3.67

4.15

u/ml

0.09

183

Rheumatic fever with heart involvement

0.00

0.79

0.0

1.0

—

14.18

—

Cramp and spasm

312

1.29

0.79

1.1

7.95

5.62

u/ml

0.49

173

Benign neoplasm: Other and unspecified parts of mouth

139

1.45

0.79

1.0

7.69

5.30

u/ml

0.24

Benign neoplasm: Bladder

0.00

0.79

0.0

1.1

—

3.97

—

Cluster headache, strict

277

1.31

0.79

1.1

5.69

7.13

u/ml

0.21

142

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.79

0.0

1.1

—

4.77

—

Car occupant injured in other and unspecified transport accidents

210

1894

1.11

0.79

1.1

9.36

6.46

u/ml

0.61

105

1019

Erythema nodosum

156

1.42

0.79

1.1

4.64

3.90

u/ml

0.15

Cluster headache, wide

286

1.30

0.79

1.1

5.69

7.26

u/ml

0.24

147

Benign neoplasm: Rectum

619

1.20

0.79

1.1

4.73

4.23

u/ml

0.07

290

Intestinal malabsorption

286

1.30

0.79

1.1

3.50

5.92

u/ml

0.54

159

Later onset COPD

340

1.24

0.78

1.0

1.05

2.55

u/ml

0.89

145

Other complications of labour and delivery, not elsewhere classified

166

1707

0.89

0.78

1.1

5.72

6.11

u/ml

0.13

909

690

0.82

0.78

1.1

1.2

5.12

6.87

u/ml

0.54

502

Other keratitis

106

916

1.16

0.78

1.0

1.1

7.12

6.17

u/ml

0.17

477

Use of other anti-dementia drugs

300

0.74

0.78

1.0

1.35

1.68

u/ml

—

122

Use of memantine

300

0.74

0.78

1.0

1.35

1.68

u/ml

—

122

Type of accident

273

2497

1.10

0.77

1.1

6.86

6.12

u/ml

0.20

150

1357

Pedestrian injured in collision with pedal cycle

174

1.39

0.77

1.1

3.27

7.09

u/ml

1.06

Corneal ulcer

169

1509

1.12

0.77

1.1

7.43

6.03

u/ml

0.40

778

Anisometropia and aniseikonia

226

1.34

0.77

1.0

1.1

2.39

6.50

u/ml

2.30

129

Pseudomembranous colitis

1.78

0.76

1.0

1.1

1.40

2.62

u/ml

—

Acquired absence of limb

0.00

0.76

0.0

1.0

—

7.43

—

Erosion and ectropion of cervix uteri

107

1.50

0.76

1.1

6.35

2.02

u/ml

—

Nail disorders

622

1.19

0.76

1.1

4.93

5.53

u/ml

0.15

333

Other specified/unspecified disorders of bone/cartilage

132

1.45

0.76

1.1

1.0

6.92

6.59

u/ml

—

Benign neoplasm: Caecum

314

1.28

0.76

1.0

1.1

2.83

3.67

u/ml

0.16

136

Other and unspecified coagulation defects

422

1.24

0.76

1.2

1.1

5.46

5.07

u/ml

0.07

232

Abnormalities of forces of labour

119

1040

1.15

0.76

1.1

4.81

4.65

u/ml

0.04

497

Medial epicondylitis

209

1.35

0.76

1.4

1.0

9.02

5.39

u/ml

0.44

Benign neoplasm: Conjunctiva

149

1.42

0.76

1.0

1.1

0.88

5.78

u/ml

2.40

Lesion of radial nerve

166

1.39

0.75

1.1

1.0

1.15

4.35

u/ml

2.08

Explicit bacterial Sepsis

615

0.81

0.75

1.0

1.1

6.20

5.70

u/ml

0.06

337

137

1209

1.14

0.75

1.1

8.14

5.80

u/ml

0.67

625

Other and unspecified injuries of thorax

1.58

0.75

1.0

9.46

9.55

u/ml

—

Nontoxic diffuse goitre

124

1.46

0.75

1.1

10.49

3.23

u/ml

0.43

Diseases of pulp and periapical tissues and dental caries

647

3125

1.06

0.75

1.1

5.12

5.68

u/ml

0.34

341

1586

Excessive vomiting in pregnancy

101

874

1.16

0.74

1.0

1.1

5.00

5.97

u/ml

0.25

463

Contact with heat and hot substances

478

1.22

0.74

1.1

6.17

6.52

u/ml

0.06

277

Glomerular disorders in diseases classified elsewhere

635

0.82

0.74

1.0

1.1

8.60

4.78

u/ml

0.63

329

Abnormal blood-pressure reading, without diagnosis

245

1.31

0.74

1.1

1.90

7.67

u/ml

2.32

132

Other specified and unspecified retinal disorders

133

1.43

0.73

1.1

1.0

1.56

6.11

u/ml

—

Diplopia

735

1.17

0.73

1.1

3.62

5.39

u/ml

0.55

370

Effects of other external causes

263

1.30

0.73

1.1

10.39

6.31

u/ml

0.31

153

Gonococcal infection

193

1.35

0.73

1.0

1.1

5.04

6.72

u/ml

0.24

103

Alzheimer’s disease (Late onset)

234

0.72

0.73

1.1

1.0

1.57

1.23

u/ml

—

Endometriosis ASRM stages 1,2

198

1790

1.11

0.73

1.1

4.48

5.20

u/ml

0.31

914

Benign lipomatous neoplasm of other sites/unspecified

307

1.27

0.73

1.1

3.17

3.72

u/ml

0.16

143

Whooping cough

1.70

0.73

1.2

1.1

0.14

7.75

u/ml

—

Lesion of plantar nerve

263

1.30

0.73

1.1

1.0

2.82

3.48

u/ml

0.19

117

Seronegative juvenile rheumatoid arthritis

253

0.70

0.73

1.0

1.1

1.70

7.89

u/ml

—

155

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

199

1494

0.90

0.73

1.1

3.35

2.96

u/ml

0.15

670

Viral encephalitis, not elsewhere classified/unspecified

1.53

0.72

1.1

13.42

4.50

u/ml

—

Benign neoplasm of bone and articular cartilage

635

1.18

0.72

1.1

7.73

6.14

u/ml

0.30

335

Chronic tubulo-interstitial nephritis

159

1.39

0.72

1.1

4.14

5.04

u/ml

0.16

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

241

0.70

0.72

1.0

1.1

0.95

4.49

u/ml

—

130

Early syphilis

1.59

0.72

1.1

1.0

3.00

11.12

u/ml

—

Ulcerative colitis

199

2196

0.90

0.72

1.1

6.05

6.43

u/ml

0.12

1187

Follicular cysts of skin and subcutaneous tissue

142

1261

1.13

0.72

1.1

5.74

5.51

u/ml

0.05

626

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

119

1353

0.88

0.72

1.0

1.1

2.71

4.51

u/ml

1.01

638

Other lesions of median nerve

1.59

0.72

1.1

1.0

4.46

4.31

u/ml

—

Hypertension, essential

698

4167

0.95

0.71

1.1

4.71

4.67

u/ml

0.02

339

2062

Qualitative platelet defects

1.96

0.71

1.2

8.58

4.15

u/ml

—

Benign neoplasm of other and unspecified endocrine glands

719

1.17

0.71

1.0

1.1

5.40

4.86

u/ml

0.08

353

Thyrotoxicosis, other and/or unspecified

166

1489

1.12

0.71

1.1

3.80

5.11

u/ml

0.73

750

Benign neoplasm: Long bones of lower limb

238

1.31

0.71

1.0

1.1

3.92

7.07

u/ml

0.77

131

Sleep disorders, other/unspecified

336

1.26

0.71

1.2

1.1

6.69

7.29

u/ml

0.06

189

Other appendicitis

572

1.19

0.71

1.0

1.1

4.61

4.93

u/ml

0.06

280

Right ventricular outflow tract obstruction

180

0.65

0.70

1.1

1.2

10.29

6.93

u/ml

—

141

Congenital malformations of heart and great arteries

135

1471

0.89

0.70

1.0

1.1

5.97

6.33

u/ml

0.10

918

Complications of labour and delivery

704

3712

1.06

0.70

1.1

5.77

5.12

u/ml

0.47

346

1851

Mixed disorders of conduct and emotions

442

0.78

0.70

1.0

1.1

5.23

7.65

u/ml

0.50

283

Cardiomyopathy (excluding other)

510

0.80

0.70

1.1

7.19

4.78

u/ml

0.33

260

Diseases caused by chlamydiae

135

1.42

0.70

1.2

1.0

11.03

6.09

u/ml

0.34

Pedestrian injured in transport accident

445

1.22

0.70

1.1

4.39

6.13

u/ml

0.38

233

Malignant neoplasm of bladder

101

1.49

0.69

1.1

1.0

3.09

4.07

u/ml

—

Maternal care for known or suspected disproportion

473

1.21

0.69

1.0

1.1

3.48

4.65

u/ml

0.26

233

Implicit fungal Sepsis

292

1.27

0.69

1.1

7.85

4.44

u/ml

0.32

137

Postprocedural disorders of nervous system

781

0.84

0.69

1.1

6.45

6.50

u/ml

0.01

431

Polycystic kidney disease

157

0.63

0.69

1.0

1.1

5.36

5.19

u/ml

—

Congenital deformities of hip

275

1.29

0.69

1.2

1.80

7.42

u/ml

3.20

182

L02BA Anti-estrogens

975

0.86

0.69

1.1

3.91

3.26

u/ml

0.23

439

Sequelae of injuries of upper limb

666

1.17

0.69

1.1

2.60

4.97

u/ml

1.21

340

Migraine with aura, drug-induced

1.66

0.69

1.2

1.1

3.00

4.01

u/ml

—

Peripheral artery operations in Hilmo

308

0.75

0.69

1.2

1.0

9.26

5.16

u/ml

0.33

139

Autoimmune diseases related-to ILD

866

7073

1.05

0.69

1.1

5.30

5.61

u/ml

0.21

409

3695

Sequelae with surgical and medical care as external cause

122

1077

1.13

0.69

1.0

1.1

4.13

4.52

u/ml

0.14

533

Undescended testicle

248

0.71

0.68

1.1

1.2

6.94

7.54

u/ml

0.05

192

Other/unspecified seropositive rheumatoid arthritis

120

1358

0.88

0.68

1.0

1.1

2.71

4.50

u/ml

1.01

639

Pterygium

1.60

0.68

1.1

1.0

1.46

2.53

u/ml

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

136

1.42

0.68

1.1

11.03

7.17

u/ml

0.33

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

124

1079

1.14

0.68

1.1

6.08

7.17

u/ml

0.30

709

Gastroduodenal ulcer

813

1.15

0.68

1.1

2.54

3.69

u/ml

0.53

371

Disorders of lens

362

2427

0.93

0.68

1.1

4.61

3.72

u/ml

0.26

179

1100

Ulcerative ileocolitis

318

0.75

0.68

1.1

9.09

5.42

u/ml

0.38

167

Open wound of hip and thigh

267

1.28

0.67

1.1

5.93

7.28

u/ml

0.17

151

Viral infections of the central nervous system

539

1.19

0.67

1.0

1.1

8.55

5.24

u/ml

0.75

289

Congenital malformations of the respiratory system

188

1.34

0.67

1.2

3.78

6.95

u/ml

0.65

132

Erectile dysfunction

203

0.69

0.67

1.0

1.1

0.26

7.29

u/ml

—

105

Perineal laceration during delivery

237

2158

0.92

0.66

1.1

6.71

6.18

u/ml

0.19

118

1140

Other viral diseases, not elsewhere classified

228

2083

1.09

0.66

1.1

6.97

6.29

u/ml

0.13

117

1212

Intracranial trauma

684

4569

1.05

0.66

1.1

5.37

6.46

u/ml

0.74

392

2492

Social disorders starting during childhood or adolecense, excluding more controls

137

1.41

0.66

1.0

1.1

1.09

7.49

u/ml

4.18

104

Congenital malformations of aortic and mitral valves

383

0.78

0.65

1.0

1.2

4.04

7.50

u/ml

0.83

239

Seropositive rheumatoid arthritis

123

1379

0.89

0.65

1.0

1.1

2.64

4.50

u/ml

1.11

633

Diabetic retinopathy

131

918

0.89

0.65

1.0

1.1

6.07

3.75

u/ml

0.71

414

Benign neoplasm: Other/unspecified site

1.62

0.65

1.1

1.0

6.24

5.37

u/ml

—

Seropositive rheumatoid arthritis, wide

123

1384

0.89

0.65

1.0

1.1

2.64

4.44

u/ml

1.06

653

Additional codes for the location of defect, injury or illness

358

1.23

0.65

1.1

8.91

5.97

u/ml

0.38

200

Venous thromboembolism

314

2817

1.08

0.65

1.0

1.1

3.89

4.24

u/ml

0.17

165

1341

Other disorders starting during childhood or adolescence

123

1083

1.13

0.65

1.1

6.08

6.99

u/ml

0.25

732

Pyogenic arthritis

313

1.25

0.65

1.2

1.1

6.34

6.64

u/ml

0.03

164

Acute peritonitis

259

0.73

0.65

1.2

1.1

0.58

4.61

u/ml

4.88

133

Vasculitis limited to skin, not elsewhere classified

120

1.42

0.65

1.2

1.1

9.11

4.23

u/ml

—

Alcohol-induced chronic pancreatitis

293

0.75

0.65

1.0

1.1

1.76

6.00

u/ml

1.94

136

Ascites

259

0.73

0.64

1.1

0.69

4.20

u/ml

—

128

Personal history of malignant neoplasm

438

0.80

0.64

1.1

13.17

4.49

u/ml

0.85

222

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

689

0.84

0.64

1.1

3.66

4.76

u/ml

0.33

342

Pervasive developmental disorders excl. Autism + Asperger

321

0.76

0.64

1.0

1.2

1.11

6.86

u/ml

6.50

251

Other symptoms and signs involving the digestive system and abdomen

124

1102

1.13

0.64

1.1

4.09

4.82

u/ml

0.23

578

Other and unspecified injuries of wrist and hand

341

1.24

0.64

1.1

9.97

6.08

u/ml

0.35

195

Other heart diseases

577

3975

0.95

0.64

1.1

6.65

5.49

u/ml

0.77

297

2165

Other and unspecified epidermal thickening

146

1.38

0.64

1.2

1.1

3.43

6.76

u/ml

0.58

Plantar fascial fibromatosis

588

1.18

0.64

1.1

2.60

5.17

u/ml

1.56

268

conjunctival haemorrhage

260

1.27

0.64

1.0

1.1

8.56

3.46

u/ml

0.67

116

342

1.24

0.64

1.1

5.78

8.36

u/ml

0.63

222

Nonspecific lymphadenitis

432

1.21

0.64

1.1

6.61

5.81

u/ml

0.12

210

Other and unspecified mononeuropathies of lower limb

129

1.40

0.63

1.0

5.04

5.30

u/ml

—

Hypotension

441

1.20

0.63

1.1

3.25

4.35

u/ml

0.34

209

Cyst of kidney

216

1.30

0.63

1.1

1.0

3.01

4.98

u/ml

—

Contact with other sharp object(s)

708

0.84

0.63

1.0

1.1

5.28

7.06

u/ml

0.62

380

Diverticular disease of intestine

451

2708

1.06

0.62

1.1

1.81

3.55

u/ml

4.96

188

1258

Disorders of continuity of bone

729

1.16

0.62

1.1

4.94

5.94

u/ml

0.23

378

Haemolytic anaemias

199

1.31

0.62

1.2

1.1

10.29

5.31

u/ml

0.47

117

Maxillary retrognathism

226

1.29

0.62

1.1

2.48

7.82

u/ml

2.54

152

Disorders in reading

262

1.27

0.62

1.1

9.04

7.50

u/ml

0.14

177

Dextrocardia

0.00

0.62

0.0

1.3

—

2.16

—

Cardiac arrest

220

0.74

0.62

1.0

1.1

7.48

4.47

u/ml

—

100

Other disorders involving the immune mechanism, not elsewhere classified

217

1.30

0.62

1.1

5.56

7.41

u/ml

0.28

123

Second line medication for Crohn's disease

503

5313

0.95

0.62

1.1

5.38

5.35

u/ml

0.01

257

2806

Cluster headache, strict, including avohilmo

443

1.20

0.62

1.1

5.76

6.31

u/ml

0.09

229

Early lumbar disc prolapse operation

138

1239

1.12

0.62

1.1

4.30

6.21

u/ml

1.01

644

Congenital malformations of eye, ear, face and neck

843

1.14

0.61

1.1

4.82

6.42

u/ml

0.49

510

Alport

0.00

0.61

0.0

1.2

—

7.56

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.61

0.0

1.1

—

5.05

—

Cerebral oedema

0.00

0.61

0.0

1.1

—

7.18

—

Noonan syndrome

0.00

0.61

0.0

1.0

—

6.81

—

Non-ischemic cardiomyopathy

888

0.88

0.61

1.0

1.1

7.08

3.10

u/ml

0.80

439

Multiple congenital exostoses

0.00

0.61

0.0

1.0

—

4.15

—

Sudden idiopathic hearing loss

425

1.20

0.61

1.1

5.82

4.42

u/ml

0.17

203

Adalimumab

952

0.87

0.61

1.1

1.55

6.22

u/ml

9.91

505

Other pleural conditions

244

1.27

0.61

1.1

1.03

4.55

u/ml

2.98

116

Varicella [chickenpox]

610

1.17

0.60

1.1

3.42

6.99

u/ml

1.75

382

Typhoid and paratyphoid fevers

0.00

0.60

0.0

1.1

—

4.45

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.60

0.0

1.0

—

7.25

—

Unattended death

0.00

0.60

0.0

1.1

—

4.94

—

Malignant neoplasm of renal pelvis, including Hilmo

0.00

0.60

0.0

1.0

—

9.58

—

Gonococcal infection

227

1.28

0.60

1.0

1.1

4.48

8.17

u/ml

0.72

125

Allergic purpura

236

1.28

0.60

1.1

5.86

8.58

u/ml

0.39

127

Neuromyelitis optica

0.00

0.60

0.0

1.0

—

3.33

—

Acute pancreatitis

1046

0.88

0.59

1.1

5.40

4.51

u/ml

0.19

510

Other disorders of bone density and structure

174

0.69

0.59

1.0

1.1

9.70

6.58

u/ml

—

Deficiency of other B group vitamins

1.53

0.59

1.2

1.0

1.17

5.23

u/ml

—

Spina bifida

0.00

0.59

0.0

1.0

—

3.57

—

Chromosomal abnormalities, not elsewhere classified

386

0.79

0.59

1.1

1.2

4.33

6.01

u/ml

0.40

274

Macular cyst

1.53

0.59

1.0

1.1

2.10

3.78

u/ml

—

Fentanyl

310

0.77

0.59

1.0

8.27

3.98

u/ml

0.31

143

L04AX Other immunosuppressants

482

5086

0.95

0.58

1.1

5.39

5.36

u/ml

0.01

249

2691

Paralytic strabismus

310

0.77

0.58

1.1

2.68

5.68

u/ml

—

163

Other disorders of amniotic fluid and membranes

176

1880

0.91

0.58

1.1

4.02

5.20

u/ml

0.66

1001

Transient ischemic attack

196

1730

0.92

0.58

1.1

2.42

3.56

u/ml

0.88

800

Other congenital malformations, not elsewhere classified

132

1.39

0.58

1.1

1.2

5.32

5.41

u/ml

—

100

Inflammatory diseases of the central nervous system

573

0.84

0.58

1.1

13.01

5.05

u/ml

1.25

303

Other bacterial intestinal infections

111

988

1.13

0.58

1.1

2.91

5.43

u/ml

1.92

504

Bacterial pneumonia (organism specified)

290

2449

1.07

0.58

1.1

5.34

5.41

u/ml

0.02

165

1252

Intracerebral haemorrhage

332

0.78

0.58

1.1

5.78

4.75

u/ml

—

162

Other and unspecified corneal deformities and disorders

184

1.31

0.58

1.1

6.96

4.75

u/ml

0.22

Other anaemias

178

1851

0.91

0.58

1.1

4.93

4.42

u/ml

0.16

931

Other vitreous opacities

149

1.35

0.58

1.1

1.03

4.31

u/ml

—

Reduction defects of upper limb

1.70

0.57

1.2

1.1

1.30

5.15

u/ml

—

Whooping cough

132

1.38

0.57

1.2

1.1

2.25

7.16

u/ml

—

Ventral hernia

140

1264

1.11

0.57

1.0

1.1

3.68

4.72

u/ml

0.41

613

Lactose intolerance, other/unspecified

211

1.29

0.57

1.0

1.1

6.53

6.98

u/ml

0.04

126

Dislocation, sprain and strain of joints and ligaments of head

438

1.19

0.57

1.1

4.77

5.62

u/ml

0.15

244

Toxic effect of carbon monoxide

1.49

0.57

1.0

2.28

10.17

u/ml

—

Valvular operations

572

0.84

0.57

1.0

1.1

5.20

4.84

u/ml

0.05

312

Superficial injury of head

209

1924

1.09

0.57

1.1

5.17

5.90

u/ml

0.27

127

1057

Pediculosis, acariasis and other infestations

202

1858

1.09

0.57

1.1

6.01

6.64

u/ml

0.17

109

1035

Precocious puberty

0.54

0.57

1.2

13.12

7.28

u/ml

—

Crowding of teeth, including avohilmo

193

1465

1.09

0.56

1.1

8.29

7.33

u/ml

0.31

142

939

Prolonged pregnancy

218

2064

0.92

0.56

1.1

6.98

5.81

u/ml

0.50

122

1110

Cluster headache, wide,, including avohilmo

457

1.19

0.56

1.1

5.76

6.18

u/ml

0.07

234

Anorexia (incl.atypical)

710

0.86

0.56

1.1

10.57

6.51

u/ml

0.68

415

Fracture of shoulder and upper arm

243

2616

0.93

0.56

1.1

4.91

6.58

u/ml

0.84

129

1423

Colon adenocarcinoma

286

0.77

0.56

1.0

1.1

0.69

2.49

u/ml

—

129

Benign neoplasm: other/unspecified salivary gland

1.51

0.56

1.1

1.0

0.48

4.23

u/ml

—

Cardiomyopathies, Primary/intrinsic

484

0.83

0.56

1.1

7.19

4.84

u/ml

0.32

249

Vitamin B12 deficiency anaemia

319

0.78

0.56

1.1

1.65

3.82

u/ml

1.34

144

Congenital deformities of feet

275

1.24

0.56

1.0

1.1

8.61

6.71

u/ml

0.23

170

Other noninflammatory disorders of cervix uteri

194

1.29

0.56

1.1

5.84

3.07

u/ml

—

Social disorders starting during childhood or adolescence

142

1.36

0.56

1.0

1.2

1.09

6.43

u/ml

3.21

105

Hyperplasia of prostate

150

770

1.11

0.55

1.0

2.68

3.32

u/ml

0.37

374

Diseases of peritoneum

476

1.18

0.55

1.1

2.67

4.84

u/ml

0.71

238

Alzheimer’s disease (Late onset), excluding more controls

136

0.72

0.55

1.1

1.0

2.09

0.96

u/ml

—

Chronic nephritic syndrome

183

0.71

0.55

1.0

9.27

7.04

u/ml

—

Artificial opening status

296

0.77

0.55

1.1

10.02

5.16

u/ml

0.25

173

Other hearing loss

110

961

1.12

0.55

1.1

4.13

4.22

u/ml

0.02

452

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

537

0.84

0.55

1.1

4.74

5.06

u/ml

0.04

269

Acute pancreatitis (for exclusion)

1039

0.88

0.55

1.1

5.40

4.66

u/ml

0.15

504

Long labour

326

2617

1.07

0.55

1.1

4.24

5.36

u/ml

0.80

166

1329

Postpartum haemorrhage due to anatomy

152

1384

1.10

0.54

1.1

6.54

5.92

u/ml

0.19

733

SLE, strict definition

205

0.73

0.54

1.2

1.1

7.29

4.55

u/ml

—

106

SLE, ICD10

205

0.73

0.54

1.2

1.1

7.29

4.55

u/ml

—

106

Coxarthrosis, primary

255

2007

1.08

0.54

1.1

1.0

2.77

3.06

u/ml

0.11

109

889

All dysplastic lesions of the vagina

182

0.71

0.54

1.0

6.73

2.72

u/ml

—

Arthropathic psoriasis

740

0.86

0.54

1.1

4.01

5.05

u/ml

0.15

373

Diseases of liver

230

2133

1.08

0.54

1.1

4.65

4.76

u/ml

0.04

112

1058

Ischaemic heart disease, wide definition

413

2707

0.94

0.54

1.1

3.41

3.60

u/ml

0.11

181

1271

Shoulder region

1.50

0.53

1.2

1.1

2.74

6.33

u/ml

—

Bacterial intestinal infections, IBD co-morbidities

110

985

1.12

0.53

1.1

2.80

5.24

u/ml

1.81

493

Use of teriflunomide

1.44

0.53

1.0

6.66

5.36

u/ml

—

Procreative management

440

3476

1.06

0.53

1.1

5.70

6.21

u/ml

0.26

259

1957

Neuromuscular dysfunction of bladder

423

1.18

0.53

1.1

4.98

5.73

u/ml

0.08

218

Vestibular neuronitis

426

0.82

0.53

1.1

5.70

4.07

u/ml

0.29

209

Malignant melanoma of skin

404

0.82

0.53

1.1

3.35

3.09

u/ml

0.06

193

Chronic suppurative otitis media, including avohilmo

647

1.15

0.53

1.1

3.42

6.14

u/ml

1.14

383

Other and unspecified anaemias

177

1835

0.92

0.53

1.1

4.98

4.34

u/ml

0.21

924

Burn and corrosion of trunk

205

1.27

0.52

1.1

6.84

7.28

u/ml

0.05

119

Respiratory and cardiovascular disorders specific to the perinatal period

622

1.15

0.52

1.2

7.11

6.29

u/ml

0.17

464

Primary open-angle glaucoma

775

0.87

0.52

1.1

1.0

2.69

2.63

u/ml

0.02

348

Benign neoplasm of meninges

387

1.19

0.52

1.0

1.1

2.68

3.59

u/ml

0.37

180

Superficial injury of abdomen, lower back and pelvis

143

1302

1.10

0.52

1.1

7.13

6.27

u/ml

0.21

709

IgA nephropathy (IgA glomerulonephritis)

126

1.36

0.52

1.0

9.20

8.24

u/ml

—

Open wound of ankle and foot

865

1.12

0.51

1.0

1.1

7.50

6.03

u/ml

0.30

467

Coxarthrosis [arthrosis of hip](FG)

270

2033

0.93

0.51

1.1

2.81

3.46

u/ml

0.32

117

880

Hyperkalaemia

126

1.35

0.51

1.0

5.02

4.47

u/ml

—

Eustachian salpingitis and obstruction

102

913

1.12

0.51

1.1

8.56

6.72

u/ml

0.36

523

Other disorders of binocular vision

109

1.39

0.51

1.1

1.0

0.27

6.95

u/ml

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

206

1.27

0.51

1.0

1.1

5.78

7.67

u/ml

0.26

117

Specific development disorders of scholastic skills

827

1.13

0.51

1.1

1.2

8.20

7.48

u/ml

0.12

551

SLE (Finngen)

225

0.75

0.51

1.2

1.1

7.29

5.01

u/ml

—

110

Dilated cardiomyopathy

413

0.82

0.51

1.1

8.66

4.51

u/ml

0.53

201

Foreign body in ear

144

1.33

0.51

1.1

9.15

5.86

u/ml

—

Disorders of psychological development

220

1895

1.08

0.51

1.1

6.90

7.99

u/ml

0.36

136

1224

Memory loss

251

1.24

0.51

1.1

1.73

4.44

u/ml

1.43

111

Volume depletion

358

0.81

0.50

1.1

9.96

5.80

u/ml

0.54

202

Other and unspecified iron deficiency

237

2207

1.07

0.50

1.1

7.87

4.93

u/ml

1.05

123

1160

Optic neuritis

379

0.81

0.50

1.0

1.1

7.69

6.15

u/ml

0.21

201

Other aneurysm

153

1.31

0.50

1.1

1.0

1.53

4.00

u/ml

1.16

Gonarthrosis,primary

518

3347

0.95

0.50

1.1

2.85

3.22

u/ml

0.33

238

1488

Other and unspecified abdominal hernia

162

1.30

0.50

1.1

0.90

3.99

u/ml

—

Gonarthrosis [arthrosis of knee](FG)

517

3153

0.95

0.50

1.1

3.04

3.71

u/ml

0.72

242

1435

Viral and other specified intestinal infections

318

2924

1.06

0.49

1.1

7.06

8.02

u/ml

0.29

196

1772

Other and unspecified nail disorders

101

1.39

0.49

1.1

1.0

1.79

6.80

u/ml

—

Use of levodopa decarboxylase inhibitor

280

0.78

0.49

1.0

1.45

3.20

u/ml

—

119

Asymmetry of jaw

136

1.33

0.49

1.2

1.1

11.56

7.97

u/ml

—

Amenorrhoea

840

1.12

0.49

1.1

3.86

5.89

u/ml

1.26

477

Congenital malformations of pulmonary and tricuspid valves

166

0.71

0.49

1.1

1.3

10.29

6.65

u/ml

—

128

Atrial fibrillation and flutter with reimbursement

134

937

0.91

0.49

1.0

1.1

2.57

3.31

u/ml

0.38

439

Other sexually transmitted chlamydial diseases

168

1548

1.09

0.49

1.1

6.16

7.94

u/ml

0.67

907

Vitreous haemorrhage

443

0.83

0.48

1.0

1.1

18.06

4.34

u/ml

0.70

230

Periodontal disease, other/unspecified

154

1.30

0.48

1.0

1.1

1.86

5.92

u/ml

2.13

Other endocrine disorders

824

1.12

0.48

1.1

1.2

4.68

6.34

u/ml

0.62

573

Bursitis of shoulder

119

1.35

0.48

1.1

1.0

1.71

7.79

u/ml

—

Benzodiazepine use

960

6832

0.97

0.48

1.1

4.29

5.38

u/ml

1.47

479

3498

Acquired haemolytic anaemia

102

1.38

0.47

1.3

1.1

19.43

4.00

u/ml

—

Congenital deformities of feet

429

1.17

0.47

1.0

1.1

6.79

6.20

u/ml

0.09

258

Other Crohn's disease

682

1.13

0.47

1.1

6.88

6.50

u/ml

0.06

366

Glaucoma

235

2163

0.93

0.47

1.0

1.1

3.67

3.94

u/ml

0.10

108

1010

Other salmonella infections

263

1.22

0.47

1.0

1.1

2.17

5.07

u/ml

1.30

133

Other disorders of binocular movement

227

1.24

0.47

1.2

1.1

3.22

7.63

u/ml

0.97

129

Carbimazole or st.post thyroidectomy, condition for graves disease

173

1599

1.08

0.47

1.0

1.1

3.92

5.01

u/ml

0.45

102

791

Hodgkin lymphoma, hilmo

165

0.72

0.46

1.3

1.1

19.46

6.03

u/ml

—

Postpartum haemorrhage

352

2806

1.06

0.46

1.1

5.60

5.28

u/ml

0.14

160

1430

Obstructed labour due to maternal pelvic abnormality

110

996

1.11

0.46

1.1

2.64

3.87

u/ml

0.52

439

Other strabismus

254

2375

1.07

0.46

1.1

4.79

6.21

u/ml

0.88

145

1355

Rheumatic fever incl heart disease

1.39

0.46

1.1

1.0

3.48

7.78

u/ml

—

Spontaneous abortion

526

3391

1.05

0.46

1.1

4.02

5.20

u/ml

1.07

243

1700

Thyrotoxicosis with diffuse goitre

121

1102

1.10

0.46

1.0

1.1

3.15

5.35

u/ml

1.65

553

Non-small cell lung cancer, including Hilmo

343

0.82

0.46

1.0

1.1

4.47

2.17

u/ml

0.23

150

Toxic effects of substances chiefly nonmedicinal as to source

111

1007

1.10

0.45

1.1

5.62

6.97

u/ml

0.34

549

Periapical abscess

360

3792

0.95

0.45

1.1

5.78

5.09

u/ml

0.34

201

1940

Herpesviral keratitis and keratoconjunctivitis

210

1.24

0.45

1.0

1.1

8.39

6.17

u/ml

0.22

104

Infections, IBD-co-morbidities

136

889

1.09

0.45

1.1

3.57

6.61

u/ml

2.05

479

Parkinson's disease, including avohilmo

352

0.82

0.45

1.0

0.99

2.99

u/ml

2.03

160

Hyperprolactinaemia

348

1.18

0.44

1.0

1.1

6.25

6.61

u/ml

0.03

187

Left ventricular outflow tract obstruction (LVOTO), broad definition

800

0.89

0.44

1.0

1.1

5.84

5.03

u/ml

0.20

466

Hypertrichosis

238

1.23

0.44

1.0

1.1

4.24

4.87

u/ml

0.11

124

Elevated blood glucose level

516

1.15

0.44

1.2

1.1

8.20

5.63

u/ml

0.37

294

Disorders of optic nerve and visual pathways

810

0.89

0.44

1.1

8.13

6.25

u/ml

0.27

460

Unspecified maternal hypertension

148

1.30

0.44

1.1

1.0

0.92

4.71

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

857

1.11

0.44

1.1

3.00

5.64

u/ml

1.43

436

Intestinal adhesions without obstruction

302

1.19

0.44

1.0

1.1

5.84

3.19

u/ml

0.27

156

Other epidermal thickening

238

1.22

0.44

1.1

5.65

u/ml

0.00

126

Left ventricular outflow tract obstruction, narrow definition

480

0.85

0.44

1.0

1.1

3.96

7.27

u/ml

1.09

298

Systemic lupus erythematosus

219

0.77

0.44

1.2

1.1

7.29

4.46

u/ml

—

113

Effects of foreign body entering through natural orifice

229

2147

1.07

0.43

1.1

7.12

5.80

u/ml

0.53

123

1215

Open wound of forearm

715

1.12

0.43

1.1

2.38

6.26

u/ml

2.87

366

Bacterial, viral and other infectious agents

782

1.12

0.43

1.1

3.56

5.80

u/ml

1.20

425

Myocardial infarction, with ST-elevation

426

0.84

0.43

1.0

1.1

2.01

4.00

u/ml

1.18

188

Hypoplasia of dental enamel

313

0.81

0.43

1.2

0.54

6.87

u/ml

9.75

256

Conduction disorders

158

1184

1.08

0.43

1.1

5.53

4.13

u/ml

0.49

612

Open bite that required surgery (Lefort1 or BSSO)

1.39

0.42

1.0

1.1

0.88

8.63

u/ml

—

Acute alcohol intoxication ICD-9

113

1.33

0.42

1.1

1.82

5.57

u/ml

—

Burn and corrosion of head and neck

162

0.74

0.42

1.0

1.1

7.87

7.41

u/ml

—

Melanocytic naevi of lower limb, including hip

322

1.18

0.42

1.1

5.06

6.41

u/ml

0.21

173

Benign neoplasm: Rectum, anus and anal canal

716

1.12

0.42

1.1

4.87

3.96

u/ml

0.14

338

Placenta praevia

553

0.86

0.42

1.0

1.1

10.08

5.46

u/ml

0.35

292

Retinoblastoma

0.00

0.42

0.0

1.0

—

9.02

—

Burkitt lymphoma, including Hilmo

0.00

0.42

0.0

1.1

—

9.15

—

Burkitt lymphoma

0.00

0.42

0.0

1.1

—

9.15

—

Retinoblastoma, including Hilmo

0.00

0.42

0.0

1.0

—

9.02

—

Burkitt lymphoma, helper endpoint

0.00

0.42

0.0

1.1

—

9.15

—

Xanthelasma of eyelid

1.57

0.42

1.0

1.1

—

4.87

—

Scarlet fever

1.45

0.42

1.0

1.1

1.35

4.76

u/ml

—

Viral agents as the cause of diseases classified to other chapters

176

1.26

0.42

1.0

1.1

3.65

5.48

u/ml

0.28

Malnutrition

149

1.28

0.42

1.3

1.2

1.79

6.19

u/ml

2.18

105

Unspecified urinary incontinence

406

1.16

0.42

1.0

1.1

5.55

4.62

u/ml

0.20

209

Other congenital malformations of spinal cord

0.00

0.42

0.0

1.0

—

4.66

—

Personal history of other diseases and conditions

177

1641

1.08

0.42

1.1

6.42

6.40

u/ml

0.01

103

993

Congenital iodine-deficiency syndrome/hypothyroidism

149

1.28

0.42

1.1

2.38

7.71

u/ml

1.65

Visual impairment including blindness (binocular or monocular)

327

0.82

0.42

1.0

1.1

5.29

6.62

u/ml

0.22

189

Parkinson's disease

338

0.83

0.42

1.0

0.99

3.08

u/ml

2.09

154

Kidney diseases associated to Fabry's disease

0.00

0.42

0.0

1.1

—

4.11

—

Viral warts

889

1.10

0.42

1.1

6.32

6.12

u/ml

0.03

491

Other embolism and thrombosis

632

1.12

0.42

1.1

4.72

4.37

u/ml

0.06

300

Sphingolipidosis, other/unspecified

0.00

0.41

0.0

1.1

—

4.11

—

Chronic Coagulation defects

206

0.77

0.41

1.1

0.91

7.44

u/ml

—

119

Ulcerative colitis, NAS

112

1225

0.91

0.41

1.1

5.50

6.39

u/ml

0.22

650

Subarachnoid haemorrhage

369

1.17

0.41

1.0

1.1

2.84

3.10

u/ml

0.06

172

Placental disorders

105

1.35

0.41

1.1

1.0

2.80

4.93

u/ml

—

Eccrine sweat disorders

0.00

0.41

0.0

1.1

—

6.16

—

Exposure to sunlight

0.00

0.41

0.0

1.1

—

17.96

—

Non-seminoma of testis

0.00

0.41

0.0

1.1

—

14.54

—

Fluid overload

0.00

0.41

0.0

1.1

—

6.16

—

Benign neoplasm: Adrenal gland

295

1.19

0.41

1.0

1.1

7.02

3.49

u/ml

0.30

138

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.41

0.0

1.0

—

1.16

—

Erectile dysfunction, exclusion

0.00

0.41

0.0

1.1

—

5.13

—

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.41

0.0

1.1

—

2.77

—

Other hyperalimentation

0.00

0.41

0.0

1.1

—

2.88

—

Complications peculiar to reattachment and amputation

0.00

0.41

0.0

1.1

—

7.92

—

Malignant neoplasm of cervix uteri, including Hilmo

161

0.74

0.41

1.0

6.75

2.76

u/ml

—

Other drug-induced secondary parkinsonism

0.00

0.41

0.0

1.1

—

14.66

—

Inguinal hernia

443

3096

0.96

0.41

1.1

5.60

6.00

u/ml

0.19

232

1663

Wide developmental disorders, excluding more controls

615

0.88

0.41

1.1

3.40

7.11

u/ml

1.28

419

Lack of expected normal physiological development

500

0.87

0.41

1.1

1.2

8.28

6.61

u/ml

0.25

380

Liveborn infants according to place of birth

198

1.23

0.41

1.1

1.2

0.88

5.48

u/ml

4.52

147

Scabies

398

1.16

0.41

1.1

1.34

6.52

u/ml

6.08

222

Benign neoplasm: Pituitary gland, craniopharyngeal duct

342

1.17

0.41

1.0

1.1

5.00

6.42

u/ml

0.16

183

Endometroid carcinoma of ovary

0.00

0.41

0.0

1.1

—

1.23

—

Macular hole

114

1.32

0.40

1.0

1.1

1.11

1.35

u/ml

—

Encephalitis

183

0.76

0.40

1.1

12.65

4.46

u/ml

—

103

Abdominal aortic aneurysm (AAA)

113

1.32

0.40

1.1

1.0

1.40

4.20

u/ml

—

Benign neoplasm: Descending colon

204

1.23

0.40

1.1

1.0

3.24

4.27

u/ml

0.16

Other maltreatment syndromes

271

0.81

0.40

1.2

1.1

8.48

6.69

u/ml

0.11

146

Mixed disorders of conduct and emotions, excluding more controls

411

0.85

0.40

1.0

1.1

5.23

7.77

u/ml

0.53

269

Contusion of toe(s) without damage to nail

241

1.21

0.40

1.1

6.89

5.26

u/ml

0.16

131

Multiple congenital exostoses

0.00

0.40

0.0

1.0

—

4.77

—

Other symptoms and signs involving the urinary system

511

1.14

0.40

1.0

1.1

2.29

5.32

u/ml

2.45

260

Other sexually transmitted chlamydial diseases

104

949

1.10

0.40

1.1

5.70

7.29

u/ml

0.46

549

Malignant neoplasm of urinary organs

282

0.81

0.40

1.0

1.1

7.54

3.85

u/ml

—

136

Other/unspecified disorders of vestibular function

168

1.25

0.40

1.1

5.21

4.72

u/ml

—

Findings of drugs and other substances, not normally found in blood

0.00

0.40

0.0

1.0

—

7.33

—

Other abnormal findings of blood chemistry

241

1.21

0.40

1.0

1.1

3.36

4.75

u/ml

0.39

127

Malignant neoplasm of gum, including Hilmo

0.00

0.40

0.0

1.1

—

3.88

—

Thrombocytopenia, unspecified

379

0.84

0.40

1.1

1.89

5.04

u/ml

2.51

215

Reduction defects of upper limb

1.45

0.40

1.2

1.1

1.56

4.04

u/ml

—

Foreign object accidentally left in body during surgical and medical care

0.00

0.39

0.0

1.1

—

2.70

—

Labyrinthitis

0.00

0.39

0.0

1.0

—

9.09

—

Internuclear ophthalmoplegia

0.00

0.39

0.0

1.1

—

2.92

—

Malignant neoplasm of ovary, including Hilmo

270

0.81

0.39

1.0

1.1

2.55

2.71

u/ml

—

133

Blindness or visual impairment, binocular

0.00

0.39

0.0

1.0

—

6.51

—

Undescended testis, unilateral

203

0.78

0.39

1.1

1.2

7.34

7.86

u/ml

—

158

Gout, idiopatic and unspecified

739

0.89

0.39

1.1

1.96

3.93

u/ml

1.76

342

Traumatic subarachnoid haemorrhage

115

1.31

0.39

1.0

6.30

6.64

u/ml

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

313

0.83

0.38

1.0

1.1

6.60

3.73

u/ml

—

153

Pneumonia due to other infectious organisms, not elsewhere classified

142

1.27

0.38

1.2

1.0

3.88

7.51

u/ml

0.71

Retinal vascular occlusion

279

1.18

0.38

1.0

6.15

3.24

u/ml

0.31

123

Autoimmune diseases

1256

6550

0.97

0.38

1.1

6.56

5.76

u/ml

0.66

664

3531

Thyrotoxicosis with toxic multinodular goitre

224

1.21

0.38

1.0

1.29

3.03

u/ml

0.97

101

Injury of intra-abdominal organs

181

0.77

0.38

1.1

4.94

8.46

u/ml

—

105

Anankastic personality disorder

366

0.84

0.38

1.2

1.1

3.96

5.59

u/ml

0.46

194

Other disorders of skin and subcutaneous tissue

518

4428

1.04

0.38

1.1

4.98

4.67

u/ml

0.16

268

2198

Generalized epilepsy

486

1.14

0.38

1.1

5.90

6.44

u/ml

0.08

293

Hypoplasia of dental enamel , including avohilmo

754

0.90

0.37

1.2

3.68

6.81

u/ml

1.26

538

Chronic respiratory disease originating in the perinatal period

0.61

0.37

1.2

9.08

5.92

u/ml

—

Superficial injury of forearm

105

963

1.09

0.37

1.1

6.39

6.57

u/ml

0.03

544

Polycystic ovarian syndrome, broad definition

168

1571

1.07

0.37

1.1

5.14

5.96

u/ml

0.33

858

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

810

1.10

0.37

1.1

3.22

5.76

u/ml

1.24

417

Glomerulonephritis

631

0.89

0.37

1.1

2.92

5.48

u/ml

0.70

360

Other and unspecified disorders of adult personality and behaviour

1.36

0.37

1.2

1.1

0.21

6.53

u/ml

—

Hydrocephalus

279

0.82

0.37

1.0

1.1

11.28

5.81

u/ml

0.30

158

Maternal care related to the fetus and amniotic cavity and possible delivery problems

589

3333

1.04

0.37

1.1

5.59

5.53

u/ml

0.03

283

1672

Other congenital malformations of face and neck

262

1.19

0.37

1.1

2.83

6.86

u/ml

1.65

157

Dislocation, sprain and strain of joints and ligaments of elbow

648

1.11

0.37

1.1

7.08

5.97

u/ml

0.16

370

Enteropathic arthropathies

152

1.26

0.37

1.1

5.15

6.76

u/ml

—

Crohn disease

133

1233

1.08

0.37

1.1

6.65

6.84

u/ml

0.04

663

Arthropathies in other diseases classified elsewhere

169

0.77

0.37

1.0

1.1

4.96

4.42

u/ml

—

Disorders of puberty, all

347

1.16

0.36

1.1

1.2

7.81

7.88

u/ml

0.01

248

Abnormal weight loss

478

1.13

0.36

1.1

3.34

5.51

u/ml

1.04

265

Iron deficiency anaemia

288

2699

1.05

0.36

1.1

7.27

4.79

u/ml

1.00

145

1399

Nontraumatic intracranial haemmorrhage

661

0.89

0.36

1.1

4.50

3.84

u/ml

0.11

312

Ankylosing spondylitis

611

1.11

0.36

1.0

1.1

4.68

5.71

u/ml

0.15

310

Venous complications and haemorrhoids in pregnancy

223

0.80

0.36

1.1

2.48

5.46

u/ml

—

115

Other benign neoplasms of connective and other soft tissue

587

0.88

0.36

1.1

4.25

5.43

u/ml

0.33

291

Pneumothorax

272

1.18

0.36

1.0

1.1

10.07

5.09

u/ml

0.30

150

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

186

1919

0.94

0.36

1.1

6.14

6.42

u/ml

0.08

118

1154

Cellulitis of external ear

0.65

0.36

1.0

1.1

7.81

6.77

u/ml

—

Short stature, not elsewhere classified

603

1.11

0.36

1.1

1.2

5.08

5.96

u/ml

0.23

455

Complications following abortion and ectopic and molar pregnancy

171

1.23

0.36

1.1

0.69

2.05

u/ml

—

Other other unspecified disorders of the circulatory system

168

0.77

0.35

1.1

0.70

6.11

u/ml

—

Preparatory care for dialysis

168

0.77

0.35

1.0

1.1

5.86

5.74

u/ml

—

Bacterial meningitis

201

0.79

0.35

1.1

15.55

5.66

u/ml

0.56

105

Gout

784

0.91

0.35

1.1

2.66

4.35

u/ml

0.90

358

Other disorders of bladder

438

0.87

0.35

1.1

5.73

5.10

u/ml

0.05

216

Other specific arthropathies, wide

108

1.30

0.35

1.1

1.0

2.29

4.64

u/ml

—

Other facial nerve disorders

144

1.25

0.35

1.4

1.1

10.10

4.08

u/ml

—

Gout, strict definition

459

0.87

0.35

1.1

2.66

4.77

u/ml

1.00

200

Other benign neoplasms of uterus

135

1.26

0.35

1.1

1.0

1.91

1.50

u/ml

—

Personality disorders

318

3037

1.05

0.35

1.1

4.98

6.16

u/ml

0.73

181

1613

Malignant neoplasm of kidney, except renal pelvis

266

0.83

0.35

1.0

1.1

7.54

3.93

u/ml

—

129

Torsion of ovary, ovarian pedicle and fallopian tube

190

1.22

0.35

1.1

4.94

4.90

u/ml

0.01

102

Burns and corrosions

139

1295

1.07

0.35

1.1

8.32

6.66

u/ml

0.35

725

Glaucoma suspect

169

1585

1.07

0.35

1.1

4.22

3.85

u/ml

0.11

758

Maternal care for cervical incompetence

292

1.17

0.34

1.0

1.1

5.36

4.43

u/ml

0.11

142

Autism

468

0.87

0.34

1.1

4.27

7.99

u/ml

0.83

303

Malignant neoplasm of rectum, including Hilmo

373

0.86

0.34

1.1

7.76

3.49

u/ml

0.56

174

Leisure time condition

156

1460

1.07

0.34

1.1

6.66

6.09

u/ml

0.14

795

Maternal care for known or suspected abnormality of pelvic organs

364

2373

1.05

0.34

1.1

5.04

5.17

u/ml

0.06

181

1230

Myeloproliferative diseases

287

0.84

0.34

1.1

1.0

0.91

4.57

u/ml

3.49

133

Weight loss

585

1.11

0.34

1.1

3.13

4.84

u/ml

0.89

327

Other and unspecified acne

145

1.25

0.34

1.2

1.1

1.93

7.47

u/ml

2.81

Retinal vascular disorders

283

1.17

0.34

1.0

6.15

3.20

u/ml

0.32

125

Benign neoplasm: Cerebral meninges

358

1.15

0.34

1.0

1.1

2.46

2.80

u/ml

0.12

171

Glucagon-like peptide-1 (GLP-1) analogues

202

1908

1.06

0.34

1.1

3.99

4.09

u/ml

0.03

900

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

202

1908

1.06

0.34

1.1

3.99

4.09

u/ml

0.03

900

Other osteochondrodysplasias

100

1.31

0.34

1.1

1.2

3.15

4.47

u/ml

—

Aggressive periodontitis

1.32

0.34

1.1

1.0

0.82

4.36

u/ml

—

Certain zoonotic bacterial diseases

145

1.25

0.34

1.3

1.1

10.14

6.85

u/ml

—

Other and unspecified injuries of head

478

0.88

0.34

1.1

5.07

5.83

u/ml

0.13

255

Implicit fungal Sepsis

136

1.25

0.33

1.1

7.25

4.81

u/ml

0.15

Syphilis

127

1.26

0.33

1.1

2.42

8.65

u/ml

—

Syphilis

127

1.26

0.33

1.1

2.42

8.65

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

825

1.09

0.33

1.0

1.1

3.53

4.37

u/ml

0.41

398

Foreign body or object entering through skin

491

1.12

0.33

1.1

2.93

6.33

u/ml

2.46

265

Other problems related to primary support group, including family circumstances

183

1678

1.06

0.33

1.1

3.20

6.39

u/ml

4.23

100

1040

Other heart diseases, wide

1027

6436

0.97

0.33

1.1

6.12

5.29

u/ml

0.77

529

3409

Methotrexate

824

0.91

0.33

1.0

1.43

6.05

u/ml

6.47

397

Hypertrophic scar

501

1.12

0.33

1.1

9.09

5.49

u/ml

0.48

274

Autoimmune hyperthyroidism

482

1.12

0.33

1.0

1.1

2.04

5.44

u/ml

2.96

232

Cerebral palsy and other paralytic syndromes

813

0.91

0.33

1.1

3.47

5.34

u/ml

0.43

441

Fracture of lumbar spine and pelvis

947

0.92

0.33

1.0

1.1

7.83

4.82

u/ml

0.58

455

Anterior Iridocyclitis

133

1425

0.93

0.33

1.1

8.19

5.62

u/ml

0.62

727

Benign neoplasm of brain and other parts of central nervous system

371

0.86

0.33

1.1

4.04

5.11

u/ml

0.23

206

Hallux valgus (acquired)

227

1547

1.06

0.33

1.1

2.47

4.22

u/ml

1.08

103

676

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

397

1.14

0.33

1.1

2.77

4.25

u/ml

0.60

196

Sequelae of injuries of head

328

0.85

0.33

1.1

1.49

6.68

u/ml

3.00

177

Other adrenocortical overactivity

1.32

0.32

1.1

1.2

4.56

6.36

u/ml

—

Azathioprine

122

1310

0.93

0.32

1.1

5.95

6.50

u/ml

0.13

711

Lung diseases due to external agents

473

1.12

0.32

1.1

3.19

5.43

u/ml

0.40

237

Benign neoplasm: Skin, unspecified

201

1.20

0.32

1.0

1.1

1.22

4.10

u/ml

2.07

102

Disorders of globe

1.35

0.32

1.0

1.1

8.58

7.75

u/ml

—

Scarlet fever

119

1.27

0.32

1.0

1.2

1.69

6.68

u/ml

—

Gonarthrosis, primary, with knee surgery

220

1846

0.95

0.32

1.0

2.23

2.90

u/ml

0.62

763

Other metabolic disorders

116

1078

1.08

0.32

1.0

1.1

3.75

5.09

u/ml

0.65

561

Gout, unspecified

571

0.89

0.32

1.1

1.39

4.43

u/ml

3.16

260

Other congenital malformations of male genital organs

197

0.80

0.32

1.3

1.2

7.95

7.66

u/ml

0.02

154

Carrier of infectious disease

183

1.21

0.32

1.2

1.1

3.54

8.33

u/ml

1.82

100

Intestinal stricture

138

1474

0.94

0.32

1.1

1.49

4.38

u/ml

7.14

727

Erythema multiforme

119

1.26

0.32

1.2

1.1

5.29

5.66

u/ml

—

Other diseases of biliary tract

332

1.15

0.32

1.1

1.49

4.16

u/ml

1.23

168

Infectious mononucleosis

132

1234

1.07

0.31

1.1

9.20

7.52

u/ml

0.44

706

Endometriosis diagnosis and infertility diagnosis occurring together

107

1153

0.93

0.31

1.0

1.1

3.37

5.14

u/ml

0.77

586

Myocardial infarction, without ST-elevation

122

1035

1.07

0.31

1.1

1.0

3.15

2.86

u/ml

0.11

458

Malignant neoplasm of endocrine gland

433

0.88

0.31

1.1

3.99

4.45

u/ml

0.13

230

Diabetic maculopathy

537

0.89

0.31

1.0

1.1

6.66

4.62

u/ml

0.27

256

Other and unspecified injuries of shoulder and upper arm

174

1.21

0.31

1.2

1.1

8.44

7.54

u/ml

0.06

Vertical strabismus

211

1.19

0.31

1.1

3.14

5.40

u/ml

0.50

114

Abscess of anal and rectal regions

627

1.10

0.31

1.1

8.31

5.24

u/ml

0.53

338

Postprocedural endocrine and metabolic disorders, not elsewhere classified

105

973

1.08

0.31

1.0

1.1

3.70

5.30

u/ml

0.75

494

Blood alcohol or alcohol intoxication level

197

0.81

0.31

1.0

1.1

9.44

8.40

u/ml

—

113

Injuries to the hip and thigh

301

2609

1.05

0.31

1.1

6.21

5.50

u/ml

0.28

153

1349

Inflammatory bowel disease, strict (require KELA)

221

2324

0.95

0.31

1.1

7.26

6.33

u/ml

0.29

1280

Habit and impulse disorders

164

0.79

0.31

1.0

1.1

9.88

8.96

u/ml

—

Melanocytic naevi of upper limb, including shoulder

147

1.23

0.31

1.1

9.98

4.12

u/ml

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

283

0.85

0.31

1.0

1.1

0.97

3.64

u/ml

—

140

Other mental disorders due to brain damage and dysfunction and to physical disease

347

0.86

0.30

1.0

1.1

6.71

4.25

u/ml

0.26

158

Obstructed labour due to malposition and malpresentation of fetus

275

2680

0.96

0.30

1.1

4.75

4.81

u/ml

0.03

141

1332

Bacterial pneumonia, not elsewhere classified

259

2177

1.05

0.30

1.0

1.1

4.42

5.45

u/ml

0.55

148

1112

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

179

1832

0.95

0.30

1.1

6.35

u/ml

0.00

114

1116

Aortic aneurysm

635

1.10

0.30

1.0

1.1

4.16

4.13

u/ml

0.00

300

Reactive arthropathies

600

1.10

0.30

1.0

1.1

9.71

5.80

u/ml

0.62

298

Multiple delivery

787

0.91

0.30

1.1

2.47

4.40

u/ml

1.13

406

Etanercept

599

0.90

0.30

1.0

1.1

1.85

5.63

u/ml

4.04

326

Injury of eye and orbit

139

1306

1.07

0.29

1.1

8.58

6.36

u/ml

0.34

708

Chronic pancreatitis

546

0.90

0.29

1.0

1.1

3.10

4.23

u/ml

0.35

269

Other CVD

601

1.10

0.29

1.1

2.79

4.40

u/ml

0.72

300

Vitamin deficiency

269

1.15

0.29

1.2

1.1

8.77

5.32

u/ml

0.75

148

Vitamin deficiency, wide

269

1.15

0.29

1.2

1.1

8.77

5.32

u/ml

0.75

148

Cholesteatoma of middle ear

195

0.82

0.29

1.1

5.98

6.17

u/ml

—

Unspecified lump in breast

108

1007

1.07

0.28

1.1

3.14

4.54

u/ml

0.51

484

Other and unspecified disorders of skin and subcutaneous tissue

326

1.14

0.28

1.1

2.65

4.70

u/ml

0.75

159

Hyperkinetic disorders (excl. ADHD)

389

1.13

0.28

1.2

5.56

7.67

u/ml

0.34

283

Scabies

176

1669

1.06

0.28

1.1

6.19

6.76

u/ml

0.14

933

Presence of other devices

101

936

1.08

0.28

1.1

3.60

4.25

u/ml

0.22

452

Pathological resorption of teeth

223

1.17

0.28

1.0

1.1

2.16

6.58

u/ml

2.54

121

Other disorders of nervous system

291

0.86

0.28

1.1

1.89

4.47

u/ml

1.20

141

Benign neoplasm: Skin of other and unspecified parts of face

469

1.11

0.28

1.1

2.90

5.30

u/ml

1.43

238

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1006

7008

0.98

0.28

1.1

5.66

5.49

u/ml

0.12

588

3655

Other specified congenital malformation syndromes affecting multiple systems

279

0.85

0.27

1.1

1.2

1.50

7.19

u/ml

4.38

194

Injuries to the shoulder and upper arm

754

5924

1.03

0.27

1.1

3.83

5.87

u/ml

3.75

379

3113

Use of glatiramer acetate

172

0.81

0.27

1.0

1.1

2.53

5.37

u/ml

—

Persons with potential health hazards related to communicable diseases

510

5206

0.97

0.27

1.1

6.44

6.50

u/ml

0.03

296

2907

Visual field defects

396

0.88

0.27

1.0

1.1

1.78

4.63

u/ml

1.37

196

Other coagulation defects

585

1.10

0.27

1.2

1.1

4.62

5.52

u/ml

0.21

314

Chronic ulcer of skin, not elsewhere classified

226

0.84

0.27

1.1

1.28

6.76

u/ml

2.96

103

Brachial plexus disorders

855

1.08

0.27

1.1

4.35

5.43

u/ml

0.44

432

Anorexia

113

1.24

0.27

1.2

1.1

7.78

6.63

u/ml

—

Recurrent dislocation of patella

663

1.09

0.27

1.1

4.20

6.88

u/ml

1.07

359

Optic atrophy

113

1.24

0.27

1.0

1.1

7.38

8.95

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

885

1.08

0.27

1.1

3.00

5.57

u/ml

1.34

451

Primary open-angle glaucoma, strict

655

0.91

0.26

1.1

1.0

1.52

2.91

u/ml

1.14

290

Respiratory tuberculosis, confirmed and not-confirmed

113

1.24

0.26

1.1

4.09

5.27

u/ml

—

Respiratory tuberculosis

113

1.24

0.26

1.1

4.09

5.27

u/ml

—

Malignant neoplasm of ovary

193

0.83

0.26

1.0

1.1

2.97

2.91

u/ml

—

Torticollis

150

1.21

0.26

1.2

1.1

11.05

6.07

u/ml

—

Parkinson's disease, strict definition

289

0.86

0.26

1.0

1.08

3.28

u/ml

1.94

124

Other disorders of optic disc

1.29

0.26

1.3

1.1

17.17

6.88

u/ml

—

Other and unspecified mononeuropathies of upper limb

171

0.82

0.26

1.1

1.0

0.37

6.50

u/ml

—

Other and unspecified psoriasis

329

1.13

0.26

1.2

1.1

2.95

5.73

u/ml

0.58

168

Infections of breast associated with childbirth

415

1.11

0.26

1.1

3.36

5.51

u/ml

0.49

218

Convulsions, not elsewhere classified

223

2299

0.96

0.26

1.1

7.47

7.09

u/ml

0.11

123

1342

Molar incisor enamel hypoplasia

789

0.92

0.25

1.2

3.63

6.79

u/ml

1.47

563

Distal bite

709

1.08

0.25

1.1

9.24

7.95

u/ml

0.22

473

Spondylopathies (FG)

131

1237

1.06

0.25

1.0

1.1

5.74

6.27

u/ml

0.09

630

Hyperfunction of pituitary gland

492

1.10

0.25

1.1

5.22

6.95

u/ml

0.25

275

Social phobias

119

1121

1.06

0.25

1.1

5.31

7.76

u/ml

1.00

637

Hemiplegia

254

1.14

0.25

1.0

1.1

1.49

4.56

u/ml

1.74

130

Dermatophytosis

704

1.08

0.25

1.1

5.94

5.15

u/ml

0.18

371

Pneumonitis due to solids and liquids

245

0.86

0.25

1.1

5.36

5.77

u/ml

0.03

128

Psoriatic arthropathies, ICD10

664

0.92

0.25

1.1

4.03

4.64

u/ml

0.08

323

Osteomyelitis

292

1.13

0.25

1.1

9.82

6.45

u/ml

0.32

155

Other disorders of male genital organs

245

1.15

0.24

1.0

1.1

4.20

10.02

u/ml

2.00

143

Open bite

831

1.07

0.24

1.1

5.66

7.07

u/ml

0.30

518

Exclusion endpoint for supernumerary teeth

180

0.83

0.24

1.2

1.1

5.60

7.94

u/ml

—

123

Injuries to the head

1223

7383

1.02

0.24

1.1

6.35

5.56

u/ml

0.69

696

3860

Other/unspecified reactive arthropathies

455

1.10

0.24

1.0

1.1

10.46

4.73

u/ml

0.87

244

Non-small cell lung cancer

200

0.84

0.24

1.0

1.1

0.69

2.40

u/ml

—

Systemic lupus erythematosus, unspecified

180

0.83

0.24

1.2

1.1

7.29

3.81

u/ml

—

Isolated proteinuria

161

1.18

0.24

1.0

1.1

7.36

5.45

u/ml

—

Certain zoonotic bacterial diseases

0.72

0.24

1.0

1.1

—

6.70

—

Follow-up examination after treatment for malignant neoplasms

297

0.87

0.24

1.1

1.0

1.11

4.50

u/ml

—

120

Corns and callosities

318

0.88

0.24

1.1

10.63

5.01

u/ml

0.43

153

Hyphaema and other vascular disorders of iris and ciliary body

0.71

0.24

1.2

1.0

11.93

8.26

u/ml

—

Chronic hepatitis, not elsewhere classified

169

0.83

0.24

1.0

1.1

3.06

3.78

u/ml

—

Sequelae of other and unspecified infectious and parasitic diseases

412

0.90

0.23

1.1

2.65

4.94

u/ml

0.85

201

Hypopituitarism

713

0.92

0.23

1.1

5.65

6.29

u/ml

0.11

444

Convalescence

303

1.12

0.23

1.2

1.1

3.94

3.81

u/ml

0.03

148

Thoracic aortic aneurysm

475

1.10

0.23

1.1

3.72

4.94

u/ml

0.21

231

Divergent concomitant strabismus

639

1.08

0.23

1.1

3.19

5.53

u/ml

1.08

340

Other diseases of pancreas

303

1.12

0.23

1.1

2.84

3.38

u/ml

0.11

148

Follow-up care involving plastic surgery

199

1.16

0.23

1.1

3.31

3.42

u/ml

—

Coagulation defects, purpura and other haemorrhagic conditions

154

1466

1.05

0.23

1.1

6.45

5.92

u/ml

0.08

785

Other cataract

201

1588

0.96

0.23

1.1

6.59

3.85

u/ml

0.55

741

Outcome of delivery

246

1581

0.96

0.23

1.1

7.74

5.28

u/ml

1.21

150

832

Other disorders of ear

803

5146

1.02

0.23

1.1

4.82

5.01

u/ml

0.09

398

2639

Patent foramen ovale

264

0.87

0.23

1.0

1.2

4.98

6.14

u/ml

0.12

180

Other obstructed labour

661

0.92

0.23

1.1

3.28

4.89

u/ml

0.47

320

Rare circulating lymphoid malignancy, including Hilmo

179

0.84

0.23

1.1

1.2

3.23

8.84

u/ml

—

124

Other specified/unspecified arthritis

214

2054

1.04

0.23

1.1

6.21

5.61

u/ml

0.17

110

1028

Pregnancy with abortive outcome

711

3794

0.98

0.23

1.1

4.59

5.50

u/ml

0.91

357

1920

Pedal cyclist injured in noncollision transport accidents

980

0.94

0.23

1.1

5.29

6.30

u/ml

0.25

520

Supervision of high-risk pregnancy

290

1807

0.96

0.23

1.1

7.23

5.27

u/ml

0.87

139

924

Mandibular prognathia

181

1.17

0.23

1.1

1.2

14.55

8.25

u/ml

0.62

125

Disorders resulting from impaired renal tubular function

168

0.83

0.23

1.0

1.1

4.38

6.68

u/ml

—

Senile cataract

300

1775

1.04

0.22

1.1

2.94

u/ml

0.00

150

764

IBD patients in KELA-register

221

2298

0.96

0.22

1.1

7.26

6.49

u/ml

0.23

1258

All dysplastic lesions of the cervix uteri

331

3180

1.03

0.22

1.1

5.68

4.90

u/ml

0.38

157

1619

Polyhydramnios

554

1.09

0.22

1.1

6.45

5.82

u/ml

0.08

297

ILD medications: azathioprine

122

1287

0.95

0.22

1.1

5.95

6.68

u/ml

0.18

698

UC patients in KELA-register (code 208), prior to 1994

189

0.85

0.22

1.0

1.1

1.15

3.90

u/ml

—

Other fall from one level to another

214

2225

0.96

0.22

1.1

5.56

6.73

u/ml

0.43

118

1296

Impacted maxillary molar

927

0.94

0.22

1.1

6.98

7.77

u/ml

0.19

531

Male infertility

429

1.10

0.22

1.1

10.14

8.93

u/ml

0.10

249

Androgen resistance syndrome

0.00

0.22

0.0

1.0

—

3.18

—

Psychotic depression

429

1.10

0.22

1.1

2.85

6.55

u/ml

1.51

241

Angina pectoris

256

1644

1.04

0.22

1.1

1.0

3.69

2.91

u/ml

0.30

754

Constipation

764

5178

1.02

0.22

1.1

3.94

4.85

u/ml

0.67

372

2726

Hirsutism in women

210

1.15

0.22

1.0

1.1

4.44

4.21

u/ml

0.04

112

Manic episode

231

0.86

0.22

1.0

1.1

8.97

7.61

u/ml

—

132

Benign neoplasm: Aortic body and other paraganglia

0.00

0.22

0.0

1.0

—

11.37

—

Other disorders of fluid, electrolyte and acid-base balance

136

1361

0.95

0.22

1.1

2.20

4.09

u/ml

1.69

684

Hypokalaemia

545

1.08

0.22

1.1

1.72

5.21

u/ml

3.35

295

Disorders of copper metabolism

0.00

0.21

0.0

1.0

—

26.39

—

Traumatic amputation of shoulder and upper arm

0.00

0.21

0.0

1.2

—

0.92

—

Dislocations, sprains and strains involving multiple body regions

0.00

0.21

0.0

1.1

—

1.40

—

Other noninfective disorders of lymphatic vessels and lymph nodes

199

0.85

0.21

1.2

1.1

6.03

5.24

u/ml

—

Other secondary gonarthrosis

210

1.14

0.21

1.0

1.1

2.62

4.55

u/ml

0.69

Hyposplenism

0.00

0.21

0.0

1.0

—

3.58

—

Hip and thigh

0.00

0.21

0.0

1.1

—

2.40

—

Other condition

121

1148

1.06

0.21

1.1

7.80

5.99

u/ml

0.28

594

Malignant neoplasm of meninges, including Hilmo

0.00

0.21

0.0

1.0

—

2.38

—

Other sideroblastic anaemias

0.00

0.21

0.0

1.0

—

4.82

—

Benign neoplasm: Scrotum

0.00

0.21

0.0

1.0

—

11.26

—

Other diseases of arteries and capillaries

401

1.10

0.21

1.1

1.90

5.14

u/ml

1.80

194

Burn and corrosion of wrist and hand

367

0.90

0.21

1.2

1.1

12.16

5.77

u/ml

0.69

219

Foreign body on external eye

122

1158

1.05

0.21

1.0

1.1

6.22

5.62

u/ml

0.13

631

Abnormal findings on antenatal screening of mother

129

1227

1.05

0.21

1.1

4.47

6.46

u/ml

0.72

688

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.21

0.0

1.0

—

2.77

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.21

0.0

1.0

—

9.94

—

Cerebral amyloid angiopathy

0.00

0.21

0.0

1.1

—

3.85

—

Malignant neoplasm of ureter, including Hilmo

0.00

0.21

0.0

1.0

—

5.04

—

Malignant neoplasm of colon, including Hilmo

564

0.92

0.21

1.1

1.0

4.95

3.54

u/ml

0.16

260

Use of interferon beta-1a

209

0.86

0.21

1.0

1.1

4.42

5.45

u/ml

—

102

Eating disorder

145

1382

1.05

0.21

1.1

5.74

6.82

u/ml

0.30

824

Melanoma in situ

126

1.19

0.21

1.1

1.0

3.29

3.28

u/ml

—

Other congenital malformations of male genital organs

187

0.85

0.21

1.3

1.2

7.95

7.38

u/ml

0.04

146

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

0.00

0.21

0.0

1.1

—

1.48

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

192

1.15

0.21

1.1

1.2

5.47

8.08

u/ml

0.27

129

Tuberculosis

126

1.19

0.21

1.1

4.09

5.42

u/ml

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.21

0.0

1.1

—

4.98

—

Thromboangiitis obliterans

0.00

0.21

0.0

1.1

—

8.17

—

Benign neoplasm: Eye, unspecified

0.00

0.21

0.0

1.1

—

2.11

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.21

0.0

1.1

—

5.96

—

Malignant neoplasm of floor of mouth

0.00

0.21

0.0

1.1

—

11.17

—

Hypertrophic disorders of skin

537

1.08

0.21

1.1

8.76

6.17

u/ml

0.33

296

Motor disorders

446

0.91

0.21

1.1

1.2

4.63

6.55

u/ml

0.41

344

Assault by sharp object

134

0.82

0.21

1.0

1.1

2.52

9.01

u/ml

—

Pedal cyclist injured in other and unspecified transport accidents

906

1.06

0.20

1.1

5.62

6.41

u/ml

0.19

475

Peripheral retinal degeneration

145

1.17

0.20

1.0

3.40

3.67

u/ml

—

Congenital absence of the vagina

0.00

0.20

0.0

1.1

—

2.71

—

Lumbosacral spina bifida and hydrocephalus

0.00

0.20

0.0

1.1

—

3.67

—

Nephrotic syndrome

240

0.87

0.20

1.3

1.1

0.55

7.41

u/ml

—

161

Deep endometriosis

780

1.07

0.20

1.1

4.76

5.39

u/ml

0.14

411

Arterial embolism and thrombosis

145

1.17

0.20

1.0

5.64

6.41

u/ml

—

Fitting and adjustment of external prosthetic device

0.00

0.20

0.0

1.1

—

9.36

—

Other parasitologically confirmed or unspecified malaria

0.00

0.20

0.0

1.0

—

11.18

—

0.00

0.20

0.0

1.1

—

2.26

—

Disorders of purine and pyrimidine metabolism

0.00

0.20

0.0

1.1

—

5.96

—

Other salmonella infections

183

1.15

0.20

1.0

1.1

2.16

5.16

u/ml

—

Toxic effect of alcohol

108

1.21

0.20

1.0

1.1

8.50

8.10

u/ml

—

Abnormal findings on examination of urine, without diagnosis

240

1.13

0.20

1.1

5.45

5.92

u/ml

0.05

131

Other disorders of choroid

1.23

0.20

1.3

1.0

44.55

5.84

u/ml

—

Other specified and unspecified personality disorders

849

1.06

0.20

1.1

4.69

6.31

u/ml

0.43

446

Chronic suppurative otitis media

509

1.08

0.20

1.1

3.75

6.54

u/ml

0.84

287

Gout, FINNGEN

859

0.94

0.20

1.1

2.66

4.11

u/ml

0.77

403

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

250

1.12

0.19

1.0

1.1

4.47

4.40

u/ml

0.01

129

Benign neoplasm of ovary

100

947

1.06

0.19

1.0

1.1

2.67

3.45

u/ml

0.34

433

Other disorders of pigmentation

231

1.13

0.19

1.2

1.1

4.76

6.58

u/ml

0.33

120

Contact with sharp glass

375

0.90

0.19

1.1

7.40

6.30

u/ml

0.10

205

Bell's palsy

762

1.06

0.19

1.0

1.1

5.47

5.69

u/ml

0.04

387

Scissor bite

524

1.08

0.19

1.1

1.2

14.05

9.37

u/ml

0.70

360

Complications of the puerperium, not elsewhere classified

481

1.08

0.19

1.0

1.1

2.82

5.59

u/ml

2.16

252

Mixed and other personality disorders

772

1.06

0.19

1.1

2.76

5.95

u/ml

2.80

400

Pleural effusion

427

0.91

0.19

1.0

1.1

3.25

3.78

u/ml

0.08

207

Transitory endocrine and metabolic disorders specific to fetus and newborn

415

1.09

0.19

1.2

7.47

6.14

u/ml

0.17

318

Contact with nonpowered hand tool

260

1.12

0.19

1.1

12.14

6.87

u/ml

0.38

137

Fetus and newborn affected by maternal complications of pregnancy

194

1.15

0.19

1.1

1.3

5.81

6.68

u/ml

0.07

150

Pyoderma

1.23

0.19

1.1

1.0

0.61

6.41

u/ml

—

Injury of muscle and tendon at wrist and hand level

952

0.94

0.19

1.1

2.95

5.87

u/ml

1.96

497

AV-block

483

0.92

0.19

1.1

2.85

4.99

u/ml

0.79

243

Somnolence, stupor and coma

207

0.87

0.19

1.1

2.72

7.02

u/ml

—

107

Necrosis of pulp, including avohilmo

575

5853

0.98

0.19

1.1

4.38

5.55

u/ml

1.16

303

2987

Other lack of coordination

1.24

0.19

1.0

3.69

6.97

u/ml

—

Ulcer of lower limb, not elsewhere classified

457

0.92

0.18

1.0

1.1

7.94

4.11

u/ml

0.52

214

Postpartum hemorraghe, all women as controls

352

3374

1.03

0.18

1.1

5.60

5.28

u/ml

0.14

160

1725

Gestational diabetes (for exclusion)

553

3766

1.02

0.18

1.1

4.84

5.52

u/ml

0.54

277

1935

Reactive arthropathies, FINNGEN

521

1.08

0.18

1.0

1.1

10.13

5.09

u/ml

0.75

263

Cirrhosis of liver, NAS

175

1.14

0.18

1.1

4.61

4.76

u/ml

0.02

Complications of other internal prosthetic devices, implants and grafts

164

0.85

0.18

1.1

4.44

6.51

u/ml

—

Melanocytic naevi of trunk

909

0.95

0.18

1.1

5.65

5.69

u/ml

0.01

477

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

164

0.85

0.18

1.0

1.1

3.66

5.82

u/ml

—

248

0.88

0.18

1.0

1.1

8.00

6.70

u/ml

—

120

Maternal care for known or suspected malpresentation of fetus

280

2089

0.97

0.18

1.1

4.93

5.13

u/ml

0.08

139

1103

Bacterial, viral and other infectious agents

716

1.06

0.18

1.0

1.1

3.65

5.71

u/ml

0.95

388

Renal cell carcinoma of kidney

1.21

0.18

1.0

—

3.02

—

Other ulcerative colitis

487

0.92

0.18

1.2

1.1

8.68

6.05

u/ml

0.32

268

Other misadventures during surgical and medical care

100

1.20

0.18

1.3

1.0

2.12

4.48

u/ml

—

Meningitis

321

0.90

0.18

1.1

16.18

5.31

u/ml

1.05

169

Myeloproliferative diseases (CML excluded)

248

0.89

0.18

1.1

1.0

0.91

4.30

u/ml

2.98

113

Tuberculosis, IBD comorbidity

166

1.15

0.18

1.1

1.0

5.47

6.56

u/ml

—

Optic atrophy

119

1.18

0.18

1.0

1.1

7.38

8.68

u/ml

—

Radial styloid tenosynovitis [de Quervain]

435

1.08

0.18

1.1

1.97

5.90

u/ml

2.72

201

Specific personality disorders

274

2662

1.03

0.17

1.1

5.18

6.32

u/ml

0.59

156

1410

Hypoglycaemia, other or unspecified

517

0.93

0.17

1.1

7.51

5.73

u/ml

0.28

307

Pneumonia, organism unspecified

913

6299

1.02

0.17

1.1

5.59

5.26

u/ml

0.24

532

3291

Disorders of calcium metabolism

289

0.90

0.17

1.1

3.22

4.94

u/ml

0.37

157

Fibrosis and cirrhosis of liver

310

1.10

0.17

1.0

3.53

3.44

u/ml

0.01

156

Nonischemic cardiomyopathy

382

0.91

0.17

1.1

4.32

5.07

u/ml

0.13

185

Duodenal ulcer

262

1.11

0.17

1.1

1.0

3.57

4.45

u/ml

0.12

113

Graves disease, strict definition

874

1.05

0.17

1.0

1.1

3.21

5.39

u/ml

1.16

449

Gingival hyperplasia

299

0.90

0.17

1.0

1.1

2.64

7.22

u/ml

1.98

189

Intrahepatic Cholestasis of Pregnancy (ICP)

845

1.05

0.17

1.1

3.22

5.77

u/ml

1.20

431

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

129

1.17

0.17

1.1

6.03

4.73

u/ml

—

Specific developmental disorder of motor function

433

0.92

0.17

1.1

1.2

4.63

7.47

u/ml

0.67

336

Open wound of head

419

4128

0.98

0.17

1.1

7.33

5.51

u/ml

1.14

242

2221

Golimumab

309

0.90

0.17

1.0

1.1

2.77

6.42

u/ml

1.63

168

Postpartum haemorrhage due to retained placenta

153

1473

1.04

0.17

1.0

1.1

6.01

5.38

u/ml

0.15

747

Seronegative rheumatoid arthritis

588

0.93

0.17

1.1

2.88

3.81

u/ml

0.33

271

Congenital malformations of ovaries, fallopian tubes and broad ligaments

592

1.07

0.16

1.1

8.58

5.40

u/ml

0.47

311

Other peripheral vascular diseases

485

1.07

0.16

1.1

3.56

5.36

u/ml

0.42

246

Twin gestation

1038

0.95

0.16

1.1

2.73

4.82

u/ml

1.63

536

Other disorders of the genitourinary system

495

0.93

0.16

1.2

1.0

3.18

2.63

u/ml

0.22

220

Polymyalgia rheumatica

288

0.90

0.16

1.0

1.1

1.30

2.67

u/ml

0.84

126

Intentional self-harm by sharp object

298

0.90

0.16

1.0

1.1

4.97

8.29

u/ml

0.58

181

Acute appendicitis, with complications

121

1262

0.96

0.16

1.1

3.42

5.05

u/ml

0.70

613

Malignant neoplasm of thyroid gland, including Hilmo

437

1.08

0.16

1.1

4.09

4.83

u/ml

0.23

224

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

321

1.09

0.16

1.0

1.1

5.97

5.11

u/ml

0.11

155

Otosclerosis

321

1.09

0.16

1.0

1.1

0.78

3.48

u/ml

2.99

147

Superficial injuries involving multiple body regions

183

0.87

0.16

1.1

7.34

8.53

u/ml

—

Motorcycle rider injured in other and unspecified transport accidents

593

1.06

0.16

1.2

1.1

8.52

7.68

u/ml

0.12

329

Fracture of forearm

480

4482

0.98

0.15

1.1

6.11

5.95

u/ml

0.07

270

2333

Granuloma annulare

0.79

0.15

1.2

1.1

—

5.29

—

Malignant neoplasm of colon

411

0.92

0.15

1.0

1.1

6.69

3.64

u/ml

0.28

195

Essential (haemorrhagic) thrombocythaemia

130

1.16

0.15

1.1

1.0

1.19

4.18

u/ml

—

Haemorrhage, not elsewhere classified

130

1.16

0.15

1.1

5.12

6.02

u/ml

—

Orchitis and epididymitis

452

0.93

0.15

1.0

1.1

3.19

7.33

u/ml

2.06

247

Presbycusis

176

1.13

0.15

1.1

1.0

0.34

1.33

u/ml

—

Pedal cyclist injured in collision with motor vehicle

245

1.10

0.15

1.1

6.68

6.83

u/ml

0.02

136

Heart failure and bmi 25plus

115

810

0.96

0.15

1.0

1.1

6.85

3.00

u/ml

0.88

352

Aneurysms, operations, SAH

731

1.05

0.15

1.1

2.73

3.28

u/ml

0.24

331

Other encephalitis

161

0.87

0.15

1.1

12.66

5.13

u/ml

—

Traumatic amputation of wrist and hand

182

0.88

0.15

1.1

6.67

7.17

u/ml

—

Myositis

102

1.18

0.15

1.3

1.0

2.35

6.97

u/ml

—

Acute and subacute iridocyclitis

130

1350

0.96

0.15

1.1

8.19

5.82

u/ml

0.55

677

Cardiac arrhythmias

721

4756

0.98

0.15

1.1

5.44

5.42

u/ml

0.01

366

2523

Speech disturbances, not elsewhere classified

348

0.92

0.15

1.0

1.1

3.55

6.41

u/ml

0.80

172

Inflammatory bowel disease

289

2961

0.98

0.15

1.1

6.37

6.16

u/ml

0.07

133

1605

Autism spe

430

0.93

0.15

1.1

4.27

7.71

u/ml

0.74

277

Disorders of speech understanding and production

663

0.94

0.14

1.2

6.06

6.85

u/ml

0.13

456

Secondary right heart disease

112

1.16

0.14

1.0

1.1

0.36

3.86

u/ml

—

Other or unspecified ileus, impaction or obstruction

703

1.05

0.14

1.1

1.00

4.08

u/ml

4.52

345

Brain meningioma, including Hilmo

202

0.89

0.14

1.1

3.31

3.34

u/ml

—

Problems related to lifestyle

941

0.96

0.14

1.1

8.78

6.45

u/ml

0.47

488

HSIL lesion of the cervix uteri

228

2220

1.03

0.14

1.0

1.1

5.85

4.92

u/ml

0.34

108

1158

Phlebitis and thrombophlebitis (not including DVT)

138

1332

1.04

0.14

1.1

3.92

4.84

u/ml

0.30

648

Other dialysis

181

0.88

0.14

1.3

1.1

0.87

7.06

u/ml

—

104

Carcinoma in situ of cervix uteri

102

1063

0.96

0.14

1.1

7.88

5.45

u/ml

0.47

576

Fracture of foot, except ankle

240

2339

1.03

0.14

1.1

5.34

6.18

u/ml

0.37

135

1236

Other assisted single delivery

212

0.89

0.14

1.0

1.1

4.02

5.41

u/ml

0.15

108

Hernia

839

5697

0.99

0.14

1.1

5.20

5.14

u/ml

0.04

450

2903

Other symptoms and signs involving cognitive functions and awareness

240

2129

1.03

0.14

1.1

4.43

4.85

u/ml

0.17

135

1052

Ectopic pregnancy

159

1540

1.03

0.14

1.1

4.42

4.52

u/ml

0.03

752

Diabetic retinopathy, strict definition

695

0.95

0.14

1.0

1.1

7.58

4.32

u/ml

0.69

326

Autism spe, excluding more controls

428

0.93

0.13

1.1

4.27

7.32

u/ml

0.64

276

Bicuspidal aortic valve syndrome

253

0.91

0.13

1.0

1.1

5.31

7.90

u/ml

0.37

147

Tuberculosis, wide

170

1.12

0.13

1.1

1.0

5.47

6.15

u/ml

—

Conductive and sensorineural hearing loss

518

3553

0.98

0.13

1.1

4.24

4.46

u/ml

0.08

240

1730

Fungal Sepsis

151

1.13

0.13

1.1

7.25

5.95

u/ml

0.08

Molar incisor enamel hypoplasia, with caries

281

0.91

0.13

1.2

0.48

7.49

u/ml

9.45

225

Other psoriatic arthropathies

643

0.95

0.13

1.1

4.03

4.58

u/ml

0.08

310

Other osteochondrodysplasias

1.18

0.13

1.1

1.2

3.47

4.34

u/ml

—

Non-invasive ventilation

205

1782

1.03

0.13

1.1

2.83

5.03

u/ml

2.21

109

929

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

405

1.07

0.13

1.2

7.94

6.13

u/ml

0.23

311

Other disorders originating in the perinatal period

287

1.09

0.13

1.2

0.57

5.71

u/ml

7.29

226

Other and unspecified glaucoma

161

1.12

0.13

1.0

6.13

3.19

u/ml

—

Salpingitis and oophoritis

111

1151

0.96

0.12

1.0

1.1

3.78

4.21

u/ml

0.12

514

Maternal care for known or suspected fetal abnormality and damage

227

2000

0.98

0.12

1.1

4.65

5.35

u/ml

0.33

126

1057

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Timothy IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS